PosterSessionOnline

AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISE..

The Liver Meeting 2025

November 7-11, 2025

N. Poster

Poster title

Applicant name

Status


1005-FRI	Liver Sinusoidal Endothelial Cell Intercellular Adhesion Molecule 1 (ICAM1) Promotes Liver Inflammation in Metabolic Dysfunction-Associated Steatohepatitis	Qianqian Guo	Received

1006-FRI	Endothelial Glycogen Synthase Kinase 3β Deletion Attenuates Mitochondrial Dysfunction, Ferroptosis, and Metabolic Dysfunction-Associated Steatohepatitis in Murine MASH.	Akitoshi Sano	Received

1007-FRI	Acetylation of Retinoid X Receptor α (RXRα) Preserves Anti-Ferroptotic Capacity and Mitigates MASH Progression	Mayank Choubey	Received

1008-FRI	Hydroxynonenal induces intracellular organelle changes in hepatocytes similar to those observed in Metabolic Dysfunction Associated Steatotic Liver Disease	Hidenori Kido	Received

1009-FRI	Alcohol Reshapes Liver Zonal Plasticity and Immune-Metabolic Reprogramming in Metabolic-Syndrome Associated Hepatocellular Carcinoma	tian tian	Received

1010-FRI	STARD1-DEPENDENT MITOCHONDRIAL CHOLESTEROL TRAFFICKING ACTIVATES THE NLRP3 INFLAMMASOME COMPLEX IN MASH	Hala Jaara	Received

1011-FRI	HECTD3 ubiquitinates and stabilizes PRDX4 to ameliorate metabolic dysfunction-associated steatohepatitis	Jie Li	Received

1014-FRI	Hepatic methyltransferase like 7B promotes fatty liver disease through mRNA stability control of lipogenesis	Xinshou Ouyang	Received

1016-FRI	Loss of endosomal microautophagy leads to development of hepatic fibrosis	Mridul Sharma	Received

1019-FRI	Macrophage Perilipin 2 Accelerates Liver Inflammation and Fibrosis in MASH	Andrew Hakeem	Received

1020-FRI	Mitochondrial Chaperone DNAJA3 and 3D Genomic Influences: Insights into MASH to HCC Transition	Yuto Shiode	Received

1021-FRI	Genome-wide CRISPR Screening Identifies ACSL3 as a Key Mediator of Lipotoxicity and ER Stress in MASH	Yuta Myojin	Received

1022-FRI	Nuclear Translocation of D-2-hydroxyglutarate dehydrogenase (D2HGDH) Drives Progression of Metabolic Dysfunction-Associated Steatohepatitis (MASH)	Xixuan Wang	Received

1023-FRI	Hepatocyte-derived arginase-2 protects from metabolic dysfunction-associated steatohepatitis	Jeongowoo Park	Received

1025-FRI	Multi-Organ Crosstalk via Exosomal TCA Cycle Enzymes Underlies Metabolic Benefits of Exercise and Daytime Time-Restricted Feeding in Murine MASH Resolution	Ruiqi Li	Received

1027-FRI	Inhibition of Bruton´s tyrosine kinase in macrophage alleviates metabolic dysfunction associated steatotic liver disease by suppressing IL-6/JAK2/STAT3/SOCS3 pathway	Shiwei Chen	Received

1028-FRI	Hepatic Deletion of the Wnt Modulators ZNRF3/RNF43 Reverses Metabolic Dysfunction-Associated Steatohepatitis	Tianliang Sun	Received

1029-FRI	Muscle driven MSTN contributes to MASLD progression via hepatocyte senescence	Jie Li	Received

1032-FRI	Regulatory T (Treg) cell depletion ameliorates HCC progression in MASH by restoring anti-tumor innate and adaptive immune responses	Joanna Picó	Received

1037-FRI	Heterozygous FADS2 deletion exacerbates HFHC diet-induced steatohepatitis via alterations in phospholipid and ceramide metabolism	Kazuyoshi Kon	Received

1039-FRI	Two Pre-clinical Short Interfering RNA Molecules Targeting Human HSD17beta13 for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis	Jieun Song	Received

1041-FRI	Inositol Hexaphosphate and inositol ameliorate metabolic dysfunction-associated steatohepatitis in WD/CCl4 treatment mice	Zhao Chen	Received

1042-FRI	Estrogen Deficiency Enhances AhR-Driven Pathways in Metabolic Liver Disease	Jessica Cassavaugh	Received

1045-FRI	Genetic or pharmacological inhibition of hepatic TMEM141 attenuates MASH and fibrosis via the ROS-HNF4α signaling pathwayNew Submission	Jiayou Wang	Received

1046-FRI	Role of Ly6D in Hepatic Lipid Metabolism and Its Therapeutic Potential in MASLD	Soyeon Shin	Received

1047-FRI	Extracellular vesicles from the iPSC-derived mesenchymal stem cells ameliorated liver fibrosis in MASH-related cirrhotic mice.	Tsuyoshi Fujioka	Received

1048-FRI	Insulin-like growth factor binding protein 7: A promising biomarker for hepatic fibrosis and cardiac dysfunction in metabolic dysfunction-associated steototic liver disease	Wenjing Ni	Received

1052-FRI	Inhibition of OX40 in CD4+ T cells attenuates hepatic inflammation in a human ex vivo model of metabolic dysfunction-associated steatohepatitis	Lucia Valenzuela Perez	Received

1053-FRI	Investigating the role of MTARC1 rs2642438 (A165T) in the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD) using human liver organoids.	Amel Ben Saad	Received

1054-FRI	MASLD and PNPLA3I148M Associate with Skeletal Fragility via Deleterious Liver-Bone Crosstalk	Galen Goldscheitter	Received

1055-FRI	The inner nuclear membrane protein SUN1 regulates cullin-3 neddylation to maintain insulin sensitivity	Kapil Upadhyay	Received

1057-FRI	The dual role of Apolipoprotein C3 in the development of MAFLD	Wei Zhang	Received

1062-FRI	Xiayuxue decoction alleviates MASH by reshaping gut microbiota and regulating arachidonic acid and bile acid metabolism via activating FXR-SHP1/2 pathway and affecting m6A transcriptional modificationon	Yang Cheng	Received

1063-FRI	Metabolic Dysfunction-Associated Steatohepatitis Sensitizes to Acetaminophen Hepatotoxicity	Jose Fernandez-Checa	Received

1064-FRI	Synergistic Effects of ECC4703, a Liver-targeting THRβ Full Agonist, in Combination with ECC0509, a Selective SSAO Inhibitor, or Semaglutide in a MASH Animal Model	Jianfeng Xu	Received

1065-FRI	TOX3 promotes MASH progression by regulating hepatic α-linolenic acid metabolism via the PI3K/Akt signaling pathway	Shaoping She	Received

1066-FRI	Leveraging multi-omic approaches to interrogate dysregulation in MASH liver disease	APOORVA MOHAN	Received

1069-FRI	Environmental exposure to bisphenol A modulates trained immunity-related pathways in Metabolic dysfunction-associated Steatotic Liver disease (MASLD), contributing to disease progression. A preliminary analysis.	Marcello Dallio	Received

1072-FRI	Role of extracellular ATP (ATPe) and associated pathways in inflammation related to Metabolic Dysfunction - Associated Steatotic Liver Disease (MASLD) progression	Vanessa Garcia-Fernandez	Received

1076-FRI	Reduced ZMPSTE24 expression leads to prelamin accumulation and development of steatosis in MASLD patients.	Joseph Schinderle	Received

1077-FRI	Proteomic Profiling of a Steatotic Monkey Liver Organoid Model for MASLD	Bowen Gao	Received

1079-FRI	Inhibition of serotonin signaling through HTR2A mitigates MASLD and liver fibrosis	WON-IL CHOI	Received

1084-FRI	Novel HAF-driven mechanisms contributing to metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma	Po-An Hu	Received

1085-FRI	Increased Severity of Diet-induced MASLD in Male Mice Was Accompanied by Liver Transcriptome Indicating Decreased Signaling Events of Fatty Acid Oxidation and Increased STING1 Signaling Xiaojing Li1, Honggui Li1, Xiaoxiao Wang1, and Chaodong Wu1	Xiaojing Li	Received

1087-FRI	AI in the Histopathology Workflow: Detecting Hepatocellular Ballooning to Support Scoring of Steatotic Liver Disease	Caitlin Langford	Received

1088-FRI	Establishment of a Murine Model of Microvesicular Steatosis Associated with Anorexia Nervosa and Its Pathophysiological Characterization	Yoshiyuki Ueno	Received

1090-FRI	Liver Regeneration and Associated Metabolic Benefits Following Vertical Sleeve Gastrectomy/Partial Hepatectomy in Diet-Induced Obese Mice	Andriy Myronovych	Received

1091-FRI	Hepatocyte Hedgehog Signaling Controls Ferroptosis to Prevent Aging-related Multi-Organ Dysfunction	Ji Hye Jun	Received

1093-FRI	Zonal Dynamics of Fibrosis Progression and Regression in a Murine MASLD-HCC Model Using AI-Based Collagen and Steatosis Analysis	Yuyun Song	Received

1094-FRI	Mesenchymal-derived extracellular vesicles as an emerging tool for the treatment of metabolic-associated fatty liver disease (MASLD).	Vanessa Garcia-Fernandez	Received

1095-FRI	Human-Specific Suppression of Hepatic Fatty Acid Catabolism by RNA-Binding Protein HuR	Shohei Takaoka	Received

1100-FRI	Combined effect of Atorvastatin and Ambrisentan on the hemodynamic alterations and liver fibrosis in a translational rat model of MASLD with advanced fibrosis	Maria de la Serra Cusidó Sabidó	Received

1101-FRI	Effects of Dietary Patterns on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study in Morbidly Obese Rats undergoing Bariatric Surgery	Wei-Yu Kao	Received

1102-FRI	Macrophage receptor LRP1 mediates necroptotic hepatocyte engulfment and suppresses a pro-fibrotic pathway involving hepatocyte TAZ downregulation in metabolic dysfunction-associated steatohepatitis	Hongxue Shi	Received

1103-FRI	Formation and Regulation of a Hepatic Lipogenic Metabolon	Xiaotong Zhu	Received

1105-FRI	Kahweol attenuates western diet-induced hepatic steatosis by suppressing fatty acid synthase.	Byoung Kuk Jang	Received

1107-FRI	Role of Otub2 in Regulating Hepatic Lipid Metabolism During Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Progression	Yeongmin Kim	Received

1108-FRI	Beneficial Effects of Milk-Derived Extracellular Vesicles on Liver Fibrosis Progression by Restoring Intestinal Barrier Integrity	Shinya Sato	Received

1109-FRI	Lobeglitazone Combined with HGF Alleviates FFAs-Induced Intracellular Lipid Accumulation by Modulating Mitochondrial Metabolism in HepG2 Cells	Yun Bin Lee	Received

1113-FRI	Integrated Analysis of WGCNA and Machine Learning Reveals Macropinocytosis-Related Biomarkers in Metabolic-Associated Steatohepatitis	Xin Wang	Received

1114-FRI	Direct Effects of GLP-1/Glucagon Dual Agonist Survodutide on Hepatic Stellate Cells and Liver Cancer Cell Lines	Toru Nakamura	Received

1115-FRI	Effects of the FGF21 Analogue Efruxifermin on Cell Proliferation and Fibrogenic Gene Expression in Hepatic Stellate Cells and Liver Cancer Cell Lines	Toru Nakamura	Received

1116-FRI	Regulation of amino acid catabolism by a human-specific IncRNA in nonalcoholic fatty liver disease	Xiangbo Ruan	Received

1117-FRI	Visceral adipose tissue from morbid obesity patients promotes the proliferation of hepatocellular carcinoma cells	Byoung Kuk Jang	Received

1118-FRI	Preclinical pharmacology and safety of CRMA-1001, a novel epigenetic editor for chronic hepatitis B that demonstrates HBV surface antigen loss in animal models via precise HBV DNA methylation	Sarah Voytek	Received

1119-FRI	Triple-targeting immunomodulator C3 treatment promotes HBV clearance through functional reconstitution of host immunity in HBV-carrier mouse models	Yu Wu	Received

1120-FRI	Treatment of Tenofovir Amibufenamide versus Tenofovir Alafenamide in Patients with Chronic Hepatitis B-related Cirrhosis: Evidence from A Multicenter Real-world Study	Jun Chen	Received

1121-FRI	Phase 3 Trial of Hydronidone for Liver Fibrosis in Chronic Hepatitis B	Xiaobo Cai	Received

1122-FRI	Global, Regional, and Age-Stratified Temporal Trend of Chronic Hepatitis B and Liver Cancer Burden: A Secondary Analysis Based on the Global Burden of Disease Study	Kimberly Ho	Received

1123-FRI	Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of AB-101, a small-molecule PD-L1 inhibitor, in chronic hepatitis B patients	Edward Gane	Received

1124-FRI	Sex Disparities in Viral Hepatitis: Clinical and Epidemiological Evidence from the Italian PITER Cohorts	Loreta Kondili	Received

1126-FRI	Divergent effects of glycemic burden on HBeAg seroclearance and HCC risks in HBeAg-positive CHB: A large multicenter cohort study	Shang-Chin Huang	Received

1129-FRI	Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Entecavir on HCC recurrence and death after curative treatment: A Korean Nationwide Real-World Study	Ji Eun Han	Received

1130-FRI	A novel mRNA-based immunotherapy induces strong HBV-specific CD8+ T cell responses in vitro and in vivo	Yuchun Nie	Received

1131-FRI	A functional cure after Nucleos(t)ide Analogue Discontinuation in Non-Cirrhotic Patients with HBeAg-Negative Chronic Hepatitis B	Zeynep Melekoglu Ellik	Received

1134-FRI	Longitudinal Patterns of Quantitative HBsAg Decline in a Large Real-World Cohort of Treated Chronic Hepatitis B Patients	Leila Amiri	Received

1135-FRI	Proteomic Characteristics and Diagnostic Biomarker Identification in the Progression of HBV-Related Liver Disease	Mengqi Li	Received

1137-FRI	HEC191834, a Highly Selective and Potent hTLR8 Agonist, Exhibits Synergistic Antiviral Activity with siRNA in an AAV-HBV Mouse Model	Pu Wang	Received

1138-FRI	iREAL-B as a simple risk score for the prediction of hepatocellular carcinoma in untreated chronic hepatitis B patients with indeterminate phase: a practice implication	Rui Huang	Received

1139-FRI	Proteomic profiling in prefilled syringe study demonstrates bepirovirsen´s immune stimulatory effect	Jennifer Singh	Received

1140-FRI	MBOAT2-ESCRT Axis Limits the Antiviral Effect of Tenofovir Alafenamide plus Interferon-α in Chronic Hepatitis B	Bei Jiang	Received

1141-FRI	The Profile of Hepatitis D Virus (HDV)-Infected Patients Receiving a Liver Transplant in the United States and Europe over the Past Two Decades	Zobair Younossi	Received

1142-FRI	A novel mRNA-based immunotherapy achieves complete elimination of human hepatitis B virus in chronic HBV mouse models	Gongxin He	Received

1145-FRI	Gaps in Hepatitis B Treatment Among U.S. Veterans: A Retrospective Analysis within the Veterans Health Administration	Phillip Chen	Received

1146-FRI	Mitochondrial respiratory chain Regulates HBV Autophagic Degradation through Dual Modulation of Lysosomal Acidification	Zhiqiang Wei	Received

1147-FRI	Integrated Care Pathways for Hepatitis B: a holistic co-designed service for people living with Hepatitis B in England	Stuart Flanagan	Received

1149-FRI	Serial increases of alpha-fetoprotein levels predict the risk of chronic hepatitis B-related hepatocellular carcinoma	Tung-Hung Su	Received

1150-FRI	Temporal Attenuation of the Parabolic Association Between Baseline HBV DNA and HCC Risk Following Antiviral Therapy in Chronic Hepatitis	Hyeyeon Hong	Received

1151-FRI	Hepatitis B Surface Antigen Level Identifies Inactive Chronic Hepatitis B Patients with HCC Risk Below Surveillance Threshold	Tai-Chung Tseng	Received

1153-FRI	IB-001 is a Partial Agonist of the Type I interferon Pathway That Exhibits Potent Anti-HBV Activity with the Potential for an Improved Safety Profile	Yueh-Ming Loo	Received

1155-FRI	Lead Optimization and Selection of a Potential Best-in-Class HBV ASO	Jin Hong	Received

1156-FRI	Higher risk of postpartum phase transition to immune-active among HBeAg-positive pregnant women with indeterminate phase	Qiao Tang	Received

1158-FRI	Safe but Not Silent: HBV Reactivation in Non-Liver Organ Transplantation	Imran Hasanoglu	Received

1159-FRI	Meeting Hepatitis B elimination goals in the Alaska Native PopulationAuthors: Brian J McMahon, Mary Snowball , Lesleigh Kowalski , Lisa Townshend-Bulson Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium	Brian McMahon	Received

1160-FRI	Imdusiran (AB-729) is safe and well-tolerated after repeat dosing in chronic hepatitis B patients: An integrated safety analysis of Phase 1 and 2 imdusiran clinical trials	Tilly Varughese	Received

1161-FRI	Hepatitis B core-related antigen (HBcrAg) measurements can predict the risk of ALT flare in patients with HBeAg-negative chronic hepatitis B infection in inactive phase.	Tetsuya Hosaka	Received

1162-FRI	Applying AASLD, EASL, and WHO Hepatitis B Treatment Guidelines to a Community-Based Hepatitis B Registry	Zinnia Dong	Received

1166-FRI	Hepatotoxic-like CD38?HLADR?PD1?CD8? T cells define a functionally distinct subset associated with HBsAg reduction and HBV-specific immunity in CHB	Hsiang-Wei Huang	Received

1168-FRI	Serum Hepatitis B Core-Related Antigen Level Stratifies Risk of Immune-Active Transition in Inactive Chronic Hepatitis B Patients	Kuan-Hui Hsin	Received

1169-FRI	Hepatitis B virus cccDNA formation regulated by DOCK11 via PARP1	Hideo Takayama	Received

1170-FRI	Durability and Outcomes of HBsAg loss in Chronic Hepatitis B Patients treated by Nucleos(t)ide Analogue	Minghui Li	Received

1172-FRI	Estimating the economic burden of chronic hepatitis B in France using the French National Health Data System.	Samuel Nilusmas	Received

1173-FRI	The Relationship Between the Durability of Response to Interferon Therapy for Hepatitis B Virus Infection and the Proportion/Function of HLA-DR+CD38+CD8+ T Lymphocytes	Minghui Li	Received

1175-FRI	Elevated HBcrAg Levels Are Associated with Young-Onset Hepatocellular Carcinoma in HBV Infection	YOSHIAKI KOBAYASHI	Received

1176-FRI	Characteristics and healthcare resource utilization for patients experiencing hepatitis B surface antigen loss and living with chronic hepatitis B virus in the United States	Myriam Drysdale	Received

1177-FRI	Construction of a Combined Predictive Model for Liver Fibrosis Staging in Chronic Hepatitis B patients based on Capsid-Antibody-Complexes	Li Zhu	Received

1178-FRI	A Phase 1 Study of the siRNA HRS-5635 in Healthy Subjects and Patients with Chronic Hepatitis B	Zhaoyi Yang	Received

1179-FRI	Hepatic steatosis inhibits hepatitis B virus replication by promoting miR-122-5p-SOX4	Ying Zhu	Received

1180-FRI	Enhanced Prediction of HBV-Related HCC Using aMAP and Liver Stiffness Assessed by Vibration-Controlled Transient Elastography	Seung Up Kim	Received

1181-FRI	Single-Cell Atlas revealed metabolically active T Cells and Monocytes as Drivers of HBsAg Seroconversion in HBV Reactivation Patients	Nirupma Trehanpati	Received

1182-FRI	Effect of tobevibart (VIR-3434) and elebsiran (VIR-2218) monotherapy on hepatitis B surface antigen composition in patients with chronic hepatitis B	Florian van Bömmel	Received

1183-FRI	Safety and Effectiveness of Peginterferon Alfa-2b Combined with Tenofovir Amibufenamide in Patients with Chronic Hepatitis B	Qing-Lei Zeng	Received

1189-FRI	HiBiT-tag enables the tracking of Polymerase activity in HBV life cycle	Wan Yu	Received

1190-FRI	The role of Alix and VPS4A in autophagy and endosomal pathways and their relation to HBV replication	Mengji Lu	Received

1191-FRI	Increased Postoperative Risk in Cirrhotic Women with Chronic Hepatitis B Undergoing Hysteroscopic Surgery	Calvin Pan	Received

1192-FRI	Single-Cell Sequencing Reveals the Mechanism of HBsAg Clearance Mediated by PD-1 Inhibitor Combined with Peg-IFNα	Chenrui Liu	Received

1194-FRI	Predicting HBsAg Seroclearance After 48 Weeks of Pegylated Interferon Therapy in Inactive Carriers: A Machine Learning Approach	Jianxia Dong	Received

1195-FRI	Circular RNA SETD2 (circSETD2) increases DDX3 expression to inhibit autophagy by sponging miR-181a-5p in Hepatitis B virus infection	MD ISMAIL	Received

1196-FRI	Proteomic analysis of serum extracellular vesicles identifies Fibulin-3 as a novel predictor of HCC in CHB patients	Emi Sometani	Received

1199-FRI	Novel Fibrogenic Macrophage Subpopulation Drives HBV-Related Liver Fibrosis and Offers a Target for Antibody Therapy	Masaya Sugiyama	Received

1200-FRI	The Global Burden of Acute and Chronic Hepatitis B in Young and Middle-Aged Adults from 1990 to 2021	Mohammed Youssef	Received

1201-FRI	Immune Dysregulation in Pregnant Women with Chronic Hepatitis B: Impaired MDSC Function and Enhanced T Cell Activation	Xingfei Pan	Received

1203-FRI	Update of 96 weeks tenofovir amibufenamide treatment in chronic HBV-infected patients with normal alanine aminotransferase (the PROMOTE study)	Honglian Gui	Received

1205-FRI	Antiviral therapy fails to resolve immune dysfunction and inflammatory signalling in innate-like CD8? T cells in chronic hepatitis B	Lung Yi Mak	Received

1206-FRI	Utilizing Immunologic and Metabolic Markers in Assessment of Low-level Viremia in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogs	Xiaoyin Wang	Received

1207-FRI	Brelovitug (BJT-778) Binds a Conformational Epitope Highly Conserved Across HBV Genotypes	Craig Pace	Received

1209-FRI	Inhibition of HSPG2 expression impairs HBV entry and replication through the c-MET signaling pathway.	Kazuhiro Murai	Received

1210-FRI	Up to 12 months´ durability of functional cure with bepirovirsen plus Peg-IFN sequential therapy in B-Together responders: B-Sure study	Carla Coffin	Received

1212-FRI	A Viral Load-Based Model to Predict Hepatocellular Carcinoma and Antiviral Treatment Benefit in Chronic Hepatitis B	Won-Mook Choi	Received

1213-FRI	Trends in Donor-Derived HBV Infection in Liver Transplant Patients	Dilara Hatipoglu	Received

1214-FRI	Intrahepatic immunophenotyping of participants with chronic hepatitis B receiving bepirovirsen in the B-Fine study reveals diverse changes in immunological status	Adam Gehring	Received

1215-FRI	Intrahepatic and peripheral immunophenotyping of participants with chronic hepatitis B receiving bepirovirsen in the B-Fine study strongly suggests that bepirovirsen may trigger a humoral response	Andre Boonstra	Received

1216-FRI	A Study on the Long-term Clinical Outcomes of HBsAg Disappearance in CHB Patients Treated with Interferon	Wen Deng	Received

1217-FRI	Effect of Switching from Prior Nucleos(t)ide Analogue(s) to Tenofovir Alafenamide on Lipid Profile and Cardiovascular Risk in Patients with Chronic Hepatitis B	Witchayaporn Praguylertluck	Received

1218-FRI	Assessment of HCC Risk Stratification and the Role of preS1/2 Deletions During Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B	KOTARO DOI	Received

1219-FRI	Characterization of the function and phenotype of NK cells in patients with chronic hepatitis B who achieved functional cure	Yuki Nakaya	Received

1220-FRI	Long-term HCC risk after NA withdrawal in patients with chronic hepatitis B - results of a global cohort study (RETRACT-B)	Edo Dongelmans	Received

1221-FRI	New SubmissionA long-acting aqueous nanosuspension of Vonafexor prodrug attenuates liver fibrosis development in CCL4 mouse fibrosis model	Natalia Osna	Received

1222-FRI	Low risk of fibrosis progression during the immune tolerant phase in chronic hepatitis B patients	Lisa van Velsen	Received

1223-FRI	Inverted U-shaped Association Between Hepatitis B Core-Related Antigen and Hepatocellular Carcinoma Incidence in Patients with Chronic Hepatitis B	Ji Eun Han	Received

1224-FRI	Persistent Disparities and Diverging Trends: State-Level and Regional Hepatitis B Burden in the United States, 1990-2021	Thanathip Suenghataiphorn	Received

1226-FRI	UNDERSTANDING QUALITY-OF-LIFE IMPACTS OF HEPATITIS DELTA VIRUS	Chari Cohen	Received

1227-FRI	Impact of HDV coinfection on liver outcomes and mortality in chronic HBV: insights from the ANRS CO22 HEPATHER Cohort	Lucia Parlati	Received

1228-FRI	Safety and Pharmacokinetics of BJT-628, an Orally Available Liver-Targeted HBV Transcript Inhibitor for the Treatment of Chronic Hepatitis B in Healthy Volunteers	Edward Gane	Received

1229-FRI	Alcohol Suppresses Type I IFN Responses in HBV Infection via RIG-I and STING Pathway Inhibition	Anup Pathania	Received

1230-FRI	Efficacy of peginterferon α-2b treatment in HBV-infected children aged <=5 years: Subgroup analysis from a large-scale, prospective study (Sprout Project)	Hongfei Zhang	Received

1232-FRI	Pharmacological activation of LUBAC synergizes with IFNα to inhibit HBV replication via IRF9 M1-linked ubiquitination	peng chen	Received

1234-FRI	Metabolic comorbidities and the risk of liver-related events in individuals with hepatitis B virus infection	Laura Telep	Received

1236-FRI	Kinetic characterization of HBV acute infection and HEPLISAV-B treatment in rAAV-HBV mouse model	Harel Dahari	Received

1239-FRI	Mathematical modeling qualitatively recapitulates HBV DNA and HBV RNA response under nucleos(t)ide analogue or nucleic acid polymers monotherapy	Harel Dahari	Received

1241-FRI	Effect of Finite Duration Peginterferon Alpha-2b With or Without Nucleos(t)ide Analogues on Long-term Prognosis in Chronic Hepatitis B: Preliminary 24-week Results From the Multicenter Real-world ´Vision´ Study in China	hongxia liang	Received

1242-FRI	Mathematical modeling suggests that 2 mg/day bulevirtide monotherapy efficacy is suboptimal in most HDV-infected patients with compensated cirrhosis and CSPH	Harel Dahari	Received

1243-FRI	Efficient HBV DNA infection launch in hepatocyte chimeric mice identifies anti-HBs neutralizing antibody resistant variants	Ype de Jong	Received

1245-FRI	Sustained functional cure in chronic hepatitis B patients treated with peginterferon alpha-2b combined with TDF: Update results of 104 weeks extended follow-up after a phase 3 trial	Guiqiang Wang	Received

1247-FRI	Hepatitis D Seropositivity is Associated with Higher Premature Mortality Among Hepatitis B Surface Antigen Carriers in the United States: Data from National Health and Nutrition Examination Survey (NHANES) 2011-2018	Zobair Younossi	Received

1249-FRI	Influencing factors of bone mineral density decline in chronic hepatitis B patients treated with tenofovir amibufenamide over 5 years	Zhihong Liu	Received

1250-FRI	Changes of Albumin Function in HBV-Related Liver Diseases	Mengqi Li	Received

1251-FRI	Capsid Assembly Modulator ALG-001075 Prevents cccDNA Formation and HBV DNA Integration In Vitro	Jordi Verheyen	Received

1252-FRI	Significance of HBV RNA in patients with hepatitis B hepatocellular carcinoma	Ning Lin	Received

1253-FRI	Hepatitis B Vaccination awareness and immunity in the United States: Gaps Between Perception and Protection	Giovanni Roldan	Received

1254-FRI	Real-world treatment rates with nucleos(t)ide analogs (NA) in patients with hepatocellular carcinoma (HCC) and hepatitis B virus (HBV) infection: a population-based U.S. study	Taotao Yan	Received

1258-FRI	Comparative Long-Term Off-Treatment Outcomes in HBeAg-Negative Chronic hepatitis B: Prophylactic Therapy in Cancer Patients vs. Finite Therapy in Non-Cancer Patients	Hsin-Che Lin	Received

1259-FRI	Machine Learning Model Integrating Biomarkers for Predicting HBsAg Seroclearance in pegylated interferon-α (PEG IFN-α)-Treated CHB Patients	Jie Li	Received

1260-FRI	Characteristics and Healthcare Resource Use of Patients Receiving Care for Chronic Hepatitis B Virus Infection in the US: A Cross-sectional Survey	Anna Coutinho	Received

1261-FRI	Association of HBV viral markers and HCC risk in HBV-related cirrhosis patients under long-term entecavir therapy	Tung-Hung Su	Received

1262-FRI	Epigenetic editors targeting chronic Hepatitis B achieve HBV surface antigen loss with a single course of treatment in multiple HBV mouse models	Glen Acosta	Received

1263-FRI	Efficacy and Safety of Switching Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients with Multidrug Resistance	Jaehong Jeong	Received

1264-FRI	Functional Analysis of Fumarylacetoacetate Hydrolase in Mediating Anti-HBV and Anti-tumor Effects	Shouichi Namikawa	Received

1265-FRI	Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir alafenamide versus entecavir	Lilian Yan Liang	Received

1266-FRI	Single-arm Meta-analysis and Systematic Review on Clinical Cure of Chronic Hepatitis B after Hematopoietic Stem Cell Transplantation: Immunoregulatory Mechanisms and Clinical Translational Insights	He Ma	Received

1267-FRI	Comparative Renal Safety of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A Korean Nationwide Study	JIHYE LIM	Received

1268-FRI	Quantification and Evaluation of intrahepatic HBV DNA and cccDNA in HBV associated hepatocellular carcinoma	Jin Li	Received

1269-FRI	An EGCG-loaded ferritin nanodrug inducing HBsAg clearance for HBV therapy	Yixin Dong	Received

1270-FRI	Optimizing HBV Combination Therapy: Dual Targeting of Intracellular Replication and Extracellular Virions with Entecavir and HBVZ10	Yong-Yuan Zhang	Received

1271-FRI	Investigating HBsAg-specific memory T cell responses in vaccine-induced long-term immune protection against HBV	Margaux BOSSIS	Received

1272-FRI	Study on the Role of NK Cells in Intermittent Interferon Therapy	Minghui Li	Received

1273-FRI	Hepatocellular Carcinoma Risk in Hispanics with Chronic Hepatitis B: A National Multi-center Study	Ariel Lee	Received

1274-FRI	Induction of strong anti-HBV immune responses in immunosuppressed mice by nasal administration of HBs/HBc containing antigen	Toyoki Shimamoto	Received

1275-FRI	Identification of serum miRNAs characteristic of cases of chronic hepatitis B that achieve functional cure	Yoshiki Murakami	Received

1276-FRI	Baseline Rates of Perinatal Hepatitis B Screening and Vaccination in Philadelphia Obstetric Clinics Prior to the Universal Triple Screening Era	M. Elle Saine	Received

1277-FRI	Risk factors and consequences of pre- and on-treatment alanine aminotransferase (ALT) flares in patients with chronic hepatitis B virus (cHBV) infection: a United States (US) cohort study	Myriam Drysdale	Received

1278-FRI	Exposure to tenofovir alafenamide and tenofovir disoproxil fumarate and the risk of hepatocellular carcinoma	W. Ray Kim	Received

1279-FRI	Sex and Age-Based Clinical Heterogeneity in High HBV DNA Patients	Guifeng Li	Received

1280-FRI	Hepatitis B Virus Reactivation in Patients with Hematologic Malignancies Receiving Chimeric Antigen Receptor T-Cell Therapy	Filippos Koutroumpakis	Received

1281-FRI	Metabolic effects and cardiovascular disease risks of TDF or TAF in patients with chronic hepatitis B:a systematic review and meta-analysis	Yuan-hai Zhou	Received

1282-FRI	Ubiquitination of NTCP at residue K340 is a critical determinant for NTCP endocytosis and Hepatitis B Virus (HBV) infectio	Stan van de Graaf	Received

1283-FRI	HBV induces liver fibrosis through the ROS and pyruvate-PPARα-dependent pathway	Wenyu Lin	Received

1284-FRI	Peginterferon alpha-2b retreatment promotes HBsAg loss in chronic hepatitis B patients with low HBsAg levels: Update results of 60-week follow-up after a phase 3 trial	Guiqiang Wang	Received

1285-FRI	Assessment of the Use and Implementation of qHBsAg in Clinical Microbiology Laboratories in Spain: Results from a National Survey.	Federico Garcia	Received

1287-FRI	Towards the elimination of mother-to-child transmission of hepatitis B virus in Hong Kong: insights from a post-vaccination serologic testing program	Vivien Tsui	Received

1289-FRI	Bridging the Gap Between ACIP Guidelines and Practice: Improving Hepatitis B Vaccination Rates in Internal Medicine Resident Clinics	Mohammad Adam	Received

1290-FRI	Economic Burden of Non-Cirrhotic Patients with Chronic Hepatitis B Virus Infection in the United States	Anna Coutinho	Received

1291-FRI	Isogenic studies of basal core promoter and precore mutant variants across Hepatitis B Virus genotypes	Leon Seifert	Received

1292-FRI	Adherence Patterns to Antiviral Therapy in Older Adults with Hepatitis B: Insights from Group-Based Trajectory Modeling	Javeria Khalid	Received

1293-FRI	HBsAg Screening and Risk Factors in a Nationwide Private Laboratory Program	Liliana-Simona Gheorghe	Received

1295-FRI	Expansion of dysfunctional memory B cells is associated with hepatitis flares and disease activity in chronic hepatitis B	Thi Kim Duyen Nguyen	Received

1297-FRI	Atezolizumab/Bevacizumab (A-B) is a widely used immunotherapy for advanced hepatocellular carcinoma (HCC), with its efficacy further enhanced when combined with radiot	Kwon Yong Tak	Received

1299-FRI	The clinical efficacy of tenofovir alafenamide re-treatment in chronic hepatitis B patients with clinical relapse after discontinuation of oral antiviral therapy	Tung-Hung Su	Received

1300-FRI	Reducing Read Time of Point-of-Care Test Does Not Affect Detection of Hepatitis B and Correlates with HBsAg levels	Judit Romero	Received

1301-FRI	Earlier and More Severe Relapse After Nucleos(t)ide analogue Discontinuation in HBeAg-Positive Chronic Hepatitis B Patients	Yen-Chun Liu	Received

1302-FRI	Identification of FDA-approved compounds that suppress HBs antigen through library screening.	Kazuhiro Murai	Received

1304-FRI	Long-Read Transcriptomic Landscape of Liver Biopsies from Patients Functionally Cured of CHB	Bei Jiang	Received

1305-FRI	Novel, High-sensitive Immunoassays for Phosphorylated and Non-phosphorylated HBcAg Detection	Rene Geissler	Received

1306-FRI	Dynamics of gene expression in the humanized liver infected with precore and basal core promoter mutated HBV.	Takuro Uchida	Received

1307-FRI	Long-term effects of peginterferon-based therapy versus nucleos(t)ide analogue monotherapy in non-cirrhotic HBeAg-positive chronic hepatitis B patients	Qiankun Hu	Received

1308-FRI	Retrospective analysis of B-Clear study HBsAg levels with the ultrasensitive Lumipulse HBsAg iTACT assay and association with response and relapse	Scott Speer	Received

1309-FRI	The rate of occult hepatitis B virus infection in high endemic areas - Value in evaluating liver fibrosis and the role of HBcrAg	Thuy Pham	Received

1314-FRI	Identification of host factors involved in inducing functional cure	Takashi Honda	Received

1315-FRI	Efficacy Comparison of Nucleos(t)ide Analogues Monotherapy versus Combination Therapy with Peg-IFNα at 48 Weeks in Patients with Chronic Hepatitis B and Low-Level Viremia: A Prospective Study	Shiyu Wang	Received

1316-FRI	Study on the effectiveness and safety of TAF in the treatment of elderly CHB patients in China	Jie Tan	Received

1319-FRI	Policy Matters: A Success Story in Hepatitis B Treatment Access Following Reimbursement Policy Change	Imran Hasanoglu	Received

1320-FRI	RELINK: Getting Hepatitis B and C Patients Back into Care in Maryland and VirginiaA community-rooted outreach strategy built on cultural trust, real relationships, and lessons learned the hard way	Sandra Marrero-Ashford	Received

1321-FRI	End-of-therapy HBsAg, HBcrAg, and HBV RNA Predict 8-year Outcomes After Nucleos(t)ide Analogue Cessation in Chronic Hepatitis B	Tung-Hung Su	Received

1322-FRI	Analysis of Immune Responses in HIV/HBV Co-infected Patients Experience HBsAg Loss After TDF/TAF-Based Antiviral Therapy in the ALLIANCE clinical study	Nikita Kolhatkar	Received

1323-FRI	Dose-Dependent but Attenuated Risk of Intrahepatic Cholestasis of Pregnancy with Increasing HBV DNA Load in Mothers with Chronic Hepatitis B	Calvin Pan	Received

1324-FRI	Clinical trials for curing chronic hepatitis B: A comprehensive analysis of design principles and their impact on trial performance	Yuanyuan Kong	Received

1326-FRI	Enhancing Chronic Hepatitis B Care Through Hospital-Based Management Interventions: The ´Hot Wave Project´ Experience	Liang Peng	Received

1327-FRI	Effectiveness and safety of tenofovir alafenamide for chronic hepatitis B patients with decompensated cirrhosis: a real-world study in China.	Wang Xiaozhong	Received

1328-FRI	Entry Inhibition Combined with IFN Immunotherapy Achieved Undetectable Intrahepatic HBV cccDNA: Results from a Phase II Randomized Double-blind Clinical Trial	Hanzhi Fang	Received

1329-FRI	HERACLIS_BLV_D: Persistency and adherence to real-life therapy with bulevirtide (BLV) in chronic hepatitis D (CHD)	George Papatheodoridis	Received

1330-FRI	CAM-E and CAM-A Compounds Differentially Affect Phosphorylated and Non-Phosphorylated Hepatitis B Core Protein In Vitro	Rene Geissler	Received

1331-FRI	Combined mutations of hepatitis B virus basal core promoter and precore region correlate with immune-mediated viral control and liver damage	Zhao Zhou	Received

1332-FRI	Apolipoprotein C3 Elevation in Isolated MAFLD versus HBV Co-Infection: Distinct Metabolic Phenotypes and Clinical Implications	Kong Xiangsha	Received

1334-FRI	Survey on the awareness and clinical application of the ´ Guidelines for the Prevention and Treatment of Chronic Hepatitis B (Chinese version 2022)´ among Chinese clinicians	Yuanyuan Kong	Received

1337-FRI	Cross-sectional association between awareness of hepatitis B infection status and health-related behaviors: NHANES 2013 to 2020	Samandika Saparamadu	Received

1338-FRI	Capsid Assembly Modulator ALG-001075 Binds and Directly Targets HBeAg	Jordi Verheyen	Received

1339-FRI	Assessing the Frequency of Hepatitis Delta Virus Screening in Patients With Chronic Hepatitis B Results From an Interactive Decision Support Tool App in Alignment With AASLD Guidance	Carley Yawn	Received

1340-FRI	Different Impact of HBV Genotype on HBsAg Decline Kinetics During and After Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B	Rachel Wen-Juei Jeng	Received

1341-FRI	Integrated Plasma Proteomics and Metabolomics Identify Fibrosis-Linked Signatures in HBeAg-Negative Naive CHB Patients with Low HBsAg	Ravinder Singh	Received

1344-FRI	Longitudinal Changes in FIB-4 Index and Risk Factors for Fibrosis Progression in Untreated Hepatitis B Virus Carriers: A Multicenter Study	KENGO WATANABE	Received

1345-FRI	Positivity of High-sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non-HBV-related HCC.	Naohiro Yasuura	Received

1346-FRI	Identification of HBV cure patients by HBV RNA and HBV genome coverage map in plasma	Daryl Lau	Received

1348-FRI	COVID-19 Pandemic Intensified Age and Sex Disparities in Diagnostic and Hepatic Event Incidences in individuals with Chronic Hepatitis B	Grace Lai-Hung Wong	Received

1349-FRI	A Markov model cost threshold analysis of potential hepatitis B virus cure regimens in the U.S.	Grace Lai-Hung Wong	Received

1350-FRI	Association of HBsAb level changes with hepatic outcomes in non-cirrhotic CHB patients following HBsAg loss	Wen Deng	Received

1351-FRI	New Submission: A long-acting lipophilic TFV phosphonate prodrug sustains suppression of HBV replication.	Natalia Osna	Received

1352-FRI	Single-Cell Dissection of the Immune Landscape in HBV-Associated Hepatocellular Carcinoma Reveals Viral-Driven Immune Dysfunction	PeiChing Chang	Received

1354-FRI	Impact of hepatitis B surface antibody (anti-HBs) level at hepatitis B surface antigen (HBsAg) seroclearance on long-term risk of HBsAg seroreversion	Terry Cheuk-Fung Yip	Received

1356-FRI	Changes in CX3CR1 expression in dendritic cells during interferon intermittent therapy in CHB patients	Minghui Li	Received

1357-FRI	Hepatitis B Virus Reactivation in Inflammatory Bowel Disease Patients on Biologics: A Systematic Review of Risk and Prevention	Lan Nguyen	Received

1359-FRI	Optimization of the preparing protocol improves human hepatocyte engraftment in humanized mice that support high infection of HBV	Ming Yin	Received

1360-FRI	Uncovering the Overuse: A Hospital-Wide Analysis of Unnecessary HBsAg Retesting	Imran Hasanoglu	Received

1362-FRI	The Bidirectional Regulation between USP20 and HBsAg and Its Potential Impact on Hepatitis B Virus Immune Evasion	Chuanwu Zhu	Received

1363-FRI	Characterization of various genotype HBV carrier mouse models generated by AAV vector delivery	Ming Yin	Received

1365-FRI	Perioperative Risks and Predictors of Complications in HBV-Related Cirrhosis Patients Undergoing Gynecologic Laparoscopy	Calvin Pan	Received

1366-FRI	HBsAg decreases in a biphasic manner after liver transplantation and HBIG mainly enhances the first phase decline	Harel Dahari	Received

1367-FRI	Efficacy of NAs Combined With PegIFNa-2b in Chronic Hepatitis B Patients With / Without Metabolic-related Fatty Liver Disease: A Multicenter, Prospective Real-world Study	Wang Xiaozhong	Received

1368-FRI	Linking Persons With a History of Experiencing Homelessness to Hepatitis C Virus (HCV) Treatment by Establishing Data Exchange Between a Public Health HCV Registry and a Homeless Services Agency - Los Angeles County, January-May, 2025	Prabhu Gounder	Received

1369-FRI	Global treatment rates and impact of direct-acting antivirals (DAA) on survival and cancer recurrence in patients with hepatitis C virus-related hepatocellular carcinoma (HCV-HCC): a systemic review and meta-analysis of 81 studies and 22,474 patients	Taotao Yan	Received

1370-FRI	National population-based hepatitis C screening and elimination programme in Lithuania: what results have we achieved?	Limas Kupcinskas	Received

1371-FRI	The impact of viral clearance by direct-acting antiviral on prognosis and liver-related events in hepatitis C virus-related decompensated cirrhosis	Yuki Tahata	Received

1372-FRI	Molecular Convergence of Post-SVR Hepatocellular Carcinoma with MASLD/MASH- and ALD-Associated HCC	Fukiko Kawai-Kitahata	Received

1373-FRI	Sofosbuvir-Based Regimen Achieved High Virological Response in Non-Genotyped HCV Patients from a Genotype 3 High-Prevalence Region of SouthWest China: A Retrospective Cohort Study (SAIN-C)	Liu Li	Received

1374-FRI	Outcomes of direct acting antiviral agents in chronic hepatitis C patients with pre-existing hepatocellular carcinoma.	Hyun Young Woo	Received

1375-FRI	Occult hepatitis C virus infection accelerates non-hepatocellular cancer development by augmenting regulatory B cells: A 15-year prospective cohort study	Ming-Ling Chang	Received

1376-FRI	Prediction of liver-related events after sustained virological response in patients with decompensated HCV cirrhosis	Lisa van Velsen	Received

1377-FRI	Incidence and risk factors for hepatocellular carcinoma after sustained virologic response change over time in patients with hepatitis C virus treated with direct-acting antiviral	Yuki Tahata	Received

1378-FRI	Safety and efficacy of 8-weeks Glecaprevir/Pibrentasvir in persons with acute hepatitis C in Germany and Austria	Johannes Hülsenbeck	Received

1379-FRI	Gender and socioeconomic-based disparities in hepatitis C treatment and cure rates in an emergency department-based screening and treatment program	Daniel Moore	Received

1380-FRI	Cumulative Review of Sofosbuvir/Velpatasvir Exposure in Pregnant Women with Hepatitis C Virus from a Pharmacovigilance Safety Database	Catherine Chappell	Received

1382-FRI	Hepatitis C Care Cascade Using Direct Acting Antiviral Medications in Rural New York State from 2013-2023; A Retrospective Study	Zoi Papalamprakopoulou	Received

1383-FRI	Decentralization in Action: Türkiye´s Policy-Driven Expansion of Hepatitis C Treatment to Secondary Care	Imran Hasanoglu	Received

1385-FRI	From Discovery to Cure - Where Are We Now? Mortality Trends in Chronic Hepatitis C: An Analysis of the CDC WONDER Database (1999-2024)	Ashraf Ullah	Received

1386-FRI	Re-Linking Hepatitis C Patients to Care: A Quality Assurance Initiative from the Calgary Liver Unit	Ofodile Joe-Uzuegbu	Received

1387-FRI	PREVALENCE OF ANTI-HCV ANTIBODIES IN AT-RISK PATIENTS IN HOSPITAL SETTINGS IN COLOMBIA: A MULTICENTER STUDY.	Javier Hernandez-Blanco	Received

1388-FRI	ProLINK-C: Leveraging Laboratory Information Systems to Recapture HCV Patients Lost to Follow-Up - A Multicenter Study from Southern Spain	Federico Garcia	Received

1389-FRI	Hepatitis C Virus Testing and Follow-up for Perinatally Exposed Infants in North Carolina: Findings from the University of North Carolina Relink Program	Cory Spencer	Received

1390-FRI	Prevalence and risk of HCV infection among psychiatric patients in Poland	Krzysztof Tomasiewicz	Received

1391-FRI	Serum growth differentiation factor 15 predicts the prognosis of patients with hepatitis C virus-related cirrhosis after virus elimination.	Yuta Myojin	Received

1393-FRI	Effective Re-engagement of Hepatitis C Patients: A Multicenter Study Based on Laboratory Records in Argentina	Fernando Cairo	Received

1394-FRI	Long-term benefits following hepatitis C virus treatment through facilitated telemedicine; experiences of people who use drugs five years after achieving a sustained virological response	Zoi Papalamprakopoulou	Received

1395-FRI	Provider education and trends in antepartum hepatitis C virus screening from 2021 - 2025 at an academic medical center in Chicago	Michelle Martin	Received

1396-FRI	Tracing children with silent Hepatitis C in the UK	Clare Rayner	Received

1398-FRI	Bemnifosbuvir and ruzasvir provided as a fixed-dose-combination demonstrates high relative bioavailability to their individual formulations and can be dosed with no regard to food	Xiao-Jian Zhou	Received

1399-FRI	Micro-elimination of hepatitis C (HCV) in a large and risky population of diabetic patients by collaborative care system.	Yung-Hsiang Lin	Received

1402-FRI	Hepatitis C in Pregnancy: Evaluating Screening and Management Practices in a Rural Population	Aleena Moin	Received

1404-FRI	High SVR Rates Achieved with Simplified Monitoring in Japanese Patients with HCV Infection Treated with Sofosbuvir/Velpatasvir: A Prospective multicenter Study	Goki Suda	Received

1406-FRI	´Reaching In, Reaching Out´: Tracing children of Hepatitis C positive women prisoners	Rachel Cockayne	Received

1407-FRI	A novel score for predicting return to drinking after alcoholic hepatitis	Richard Sterling	Received

1408-FRI	HCV Medication Turnaround Time Using Specialty Mail Oder Pharmacy vs. Local Pharmacy	Paulina Deming	Received

1409-FRI	Vertical Transmission of Hepatitis C Virus Runs in Families: Having a Child Infected Increases the Risk of Future Vertical Transmission	Andrew Mendlowitz	Received

1410-FRI	Long-Term Restoration of HCV-Specific CD4+ T Cell Immunity Following DAA-Mediated Clearance of Chronic HCV Infection	Tetiana Pozniak	Received

1412-FRI	Milestone-Based Incentives Improve Hepatitis C Treatment Completion in an Underserved Population: A Pilot Study	Aaron Skiles	Received

1414-FRI	Modeling suggests that undetectable HCV RNA at weeks 1 or 2 of DAA therapy could identify adults with recent HCV for shorter treatment duration	Harel Dahari	Received

1415-FRI	The Use of Direct-Acting Antivirals to Enhance Access to Cancer Clinical Trials for Patients with Chronic Hepatitis C Virus Infection and Cancer	Harrys Torres	Received

1416-FRI	Re-engagement to rescue therapy with sofosbuvir/velpatasvir/voxilaprevir in hepatitis C after direct-acting antiviral failure	Seung Up Kim	Received

1417-FRI	Effect of direct acting antiviral treatment on hepatic steatosis in patients with chronic hepatitis C	WonKyung Cho	Received

1418-FRI	Sofosbuvir based regimens are effective for hepatitis C treatment in patients with end-stage renal disease in real-life setting	Radha Dhiman	Received

1420-FRI	Real-World Outcomes of Sofosbuvir/Velpatasvir in a variety of hepatitis C patient populations: A Retrospective Cohort Study	Hyun Young Woo	Received

1421-FRI	Women of Childbearing Age with Untreated or Incompletely Diagnosed Hepatitis C Virus: Interim Results of a Prospective Cohort and Linkage-to-Care Program	Mai Sedki	Received

1422-FRI	Metabolic Implications of HDL-C/ApoA1 Ratio in HCV-Infected Patients: A Comparative Analysis of Diabetic and Non-Diabetic Patients Following Sustained Virological Response	Victoria Arama	Received

1423-FRI	Prediction Risk Score for Development of Hepatocellular Carcinoma in Compensated Advanced Chronic Hepatitis C after Sustained Virological Response	Sirajuk Khongviwatsathien	Received

1427-FRI	HCV DAA prescribing patterns among specialists and non-specialists in Ontario, Canada, from 2017-2024	Mia Biondi	Received

1429-FRI	Clinical characteristics and risk factors of HCV GT3 patients in Qinghai Province	Guoying Yu	Received

1431-FRI	Prevalence and Trends of Hepatitis C Virus Infection Among Pregnant Women in Xi´an, China: An 11-Year Retrospective Study	gengwen liu	Received

1432-FRI	HCV Reinfection after DAA Therapy Among HIV/HCV-coinfected individuals in the Country of Georgia: A National Cohort Study, 2015-2024	Otar Chokoshvili	Received

1433-FRI	Development of Nested-RPA based diagnostic platform for the identification of HCV RNA using CRISPR/Cas13a system	Senthil Venugopal	Received

1434-FRI	Hepatitis C Virus (HCV) RNA Point-of-Care Testing in a Tribal Health Setting: Implementation, Challenges, and Lessons Learned	Jorge Mera	Received

1436-FRI	Relink HCV patients with limited health care resource to care	Tsung-Hui Hu	Received

1437-FRI	Evaluating Hepatitis C Treatment Attachment Rate Following Implementation of an Emergency Department-based Pharmacist-led Treatment Program	Benjamin Coy	Received

1438-FRI	Clinical Outcome of HCV infection in children: an analysis based on six cases of HCV infected children	Guoying Yu	Received

1441-FRI	FIB-4 Predicts Long-Term Outcomes After SVR in HCV Patients With Cirrhosis: Gone but Not to Be Forgotten	Anas Aljabi	Received

1442-FRI	Hepatitis C in Prisons: Maintaining Vigilance is Essential	Francisco Jorquera	Received

1443-FRI	Hepatic Stiffness, Neurovascular Coupling, and Working Memory: An MRE-Driven Exploration of Liver-Brain Crosstalk	Zhuoru Jiang	Received

1446-FRI	A Tcf21-mimetic small molecule serves as a novel drug candidate for steatohepatitis and fibrosis by altering the functional features and cellular crosstalk of hepatic stellate cell	Takayo Yanagawa	Received

1449-FRI	An Association of Covert Hepatic Encephalopathy with Non-elderly and MASLD in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Data-mining Analyses	Dan Nakano	Received

1450-FRI	Impact of Age-Adjusted Skeletal Muscle Index and Modest Alcohol Use on Liver Steatosis and Fibrosis in male MASLD	Jung Hee Kim	Received

1452-FRI	The Relevance of Data-Driven MASLD Clusters and Their Relationship with MASH and Advanced fibrosis in Patients with Type 2 Diabetes from the Quid-NASH Cohort	Laurent Castera	Received

1453-FRI	Rationale and Design of the FIBROLITE Study Evaluating Safety, Pharmacokinetics, and Pharmacodynamics of Afimkibart in Patients with Advanced Liver Fibrosis	Mazen Noureddin	Received

1454-FRI	MetALD exhibits an intermediate hepatic lipidomic profile: overall similar to MASLD with ALD-linked ceramide features	Kazuyoshi Kon	Received

1455-FRI	GM60106: A novel clinical treatment for Metabolic Dysfunction-Associated Steatohepatitis (MASH)	Hail Kim	Received

1458-FRI	Prediction of Steatotic Liver Disease: Machine Learning-Based Study in Taiwan	Chia-Yen Dai	Received

1461-FRI	Effect of Moderate and Severe Hepatic Impairment on Pharmacokinetics, Safety and Tolerability of Pegozafermin After Subcutaneous Administration	Eric Lawitz	Received

1462-FRI	Steatotic liver disease is an unfavorable prognostic factor of the recurrence following resection in early-stage oral squamous cell carcinoma	Hidetoshi Nomura	Received

1463-FRI	BEYOND THE AIRWAY: THE POSSIBLE HEPATIC COST OF CPAP IN OBSTRUCTIVE SLEEP APNEA	Muhammad Ali Ibrahim Kazi	Received

1466-FRI	Unique Sex-Specific Associations of Metabolic and Hormonal Factors with Metabolic Dysfunction-Associated Steatohepatitis (MASH)	Norah Terrault	Received

1467-FRI	Impact of Fasting Glucose Control on Clinical Outcomes in Hospitalized Patients with Metabolic Dysfunction and Alcohol-Related Liver Disease (MetALD) and Diabetes Mellitus	Nariman Hossein-Javaheri	Received

1468-FRI	Risk of Pyogenic Liver Abscess and its Clinical Complications in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Cohort Study	Na Ryung Choi	Received

1469-FRI	Patients with diabetes at high risk of undiagnosed advanced liver fibrosis are at increased risk of postoperative mortality after elective surgery	Christen En Ya Ong	Received

1470-FRI	Transcriptomic Regulation of E2F1 in MASLD Progression in African Americans	Tanmoy Mondal	Received

1471-FRI	Clinical, histological and bile acids profile features of lean metabolic-associated fatty liver disease	Jie Liu	Received

1472-FRI	The FADS2 rs174583 risk allele alters the hepatic phospholipid profile and contributes to fibrosis progression in MASLD	Shunsuke Ikejima	Received

1473-FRI	WHERE IS THE MASLD?: THE DIFFICULTY OF IDENTIFYING PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE WITHIN A GLOBAL DATABASE	Taylor Seacor	Received

1474-FRI	Exploring Optimal Glycemic Control in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Diabetes: A Retrospective Propensity-Matched Cohort Analysis	Saad Ahmed	Received

1475-FRI	Higher Hemoglobin Targets Linked to Reduced Decompensation in Patients with Cirrhosis and Coronary Artery Disease	Saad Ahmed	Received

1476-FRI	DOACs and Antiplatelets in MASLD: Are We Targeting Fibrosis by Accident?	Syeda Najwa Hussain	Received

1477-FRI	Fatty Liver Index as a Long-Term Predictor of Metabolic Dysfunction: A 10-Year Follow-Up in a Japanese Population	Yoshitaka Arase	Received

1478-FRI	Machine learning-based survival analysis and risk stratification for hepatocellular carcinoma patients with concurrent MASLD undergoing surgical resection	Henry Sheng	Received

1479-FRI	Lipid-related insulin resistance indices for the diagnosis of non-alcoholic fatty liver disease in Chinese adults	Weihua Cao	Received

1480-FRI	A head-to-head comparison of MASLD with MAFLD diagnostic criteria in longitudinally estimating the risk of acute cardiovascular events in steatotic liver disease patients: a real-life preliminary observation.	Mario Romeo	Received

1481-FRI	Hotspot mutations in TGF-β/SMAD3/4 and SPTBN1 reveal new roles in Alcohol and Obesity induced HCC	Puja Ghosh	Received

1482-FRI	Understanding ICU Stays in Alcohol-associated Liver Disease: Bridging Disease-specific Modeling and Clinical Knowledge	Sue Hyon Kim	Received

1484-FRI	Phosphatidylethanol Testing: Real-World Patterns, Demographic and Clinical Correlates	Pranay Nadella	Received

1486-FRI	Natural History of Histologic Alcohol-Associated Hepatitis: A Multi-Center Analysis of 128 Explants from Early Liver Transplantation	Brian Lee	Received

1487-FRI	Increasing Rates of Pharmacotherapy Prescriptions for Alcohol Use Disorder After Liver Transplantation: An Analysis of Epic Cosmos Data	Hersh Shroff	Received

1488-FRI	Sex-Specific Risk Thresholds of Binge Drinking Frequency for Advanced Fibrosis in the United States	Winston Dunn	Received

1490-FRI	Alcohol-associated liver disease exhibits higher cut-points of liver stiffness measurement to stage advanced fibrosis compared to metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis	Wei Wang	Received

1493-FRI	Semaglutide reduces hepatic Cyp2e1 levels in mice independent of ethanol intake and increases blood ethanol concentrations	frhaan zahrawi	Received

1495-FRI	HSD17B13 EXPRESSION IS INCREASED IN BALLOONED HEPATOCYTES FROM PATIENTS WITH STEATOTIC LIVER DISEASE (SLD) AND CAN BE THERAPEUTICALLY TARGETED BY GSK4532990 IN PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE (ALD)	Nikhil Vergis	Received

1497-FRI	Premature Mortality Across the Steatotic Liver Disease (SLD) Spectrum Is Driven by Binge Drinking and Metabolic Conditions	Zobair Younossi	Received

1498-FRI	Characterizing Sex Differences in Liver-Related Complications Among Patients Hospitalized for Alcohol-Related Conditions	Elina Stoffel	Received

1500-FRI	Gut-Brain Axis: Emerging Therapeutic Target For Alcohol Use Disorder In Patients With Alcohol-Associated Liver Disease	Prabha Bhandari	Received

1501-FRI	Epigenetic changes in alcohol exposed hepatocytes drive pathogenic hepatocyte-macrophage feedback loop leading to loss of liver function	Kruti Nataraj	Received

1502-FRI	DIVERGING TRENDS IN INCIDENCE OF ALCOHOL USE DISORDER AND ALCOHOL-ASSSOCIATED LIVER DISEASE: A 28-YEAR POPULATION-BASED COHORT STUDY	Kamalpreet Hara	Received

1503-FRI	Alcohol Use Disorder, Liver Decompensation, and Mortality Risk Across Cirrhosis Etiologies: A Population-based Study.	Samer Gawrieh	Received

1504-FRI	Physical activity reduces the risk for dementia with reduced alcohol consumption in alcohol related liver disease (ALD): a large population based analysis	Amy Attaway	Received

1505-FRI	Fas-associated Factor Family Member 2 Expression in The Liver Mitigates Alcohol-Associated Liver Disease in Mice	Jingjing ZHANG	Received

1506-FRI	Explant Histology of MetALD resembles AC more than MASLD	Priyanka Singh	Received

1508-FRI	Non-Absorbable Antibiotics Worsen Alcohol-Associated Liver Disease in Gastric Acid-Suppressed Mice	Fernanda Raya Tonetti	Received

1509-FRI	Ethanol decreases CPT2-mediated Carnitine catabolism to promote stemness in alcoholic hepatocellular carcinoma	Qi Wang	Received

1512-FRI	Impact of prevention strategies on morbidity and mortality among people with alcohol use disorders in France: a modelling study (MOENA project)	Abbas MOURAD	Received

1515-FRI	Alcoholic hepatitis is associated with distinct phenotypic changes of the hepatic fibrotic matrix as evidenced by quantitative digital pathology: implications for diagnosis and prognosis	Marika Rudler	Received

1516-FRI	Pre-Transplant Sobriety Predicts When, Not If, Patients Return to Alcohol use after Liver Transplant	Sienna Li	Received

1519-FRI	Evaluating semaglutide and lifestyle interventions in a novel dietary rat model of metabolic and alcohol-related liver disease with advanced fibrosis	María Martínez Gómez	Received

1520-FRI	START DOMAIN-CONTAINING PROTEIN 10 MODULATES RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2 -MEDIATED LIPOGENESIS IN ALCOHOL-ASSOCIATED LIVER DISEASE	Manisha Dagar	Received

1521-FRI	Impact of Glucagon-like Peptide-1 Receptor Agonists on Alcohol Consumption and Liver-Related Outcomes: a Systematic Review and Meta-analysis	Guilherme Cançado	Received

1523-FRI	Longitudinal Transitions between Alcohol Consumption Levels in US adults: Insights from the PATH Study	Olajide Adekunle	Received

1529-FRI	An Interim Update from the Dallas Dionysus Study - an Ongoing Prospective Observational Cohort of Early-Stage Metabolic and Alcohol-Associated Liver Disease (metALD) and ALD Patients	Elias Rady	Received

1531-FRI	Impact of a Substance Use Navigation Program on Clinical Outcomes in Patients with Alcoholic Hepatitis	James Vu	Received

1532-FRI	Clinical Characteristics and Influencing Factors of Recompensation in Decompensated Alcoholic Liver Cirrhosis	jingyuan zhou	Received

1533-FRI	Dynamic changes of hepatic macrophages upon cessation of alcohol consumption in mice	Isabel Aranzazu Pulido Ruiz	Received

1535-FRI	Role of Kupffer cell SPP1 in alcohol-associated liver disease	Nithyananthan Subramaniyam	Received

1537-FRI	Increased FGF21 Mediates Alcohol-Induced Metabolic Alterations in TGR5-Deficient Mice	SHIFAT-E FERDOUS	Received

1538-FRI	Preventing Nuclear Prohibitin 1 Depletion Protects Against Alcohol-Associated Liver Injury and Sensitization to Colorectal Liver Metastasis	Jyoti Chhimwal	Received

1539-FRI	Naltrexone vs Acamprosate in Alcohol Use Disorder with Alcohol-Associated Cirrhosis: A Propensity-Matched Real-World Analysis of Mortality and Morbidity	Ali Shaat	Received

1543-FRI	Nationwide Trends of Six Medications for Alcohol Use Disorder Prescriptions Post-discharge in Patients Hospitalized with Alcohol-Associated Liver Disease Between 2015 to 2024	Emily Shu-Yen Chan	Received

1544-FRI	Housing Status and Its Association with Complications and Hospital Outcomes in Alcohol-Associated Liver Disease	Ki Jung Lee	Received

1545-FRI	Incidence and clinical implications of abstinence-induced hepatic recompensation in decompensated alcohol-related cirrhosis: a Baveno multicentre study	Benedikt Hofer	Received

1546-FRI	Characteristics of Patients With Alcohol-Associated Hepatitis Recorded in a Claims Database From 2016 to 2024	Jayashri Desai	Received

1547-FRI	Trends in Liver Transplantation for Alcohol-Associated Liver Disease in the US From 2018 to 2024: A Descriptive Analysis of UNOS Data	Jayashri Desai	Received

1548-FRI	Acute phase response activation in hepatocytes promotes liver niche remodeling required for fibrosis resolution after alcohol cessation	Irina Tikhanovich	Received

1549-FRI	Real-World Impact of Alcohol Use Disorder Pharmacotherapy on Healthcare Utilization, Costs, and Cost-Effectiveness in the U.S.	Suthat Liangpunsakul	Received

1550-FRI	Loss of Hepatic Peroxin 3 Aggravates Alcohol-Induced Liver Injury via Bile Acid Intermediate Accumulation in Mice	Wei Zhong	Received

1552-FRI	Rising Tide: Shifts in Alcohol-Associated Liver Transplantation in the United States, 2012 - 2023	Ashraf Ullah	Received

1554-FRI	Bruton´s Tyrosine Kinase Inhibition as a Novel Multimodal Therapy for Alcohol-Associated Hepatitis	Prashanth Thevkar Nagesh	Received

1555-FRI	The Effect of Medical Assisted Therapy on Liver-Related Outcomes in Patients with Alcohol Use Disorder After Transplantation	Ami Patel	Received

1556-FRI	Factors Associated with Increased Liver Fibrosis in Adults with MetALD: Data from US NHANES 2017 - 2023	Alex Chang	Received

1557-FRI	Omega-5 fatty acid as an Adjuvant Reduces Inflamma-Oxidation in Patients with Severe Alcohol-Associated HepatitisNew Submission	Gabriela Gutierrez-Reyes	Received

1560-FRI	Mortality Trends and Risk Factors in Alcohol-Associated Hepatitis: A Systematic Review and Meta-analysis	Francisco Idalsoaga	Received

1561-FRI	Intestinal inflammation (II) measured by fecal calprotectin (FC) in decompensated advanced chronic liver disease (dACLD) inpatients is higher when triggered by alcohol-associated hepatitis (AH), but: Do II/FC independently associate with adverse outc	Lubomir Skladaný	Received

1565-FRI	A superoxide dismutase-mimetic (BMX-001) mitigates lipid peroxidation in a mouse model of alcohol-associated liver disease.	Delia Omar	Received

1566-FRI	Patterns of pre-alcohol-associated hepatitis healthcare utilization and outcomes among adolescents and young adults in Ontario	Gabrielle Jutras	Received

1567-FRI	Clinical Outcomes Between Alcohol-Associated Liver Disease And Chronic Viral Hepatitis in Taiwan	Chun-Ming Hong	Received

1568-FRI	Safety and Effectiveness of Phenobarbital vs. Benzodiazepines for Severe Alcohol Withdrawal in Alcohol-Associated Liver Disease	Rajalakshmi Govalan	Received

1569-FRI	Hepatic SIRT7 Promotes PMN-MDSCs Differentiation and Alcohol Related Liver Injury via FXR-Dependent Bile Acid Metabolism	ZHUAN LI	Received

1570-FRI	AGE RELATED IMPACT OF OUTCOMES IN HOSPITALIZED PATIENTS WITH CIRRHOSIS AND ALCOHOL-ASSOCIATED LIVER DISEASE	Dhweeja Dasarathy	Received

1571-FRI	Phosphatidylethanol Predicts Short-Term Hepatic Decompensation but Shows Rapid Decline in Prognostic Discrimination	Nikolaj Torp	Received

1572-FRI	Clinical Outcomes Across Organ Systems in Alcohol-Associated Liver Disease With Metabolic Risk	Pojsakorn Danpanichkul	Received

1574-FRI	Multicenter Validation of Prediction Models for Transplant-Free Survival in Severe Alcohol-Associated Hepatitis	Elina Stoffel	Received

1575-FRI	Accelerated Progression to Cirrhosis and Hepatic Decompensation in MetALD and ALD Compared to MASLD: A Global Study	Luis Antonio Diaz	Received

1577-FRI	Loss of MAP3K8 in myeloid cells protects against preclinical ALD and MetALD	Alejandro H. Gutierrez	Received

1578-FRI	Infection as a Predictor of Mortality and Decompensation in Alcohol-associated Hepatitis with Leukocytosis	Khawaja Hassam	Received

1580-FRI	Fecal Microbiota Transplant from Specific Human Donors Reduce Alcohol Preference and Intake in Conventional Female Mice	Jasmohan Bajaj	Received

1581-FRI	Private Insurance and a Diagnosis of Alcohol-Associated Hepatitis are Associated with Higher Participation in Virtual Group-Based Post-Liver Transplant Relapse Prevention Therapy	Hersh Shroff	Received

1583-FRI	Area-level Deprivation Strongly Contributes to Disparities in Access to Liver Transplantation and Outcomes among Patients with Severe Alcohol-associated Hepatitis: Results from a Prospective Multicenter Study	Lauren Nephew	Received

1584-FRI	Sarcopenia and Alcohol-Associated Liver Disease: Influence on Inpatient Outcomes - A Nationwide Cohort Analysis	Carla Barberan Parraga	Received

1588-FRI	Trends in Phosphatidylethanol Testing for Liver Transplant Evaluation	Natalia Salinas Parra	Received

1589-FRI	Mortality and Hepatic Outcomes of SGLT2 Inhibitors in Patients with Alcoholic Cirrhosis, Obesity, and Diabetes: A Global Cohort Study	Mohamad Mahdi Osman	Received

1591-FRI	ONE FIFTH OF INDIVIDUALS HAVING ALCOHOL USE DISORDER ARE SARCOPENIC	Chittaranjan Panda	Received

1592-FRI	Targeting PDK4-Mediated SEPT2 Phosphorylation to Combat Mitochondrial Dysfunction in Alcohol-Associated Liver Disease	THEMIS THOUDAM	Received

1593-FRI	In vivo protein half-life analysis unveils the role of the SREBF1-SLC27a5 axis in alleviating Alcohol-induced Liver Damage	NUPUR SHARMA	Received

1594-FRI	Clinical Utility of Phosphatidylethanol as an Objective Biomarker for Quantifying Alcohol Use in Steatotic Liver Disease: Evidence from the San Diego Liver Study	Federica Tavaglione	Received

1595-FRI	Multidisciplinary Management of ALD: Improved Patient Outcomes and Reduced Healthcare Utilization	Nabeeha Mohy-ud-din	Received

1598-FRI	Patients with Higher MELD Scores May Be At Higher Risk of Being Misclassified as Low Risk for Alcohol Relapse by Pre-Transplant SIPAT Evaluation	Alex Chang	Received

1600-FRI	Implementing a participatory process to sustain bio-psycho-social support for AUD, MetALD, and ALD patients	Jennifer Jones	Received

1601-FRI	Pre-transplant Alcohol-related Liver Disease Clinic: A Multidisciplinary Clinic Approach to Treatment of Alcohol-related Liver Disease and Alcohol Use Disorder	Jasleen Singh	Received

1609-FRI	Peptide YY reduces cytotoxicity of Candida albicans in alcohol-associated liver disease	Henriette Kreimeyer	Received

1611-FRI	First in Line: A Successful Early Liver Transplant for Catastrophic Severe Alcohol-Associated Hepatitis Using the ELFSAH Protocol at a Tertiary Center	Rachel Patel	Received

1612-FRI	Non-invasive tests for prognostication in steatotic liver diseases: results from a long term follow-up cohort of 3,442 patients	Jérôme Boursier	Received

1613-FRI	Muscle injury is closely related to hepatic encephalopathy in male Chinese patients with alcohol - related liver disease	xiaoting Ma	Received

1614-FRI	Polyene phosphatidylcholine injection regulates lipid homeostasis via AKT-PDE3-PKA in mice	Yang Hu	Received

1615-FRI	Serum levels of Candida albicans 65-kDa mannoprotein (CaMp65p) correlate with liver disease in patients with alcohol use disorder	Julia Schnabl	Received

1617-FRI	Shifting the Prognostic Window: Day-4 Lille Score as a Tool for Early Clinical Decision-Making in Alcoholic Hepatitis	Mallikarjun Patil	Received

1618-FRI	Targeting the leukotriene-mediated pathway improves alcohol-associated liver damage in a mouse model	Shengmin Yan	Received

1621-FRI	Health Care Utilization, Costs, and Advance Care Planning in Severe Alcoholic Hepatitis Patients	Tanisha Ronnie	Received

1622-FRI	Disparate Referral Patterns for Patients with Alcohol Use Disorder Referred to Hepatology Clinics	Elizabeth Sun	Received

1624-FRI	Platanosides increases mitochondrial biogenesis (MB) after chronic-binge ethanol (CBE) treatment in mice	Devadoss Samuvel	Received

1625-FRI	Transient Elastography as Theranostic Intervention in Alcohol-associated Liver Disease: Systematic Review and Meta-analysis	Gene Im	Received

1626-FRI	Outcomes of Patients with Alcohol-Associated Hepatitis Evaluated for Early Liver Transplantation	Darine Daher	Received

1627-FRI	Significant Liver Disease among Increased Alcohol Consumers Tripled from 1999-2018 Alongside Evolving US Population Demographics	Kalpana Gopalkrishnan	Received

1628-FRI	PHOSPHORYLATED UBIQUITIN CONJUGATING ENZYME 9 AS A NOVEL REGULATOR OF LIPOGENESIS IN ALCOHOL-ASSOCIATED LIVER DISEASE	Swati Chandla	Received

1632-FRI	New SubmissionComparative Inpatient Outcomes and Comorbidity Profiles in Patients with Alcohol-Associated Liver Disease With and Without Metabolic Syndrome: Insights from a Nationally Representative Database	Talal Bhatti	Received

1633-FRI	Macrophage Dysfunction, Not Hepatocyte or Neutrophil Impairment, Drives Alcohol-Induced Susceptibility to Klebsiella pneumoniae Infection	Tiantian Yao	Received

1636-FRI	Therapeutic plasma exchange-induced Shifts in Bile Salt Composition in Alcohol-related Hepatitis: Insights into Mechanisms and Therapeutic Potential	Francisco Idalsoaga	Received

1637-FRI	Does a diagnosis of alcohol-associated liver disease increase prescription of alcohol use disorder medication? Danish and English cohort studies	Gro Askgaard	Received

1639-FRI	Institutional Approaches to Alcohol Monitoring and Treatment after Liver Transplantation (LT) for Alcohol-Associated Liver Disease (ALD): A Multicenter Protocol-Based Comparison	Sheila Eswaran	Received

1640-FRI	Underlying Cirrhosis in Patients Receiving Liver Transplantation for Alcohol-Associated Hepatitis: A Histopathologic and Clinical Analysis	Qusai Al Zureikat	Received

1642-FRI	Long-Term Major Adverse Liver Outcomes in Lean and Non-Lean Patients with Alcohol-Associated Liver Disease	Pojsakorn Danpanichkul	Received

1646-FRI	A Novel Program for Management of Alcohol Use Disorder in a Liver Transplant Program	Lynda Coraluzzi	Received

1647-FRI	Cardiovascular Mortality in Alcohol-Related Liver Disease: National Trends Analysis	Pojsakorn Danpanichkul	Received

1648-FRI	Integrative Transcriptome Meta-Analysis Identifies Upstream Regulatory Targets in Alcoholic Hepatitis Across Liver and Blood	Seul Ki Han	Received

1651-FRI	Outcomes of Early and Late Alcohol Relapse in Liver Transplant Recipients with Alcohol-Associated Liver Disease	Garren Montgomery	Received

1652-FRI	BLACK PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE IS ASSOCIATED GREATER INCIDENCE OF COMPLICATIONS AND HOSPITAL-RELATED OUTCOMES	Ki Jung Lee	Received

1653-FRI	ROLE OF SHEAR WAVE VISCOSITY (SWV) AS AN IMAGING BIOMARKER FOR EVALUATION OF ALCOHOLIC HEPATITISNew Submission	Carmen Fierbinteanu Braticevici	Received

1656-FRI	LOW BLOOD UREA NITROGEN DURING ALCOHOL-ASSOCIATED ADMISSION PREDICTS CIRRHOSIS IN PATIENTS WITHOUT PRE-EXISTING LIVER DISEASE: RESULTS FROM A LARGE NATIONWIDE VETERANS AFFAIRS DATABASE	Prowpanga Udompap	Received

2003-SAT	Cross-National Validation of Fibro-Scope for Liver Fibrosis in MASLD: Insights from Japan and the U.S.	yuya seko	Received

2004-SAT	Improvement of Hepatic Steatosis and Reduction in Cardiovascular Event in Patients with Diabetes Mellitus: A Prospective Study	Yoonseok Lee	Received

2006-SAT	Validation of New Clinical Obesity Criteria for Steatotic Liver Disease in the United States	Nikhil Kalita	Received

2007-SAT	Patients with MASLD decompensate at a lower hepatic venous pressure gradient threshold: Data from a multicentric retrospective cohort study	Xiao Yu Xie	Received

2008-SAT	High-Resolution Collagen Profiling Reveals Stage-Specific Fibrosis Patterns in Pediatric MASLD Using Digital Pathology and UMAP	Li Chen	Received

2009-SAT	DIFFERENT LIPIDOMIC SIGNATURE IN EXTRACELLULAR VESICLES IN PATIENTS WITH MASLD-HCC: ANALYSIS OF DIFFERENT STAGES OF MASLD	Mario Alvares-da-Silva	Received

2010-SAT	Population Screening Strategies for Significant Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease in the Era of Disease-Specific Therapy	Winston Dunn	Received

2013-SAT	Current Care Pathway and Referral Patterns Identify Gaps in Screening, Diagnosis, and Treatment of MASLD/MASH in Ambulatory Care Setting	Rahul Sandella	Received

2014-SAT	MISSED OPPORTUNITIES FOR EARLY MASLD TREATMENT: TRENDS IN FIBROSIS BURDEN AND DISEASE AWARENESS IN THE U.S. POPULATION - RESULTS FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2017-2023	Jameel Alp	Received

2016-SAT	LiverPRO can optimize trial recruitment and lower screen failure rates in steatotic liver disease	Julie Astono	Received

2017-SAT	Identification of signature genes and pathways in the progression of metabolic dysfunction-associated steatohepatitis: a meta-analysis in liver transcriptomics	Wei Zhang	Received

2018-SAT	The Smell of MASLD: Discriminatory Breath VOC Signature in Children with MASLD; A Prospective Cohort Study	Jennifer Panganiban	Received

2019-SAT	Comparison of digital images versus glass slides for the histopathological evaluation of liver biopsy samples according to the NASH-CRN scoring system for MASH: A validation performed as part of the NATiV3 study	Carolin Lackner	Received

2020-SAT	ZONE-SPECIFIC FIBROSIS REDUCTIONS INDUCED BY PEGOZAFERMIN OVER 24 WEEKS ARE SIMILAR IN NON-CIRRHOTIC (F2/F3) AND CIRRHOTIC (F4) MASH	Quentin Anstee	Received

2021-SAT	Validation of Agile-3+ and Agile-4 scores for Noninvasive Detection of Fibrosis and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Latin America	Carlos Esteban Coronel-Castillo	Received

2023-SAT	LIBRA (LIver BReath Analysis) assessment of liver dysfunction for cirrhosis detection in at-risk populations	Edward Jackson	Received

2024-SAT	Liver iron concentration characterises progression of MASLD to MetALD	Andrea Dennis	Received

2025-SAT	FAST and CAP Scores as Early Biomarkers of Treatment Response in MASLD Patients Receiving Resmetirom: A Real-World Study	Winston Dunn	Received

2026-SAT	Allyl Nonanoate: A Bile Metabolite and Potential Biomarker for Hepatic Fibrosis in MASLD	Hyo Young Lee	Received

2027-SAT	Development and Validation of qInflammation: An AI-Driven Digital Pathology Algorithm for Differentiating Portal and Lobular Inflammation in Metabolic-Associated Steatohepatitis	Yayun Ren	Received

2028-SAT	Improving the Prediction of MASLD with Advanced Fibrosis among Primary Care Patients with Obesity, Diabetes, or Both: A Prospective Cohort Study Implementing Screening with FIB-4 and SAFE Scores	Max Goldman	Received

2029-SAT	New SubmissionA machine learning-validated model can differentiate three subtypes of steatotic liver disease based on self-reported alcohol use: Analysis of NHANES database	Talal Bhatti	Received

2031-SAT	Predictors of longitudinal changes in liver corrected T1 value based on UK Biobank cohort.	Ju Dong Yang	Received

2034-SAT	Hepatocellular Carcinoma Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease	Huapeng LIN	Received

2037-SAT	Does subcutaneous fibrosis predict the severity of liver fibrosis?	Alina Iuliana Onoiu	Received

2038-SAT	Serum Histamine N-methyltransferase as a potential biomarker for liver histologic severity in MASLD: insights from immune-related proteomic signatures	Rui-Xu Yang	Received

2039-SAT	Prospective Cohort Study Identifies Dietary and Oral Microbial Signatures Associated with Significant MASLD Fibrosis	Xiaotao Zhang	Received

2040-SAT	Large language models (LLMs) accurately extract VCTE measurements from unstructured documentation and enable at-scale predictive modeling in real-world cohorts	Aryana Far	Received

2041-SAT	Performance of FIB-4 Varies Greatly According to Age Groups in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Data from Global MASLD Project	Zobair Younossi	Received

2042-SAT	Development of a Neural Network to Detect Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease	Masashi Hirooka	Received

2046-SAT	Novel matricellular serum marker scores for improved prediction of liver fibrosis and fibrogenesis in patients with MASLD undergoing bariatric surgery	Rambabu Surabattula	Received

2047-SAT	FAP Index: A new statistical model in improving triage for advanced liver fibrosis in obese or metabolic dysfunction-associated steatotic individuals using a specific marker of activated stellate cells and myofibroblasts.	Bobby Boumelhem	Received

2049-SAT	Predictive value of non-invasive tests varies across novel data-driven MASLD clusters	Nicolas Desmons	Received

2051-SAT	Longitudinal follow-up of a TGF-β Pathway-related Biomarker Panel that Stratifies HCC Risk in Cirrhotic patients	Xiyan Xiang	Received

2052-SAT	Prevalence of steatosis and liver fibrosis in patients with MASLD/MASH from non-hepatology centers in the USA and Europe	Victor de Lédinghen	Received

2053-SAT	Novel multiparametric MRI imaging predicts histologic response in resmetirom versus placebo in the multicentre, international, MAESTRO-NASH Phase 3 trial	Rohit Loomba	Received

2054-SAT	Impact of PNPLA3 p.I148M variant on qFibrosis-based liver fibrosis features in MASLD biopsies in the Milan Biobank cohort	Luca Vittorio Carlo Valenti	Received

2056-SAT	Longitudinal assessment of fibrosis distribution changes after treatment in metabolic dysfunction-associated steatotic liver disease (MASLD)	Daniela Allende	Received

2058-SAT	Innovative Scoring System to simulate Magnetic Resonance Elastography in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)	Isabel Fernandez-Lizaranzu	Received

2060-SAT	Isolated HBcAb Positivity is not associated with HCC Risk in patients with MASLD	Abdelrahman M Attia	Received

2063-SAT	Enhancing Steatotic Liver Disease (SLD) Detection via Opportunistic Screening	Vignesh Rajasekaran	Received

2064-SAT	The METAL Score (WESKEL-GP): A Primary Care Fibrosis Risk Tool for Silent MetALD - A Guideline-Aligned Response to the MASLD Classification Gap	KSHEETIJ KOTHARI	Received

2065-SAT	Machine Learning Extracted Features of Quantitative Abdominal Imaging Finds Visceral Fat as Primary Predictor of Hepatic Steatosis	Wesley Dixon	Received

2068-SAT	Deep Learning-Based Model for Assessing Hepatic Steatosis in Living Liver Donor	Jonggi Choi	Received

2069-SAT	A Real-Time Natural Language Processing Pipeline to Extract Elastography Results from Electronic Health Record	Lale Ertuglu	Received

2072-SAT	Understanding the Functional and Physiologic Heterogeneity of Advanced MASH as Defined by the Oral Cholate Challenge Test May Enhance Clinical Trial Design	Mazen Noureddin	Received

2073-SAT	FIB-4 serves as a referral index for coronary artery calcification in patients with metabolic dysfunction-associated steatotic liver disease	Ming-Lung Yu	Received

2074-SAT	Reliable monitoring of patients with MASLD using imaging: Systematic literature review and meta-analysis on measurement repeatability	Anneli Andersson	Received

2075-SAT	SomaSignal defined MASH disease components are prognostic of secondary cardiovascular disease - A post-hoc analysis of the SELECT trial	Arun Sanyal	Received

2077-SAT	Maximizing the Diagnostic Yield of Non-Invasive Tests: Simultaneous Optimization of Key Performance Metrics for Fibrotic Liver Disease with a FIB-4 and MASEF (OWLiver) Strategy	Mirella Zulueta	Received

2079-SAT	Evaluating the Noninvasive Diagnostic Pathways for Identifying MASH Patients Eligible for Resmetirom Therapy	Larissa Lushniak	Received

2082-SAT	Limitations of FIB-4 in MASLD: One in Three Cases of Advanced Fibrosis Missed in Biopsy-Proven Cohort	Tanya Jayakar	Received

2083-SAT	Risk stratification using non-invasive tests and magnetic resonance elastography reveals similar patterns in MetALD and MASLD	Akash Roy	Received

2086-SAT	Second harmonic generated imaging with qFibrosis provides quantitative information on fibrosis severity and predicts the future course of fibrosis in metabolic dysfunction associated steatotic liver disease (MASLD)	David Kleiner	Received

2090-SAT	The obesity-related mutation genes on hepatocarcinogenesis in metabolic dysfunction-associated steatotic liver disease	Jee-Fu Huang	Received

2091-SAT	Lipidomic analysis and machine learning models for predicting significant liver fibrosis in patients with severe obesity undergoing bariatric surgery	Chien-Hung Lu	Received

2092-SAT	Clinical Obesity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is associated with Advanced Fibrosis and Severe Steatosis: Validating Clinical Obesity Definition in a MASLD Cohort	Karen Cheuk Ying Ho	Received

2096-SAT	Divergent Immune-Inflammatory Signatures in Steatotic liver disease phenotypes with a Unified Lab-Based Fibrosis Prediction Tool	Sunil Dadhich	Received

2097-SAT	C7 as a predictor of fibrosis and liver-related events in MASLD	Shohei Kondo	Received

2098-SAT	Association of circulating Z-polymer with hepatic fibrosis in adults at-risk for MASLD and the alpha-1 antitrypsin Pi*MZ variant	Monika Sigg	Received

2102-SAT	Digital Pathology identifies intra-stage responders in the ALPINE4 Cirrhosis Study	Mathieu Petitjean	Received

2106-SAT	Achieving Operator Competency in Transient Elastography (TE): A Structured Protocol for Training Non-Experts to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - A Multicenter Experience	Faisal Abaalkhail	Received

2107-SAT	Development of a novel model using machine learning algorithms to predict presence of metabolic associated steatotic liver disease improving on FIB-4 and ELF. A population screening tool.	Charlene Cheong	Received

2108-SAT	Normal liver enzymes in patients with diabetes mellitus and advanced fibrosis by FIB-4	Emily Leven	Received

2109-SAT	Distinct Transcriptomic Signatures in Platelet-Derived Extracellular vesicles (pEVs) associated with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).	Vanessa Garcia-Fernandez	Received

2112-SAT	Prognostic value of the TLM3 biomarker panel for early fibrosis development in MASLD within the general population	Lars Verschuren	Received

2114-SAT	CHANGES IN THE FIBROSIS-4 (FIB-4) SCORE ACCURATELY REFLECTS THE DISEASE TRAJECTORY OF METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE	Vinay Jahagirdar	Received

2116-SAT	Prevalence and health checkup-based detection of metabolic dysfunction-associated steatotic liver disease in Japanese young adults	Satoko Tajirika	Received

2117-SAT	The Efficacy of Measuring Natural Killer Activating Receptor Ligands and Bile Acids to Predict the Pathogenesis of MASLD	Jun Arai	Received

2118-SAT	Predicting Hepatic Steatosis: A Study of Deceased Liver Donors	Jaimie Chang	Received

2120-SAT	Evaluation for hepatic fibrosis risk by FIB4 score, liver stiffness (Fibroscan, ShearWave), LiverRisk score and EASL/AASLD-2 step approach in 1169 patients followed for MASLD New Submission	Denis Ouzan	Received

2121-SAT	Diagnostic performance of FIB-4, LiverRisk score, SAFE and MAF-5 as index screening tool for liver fibrosis among community-dwelling individuals with high metabolic risk	Laurens van Kleef	Received

2122-SAT	Risk stratification in steatotic liver diseases: changing the reference to develop new non-invasive tests well adapted to the context of use	Jérôme Boursier	Received

2123-SAT	Evaluation of Nutritional Abnormalities and Frailty Indices in Patients with ALD, MASLD and MetALD	Anastasia Xynogala	Received

2125-SAT	The new assay type IV collagen 7S (CLEIA) is a useful test to identify progressive fibrosis in chronic liver disease: A study based on magnetic resonance elastography	Miwa Kawanaka	Received

2126-SAT	Decrease in Liver Stiffness is not Associated with Reduced Cardiovascular Events in Patients with Diabetes Mellitus: A Prospective Study	Yoonseok Lee	Received

2127-SAT	Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and risk of developing MASLD and its subgroups.	Yidi Ge	Received

2128-SAT	Defining Cut-offs of Anthropometric and Metabolic Markers in Mexico for Early Detection and Prevention of Chronic Metabolic Diseases	Arturo Panduro	Received

2129-SAT	A comparison of non-invasive diagnostic methods used to identify high-risk patients eligible for resmetirom therapy: a biopsy proven study from Türkiye	Eda Kaya	Received

2130-SAT	To verify the diagnostic efficacy of FAST score for high-risk MASH in patients with metabolic-related fatty liver disease based on liver biopsy.	Wang Xiaozhong	Received

2131-SAT	AI-assisted digital pathology unveils patient heterogeneity in the antifibrotic response following bariatric surgery	Vlad Ratziu	Received

2132-SAT	Comparing Non-Invasive Fibrosis Scores to Transient Elastography Measurements Across the Spectrum of Steatotic Liver Disease: A US NHANES 2017-2020 Study	Alex Chang	Received

2134-SAT	Atherosclerotic cardiovascular disease risk using the two-step algorithms from the KASL/EASL and AGA Guidelines in individuals with MASLD	Jungpyo Hong	Received

2136-SAT	Performance of Attenuation Imaging (ATI) Compared to Controlled Attenuation Parameter (CAP) for Non-Invasive Assessment of Hepatic Steatosis in a Cohort of Mixed Chronic Liver Diseases	Thales Saad	Received

2137-SAT	Liver shear wave dispersion slope measurement is higher in patients with significant and advanced fibrosis due to MASLD.	Joao Marcello de Araujo-Neto	Received

2140-SAT	AI-powered pathology reveals surgery-induced changes in the cellular composition of the liver in patients with MASLD	Alina Iuliana Onoiu	Received

2141-SAT	Polymorphism Rs7903146 of TCF7L2 Gene is Associated with Type 2 Diabetes and Cardiovascular Risk Biomarker in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)	Brian Lam	Received

2142-SAT	Evaluation of multisensorial electronic technologies as noninvasive tools for the detection of fibrotic-MASH in MASLD patients	Francesca Terracciani	Received

2143-SAT	Multiple quantitative ultrasound parameters for the evaluation of metabolic dysfunction-associated steatohepatitis: a prospective study	Yi Dong	Received

2144-SAT	Impact of PNPLA3 rs738409 Variant on IL-6-Mediated Inflammation in African Americans with MASLD	Morinne Osborne	Received

2145-SAT	Evaluation of Accuracy of AST to Platelet Ratio Index (APRI) in Various Age Groups with Biopsy-Proven MASLD or MASH: A Comprehensive Retrospective Study	Frank Lin	Received

2146-SAT	Development of a noninvasive model for significant fibrosis in MAFLD using LASSO regression	Wen Deng	Received

2147-SAT	Combination of ELF Score and Cytokeratin-18 Fragment for Efficient Detection of at-risk MASH	Takemi Akahane	Received

2149-SAT	Association of sensitivity to thyroid hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease in euthyroid adults	Hyun Woo Oh	Received

2150-SAT	Improving Metabolic Dysfunction-Associated Steatotic Liver Disease Screening in a Resident Clinic: A Quality Improvement Initiative	Reeti Gulati	Received

2151-SAT	Exploring the Multidimensional Structure of Noninvasive Liver Fibrosis Assessments in MASLD	Stephanie Chang	Received

2153-SAT	Utilization of Enhanced Liver Fibrosis (ELF) Test in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease	Chukwuemeka Oko	Received

2154-SAT	The NFS Score Demonstrates Superior Diagnostic Performance in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Cirrhosis.	Guo Feng	Received

2155-SAT	Common Single Nucleotide Polymorphism Distribution and Associations with A Surrogate of Liver Disease Severity in MASLD Patients from the United States (U.S.) and Taiwan	Zobair Younossi	Received

2156-SAT	Non-invasive tests accuracy for liver fibrosis stratification in adults with grade II-III obesity in the waiting list for metabolic and bariatric surgery in Brazil - a multicentric study	Cristiane Villela-Nogueira	Received

2158-SAT	Associated Parameters that May Affect PDFF Trial Outcomes	Elisabeth Verwest	Received

2159-SAT	How the Cause of Liver Failure Shapes the Post-Transplant Journey: Patient-Reported Outcomes Across Etiologic Categories	Lorrinda Gray-Davis	Received

2160-SAT	Impaired Working Memory in Individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Fatigue	Ali Weinstein	Received

2161-SAT	LiverPal: A Formative Evaluation of a Longitudinal Specialty-Aligned Palliative Care Intervention for Hospitalized Patients with Advanced Liver Disease (AdvLD)	Nancy Mason	Received

2163-SAT	Navigating the Hepatitis C Care Cascade with Advanced Practice Provider and Electronic Health Record in an Urban Emergency Department and Outpatient Clinics	Vicki Shah	Received

2164-SAT	Barriers and Facilitators to Engaging in Alcohol Treatment among persons with Alcohol-associated Liver Disease: a Mixed-methods Systematic Review	Sue Hyon Kim	Received

2165-SAT	Reduced health-related quality of life predicts unfavorable outcomes in patients with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab.New Submission	Masako Shomura	Received

2166-SAT	Two-Decade Trends in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) and Its Complications in the Middle East and North Africa (MENA) (2010-2021)	Zobair Younossi	Received

2167-SAT	Sexual Health After Liver Transplantation: An Unrecognized Problem Affecting Quality of Life	Chanattha Thimphitthaya	Received

2168-SAT	Socioeconomic disparities in incidence, treatment and survival after hepatocellular carcinoma in alcohol-associated cirrhosis: nationwide data from Denmark	Gro Askgaard	Received

2169-SAT	Nourishing the Mind: Food Insecurity is a Key Determinant of Hepatic Encephalopathy Risk in Cirrhosis	Somaya Albhaisi	Received

2170-SAT	Risk Factors for Liver Involvement of Hypertensive Disorders of Pregnancy	Sorvena Yoyo	Received

2171-SAT	Demographic Disparities in Recruitment for Liver Transplant Clinical Trials in The United States	Razan Aburumman	Received

2172-SAT	Significant Disparities in Inpatient Palliative Care Consultation and Mortality Among Hospitalized Adults with Decompensated Cirrhosis	Shyam Patel	Received

2175-SAT	Hepatocellular Carcinoma (HCC) in Cirrhotics vs Non-Cirrhotic Patients: Demographics, Survival Gaps, Racial Disparities: A SEER Registry Data Analysis (2011-2021)	Eunice Aregbesola	Received

2177-SAT	Differentiating between pregnancy- and non-pregnancy related causes of liver enzyme elevations in the second and third trimester: a multicenter retrospective cohort study	Jeffrey Lowell	Received

2178-SAT	Improving Linkage to Care for HBV/HCV-Exposed Mother-Infant Dyads in North Carolina: University of North Carolina Relink Program	Cory Spencer	Received

2181-SAT	Addressing Food Insecurity Among Patients with and at-risk for MASLD: A Qualitative Study to Optimize a Food Pharmacy Program	Rebecca Kim	Received

2183-SAT	Low Disease Awareness Among Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) and MASLD Cirrhosis in the United States	Zobair Younossi	Received

2185-SAT	Medical Mistrust Among Patients with Early-Stage Alcohol-Associated Liver Disease: Insights from the Prospective Dallas Dionysus Cohort	Elias Rady	Received

2186-SAT	Analyzing the Readability of LLM-generated Patient Information for Liver Diseases	Husayn Ramji	Received

2187-SAT	Alcohol, Inequality, and Liver Cirrhosis: Can Drinking Patterns and Cardiometabolic Risk Factors Explain the Socioeconomic Gap?	Jonas Rønn	Received

2190-SAT	Social Risk Screening among Liver Transplant Candidates: Impact of Material Deprivation on Transplant Outcomes	Mark Wang	Received

2191-SAT	The Role of Social Determinants of Health on Hepatitis B During Pregnancy in Massachusetts and Within the United States	Ami Patel	Received

2192-SAT	Sex-Specific Differences in Cardiometabolic Risk Factors and Risk of Significant Liver Fibrosis in the U.S. General Population: An Analysis of NHANES 2017-2020	Somaya Albhaisi	Received

2193-SAT	The impact of individualized socioeconomic measures on liver transplant waitlist outcomes in a multicentered study	Saurav Panda	Received

2194-SAT	Social Needs Screening and Community Resource Referrals Integrated into Routine Hepatology Care	Rebecca Kim	Received

2195-SAT	Demographic and Regional Disparities in GLP-1 Receptor Agonist Clinical Trials for Weight Loss with a specific focus on MASLD/MASH: A Comparative Meta-Analysis of US and International RCTs	Kimberly Ho	Received

2196-SAT	Longitudinal Adherence to Hepatocellular Carcinoma Surveillance Following Ultrasound LI-RADS Implementation in a Safety Net Healthcare System	Stephanie Kim	Received

2198-SAT	Beyond Primary Care: Specialist Density as a Driver of Liver Disease Mortality in Non-ALD Populations	Olivia Blocker	Received

2199-SAT	Racial/Ethnic Disparities in Access to Liver Transplantation - A Systematic Review and Meta-Analysis.	Rajalakshmi Govalan	Received

2200-SAT	Clinician Knowledge and Practice of Transgender and Gender Diverse Healthcare in Liver Transplant	Sonali Paul	Received

2201-SAT	Women of Reproductive Age with Untreated HCV: Positive and Negative Patient-Reported Experiences from a Qualitative Survey	Mai Sedki	Received

2202-SAT	Missed Opportunities for Liver Health in Women with Substance Use Disorder	Iva Kosuta	Received

2203-SAT	Barriers to Obtaining Breast Cancer Screening During Liver Transplant Evaluation: A Contributor to Sex Disparities in Liver Transplantation Listing	Madison Force	Received

2204-SAT	Sex for the purposes of MELD 3.0 calculation: When this differs from assigned sex at birth and implications for policy	Nikki Duong	Received

2207-SAT	Trends in MAT and GLP-1 Utilization after Liver Transplantation Based on Sociodemographic Variables: A National Cohort Analysis	Ami Patel	Received

2208-SAT	Incidence of Etiology of Hepatocellular Carcinoma by Social Determinants of Health, A Trend From 2016-2021	Andrej Sodoma	Received

2209-SAT	A Review of the Impact of Bias in Artificial Intelligence in Ensuring Health Equity in Hepatology	Sara Romero-Otero	Received

2211-SAT	Influence of Social Vulnerability on Complications of Alcohol-Associated Liver Disease	Pojsakorn Danpanichkul	Received

2212-SAT	A Lower Social Deprivation Index is Associated with Increased Mortality and Major Adverse Cardiovascular Events in Patients with Alcohol-Associated Liver Disease	Leith Ghani	Received

2213-SAT	Impact of Social Determinants of Health on Clinical Outcomes in Alcohol-Associated Hepatitis: A National Inpatient Analysis 2020-2021	Shubham Gupta	Received

2214-SAT	Determinants of Continuity of Care Beyond Direct-Acting Antiviral Initiation in Patients with Hepatitis C	WonKyung Cho	Received

2215-SAT	UNMASKING HEALTH DISPARITIES IN APPALACHIA: THE IMPACT OF THE COVID-19 PANDEMIC ON LIVER RELATED MORTALITY	Jordan Woodard	Received

2216-SAT	Prevalence of advanced hepatic fibrosis and steatosis in an underserved Hispanic population	Christopher Danford	Received

2217-SAT	Persistent Liver Injury and Recurrence after HELLP Syndrome: Incidence and Outcomes in a Retrospective Cohort (2009-2024)	Cecilia Katzenstein	Received

2220-SAT	Racial Differences in Fibrosis Progression After Liver Transplantation	Michael Attanasi	Received

2223-SAT	Alcohol Intake Adjustment and Previous History of Alcohol Use Uncover Hidden Risk of Premature Mortality Among Patients with Steatotic Liver Disease	James Paik	Received

2224-SAT	Hepatorenal Mortality Trend and Healthcare Disparities in the United States (1999-2020)	Tooba Laeeq	Received

2225-SAT	Challenges Facing Patients with Cirrhosis	Deanna Oliver	Received

2228-SAT	Racial disparities in incidence of cirrhosis and extrahepatic manifestations in alcohol-associated liver disease	Majd Aboona	Received

2229-SAT	High Adherence to a Planetary Health Diet is Associated with Lower Risk of Hepatocellular Carcinoma	Roselyn Tanghal	Received

2230-SAT	Food Insecurity Experiences in Liver Disease: A pilot of food insecurity screening in patients with cirrhosis	David Goldberg	Received

2231-SAT	A Capacity Building Initiative to Expand Hepatitis B and C Screening and Treatment in Vulnerable Communities	Mark Sulkowski	Received

2232-SAT	Association Between Country of Birth and Liver Fibrosis Severity in Obese U.S. Adults: An NHANES 2017-2023 Study	Mahinaz Mohsen	Received

2233-SAT	Breast cancer screening as a barrier to expedited liver transplant listing in inpatients: A retrospective chart review	Madison Force	Received

2235-SAT	Liver Abscesses in a Medically Underserved, Predominantly Black Population: A Retrospective Study from 2013 to 2024 at a U.S. Safety-Net Hospital	Nakul Ganju	Received

2236-SAT	Identifying provider prescribing practices for GLP1RAs and SGLT-2is in patients with type 2 diabetes to address pharmacoinequity in liver disease	Ponni Perumalswami	Received

2237-SAT	MELD and the Risk of Mortality in Black and White Patients with Advanced Fibrosis	Michael Attanasi	Received

2239-SAT	Health Literacy as a Determinant of Frailty in Patients with Liver Cirrhosis	ISMAEL YEPES	Received

2240-SAT	Longitudinal Changes in Hepatocellular Carcinoma Surveillance Patterns Among Safety-Net Health System Patients with Cirrhosis	Robert Wong	Received

2241-SAT	SOCIO-DEMOGRAPHIC FACTORS ASSOCIATED WITH LINKAGE TO SPECIALTY CARE AMONG PATIENTS WITH CIRRHOSIS-RELATED DIAGNOSES AT TWO LARGE HOSPITAL SYSTEMS	Reid Grinspoon	Received

2242-SAT	Reaching the Remaining One-Third: A Review of Barriers to Hepatitis C Elimination Within a Large Academic Medical Center	Hannah Laird	Received

2243-SAT	PERFORMANCES OF BAVENO VII AND AASLD 2024 CRITERIA FOR IDENTIFYING CLINICALLY SIGNIFICANT PORTAL HYPERTENSION WITH GASTROESOPHAGEAL VARICES IN TREATMENT-NAIVE PATIENTS WITH HDV CIRRHOSIS: A MULTICENTER VALIDATION STUDY	Maria Paola Anolli	Received

2247-SAT	RATES OF HDV RNA UNDETECTABILITY DURING LONG-TERM BULEVERTIDE MONOTHERPAY IN PATIENTS WITH CHD ARE ASSAY-DEPENDENT	Maria Paola Anolli	Received

2248-SAT	Plasma metabolomics and 16S rRNA sequencing identifies distinct signatures of worse outcomes in Hepatitis A-induced acute liver failure compared to drug induced liver failure	Anoushka Saxena	Received

2249-SAT	Hepatitis D in prison populations: high prevalence, coinfection with HCV/HIV, and limited treatment access in Spain.	Adriana Palom	Received

2250-SAT	Two Decades of Hepatitis D in the United States: Escalating Incidence, Sex- and Race-Specific Patterns, and Nearly-Doubled Risks of Cirrhosis and Decompensation Among Adults With Chronic Hepatitis B	Himsikhar Khataniar	Received

2251-SAT	MAINTAINED HDV RNA UNDETECTABILITY DURING LONG-TERM BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH HDV-RELATED COMPENSATED CIRRHOSIS: A SUBANALYSIS OF THE RETROSPECTIVE MULTICENTER EUROPEAN STUDY (SAVE-D)	Elisabetta Degasperi	Received

2252-SAT	Clinico-pathological Spectrum and Outcomes of Hepatitis-A Outbreak in Southern India: A Multicentric Cross-Sectional Study and an updated analysis	Arun Valsan	Received

2253-SAT	SAFETY, EFFECTIVENESS AND CLINICAL OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS DELTA TREATED WITH BULEVIRTIDE MONOTHERAPY: A POOLED ANALYSIS ON 689 PATIENTS ENROLLED IN THE SAVE-D AND D-SHIELD STUDIES	Elisabetta Degasperi	Received

2256-SAT	Impact of a Pharmacist-led support program on patient-reported outcomes (PROs) in patients with Chronic Hepatitis Delta undergoing bulevirtide therapy: 60-week results from the EXPLAIN study	Francesco Paolo Russo	Received

2257-SAT	Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection: a three-country, cross-sectional study in Europe	Anders Boyd	Received

2259-SAT	A Conserved G-Quadruplex in Hepatitis E Virus Negative-Stranded RNA Promotes Viral Replication via RNA Stabilization	Lin Wang	Received

2260-SAT	Nationwide HDV Diagnosis and Characterization in Spain: Insights from the Delta Double Reflex (DDR) Study	Federico Garcia	Received

2264-SAT	Declining burden of acute viral hepatitis in Adolescents and Adults ages 15-45 in Africa, 1991-2021: A Global Burden of Disease Study	Mohammed Youssef	Received

2265-SAT	The nucleoside analogue NITD008 used alone or in combination with Ribavirin strongly suppresses viral replication in immunodeficient humanized mice stably infected with the hepatitis E virus	Maura Dandri	Received

2267-SAT	3 YEARS OF BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH HDV-RELATED COMPENSATED CIRRHOSIS: VIROLOGIAL OUTCOMES AND SAFETY DATA FROM THE RETROSPECTIVE MULTICENTER EUROPEAN STUDY (SAVE-D)	Elisabetta Degasperi	Received

2269-SAT	Clinical and Epidemiological Characteristics of 92 Hepatitis E Patients	Lihua Yuan	Received

2271-SAT	Low hepatitis D viremia and cirrhosis burden among African patients: a multicenter prospective study	Adriana Palom	Received

2272-SAT	Evaluating the efficacy of Bulevirtide monotherapy in suppressing Hepatitis Delta Virus (HDV) RNA and achieving ALT normalization: A systematic review and meta-analysis	Rohan Karkra	Received

2274-SAT	Effect of 48-week Bulevirtide therapy on Non-Invasive Markers of Liver Fibrosis in Patients with HBeAg negative Chronic Hepatitis B/D	Iliana Mani	Received

2275-SAT	Spectrum and Outcomes of Hepatitis A Virus-Associated Acute Liver Failure: Insights into Extrahepatic Manifestations and Role of Extracorporeal Therapies	Ayush Jain	Received

2277-SAT	The Importance of Interferon and Wnt-Related Signaling Pathways in Acute Hepatitis A: Insights from a Mouse Xenograft Model	Reina Sasaki-Tanaka	Received

2279-SAT	HDV Molecular Characterization in Spain: Genotype Distribution via Whole-Genome Sequencing	Federico Garcia	Received

2281-SAT	A prospective randomized controlled, open labeled, two arm pilot study with blinded endpoints to evaluate the efficacy of torsemide-spironolactone versus furosemide-spironolactone combination in cirrhosis patients with newly diagnosed ascites	Arun Valsan	Received

2282-SAT	POCUS-Guided Fluid Resuscitation comparing Plasmalyte Plus 20% Albumin vs 5% Albumin in Cirrhosis with Sepsis-Induced Hypotension: A Randomized controlled trial (ALPS plus)	Ayush Jain	Received

2283-SAT	SPleen stiffness measurement reliably Assesses the REsponse to β-blocker therapy (SPARE-B) for primary prophylaxis of high-risk varices	Omkar Rudra	Received

2285-SAT	Reversal of Hepatorenal Syndrome-Acute Kidney Injury Does Not Impact Liver Transplant Rates	Kavish Patidar	Received

2287-SAT	A Machine Learning Approach to Non-Invasively Predict Hepatic Decompensation in Advanced Chronic Liver Disease	Georg Kramer	Received

2288-SAT	Prediction of incident overt hepatic encephalopathy using measures of minimal hepatic encephalopathy: The PrO-MHE Study	Akash Roy	Received

2290-SAT	Impact of Cirrhotic Cardiomyopathy and Cardiometabolic Risk on Hepatic Decompensation and Survival in patients with Cirrhosis	Madhumita Premkumar	Received

2291-SAT	Reduced Risk of Hepatic Decompensation and Overall Mortality in Patients with Compensated Cirrhosis and Statin Therapy: A Propensity Score-Matched Analysis of a Population Based Cohort of 14,034 Adults	Monica Tincopa	Received

2293-SAT	Allopurinol Use Is Associated with Decreased Incidence of Hepatic Decompensation and Overall Mortality Among Adults with Compensated Cirrhosis: A Population-Based Propensity-Matched Cohort Study of 10,716 Individuals	Monica Tincopa	Received

2294-SAT	Rifaximin Monotherapy Reduces the Risk of New-Onset Hepatic Encephalopathy and Mortality Compared to Lactulose Monotherapy in Compensated Cirrhosis: A Real-World Propensity-Matched Study	Himsikhar Khataniar	Received

2295-SAT	Latent Class Analysis (LCA) Identifies Distinct Ascites Phenotypes Associated with Clinical Outcomes and with Implications for Targeted Therapy in Patients with Decompensated Cirrhosis and Ascites	Giuseppe Cullaro	Received

2296-SAT	Dysphagia impairs health-related quality of life in patients with chronic liver disease	Takao Miwa	Received

2297-SAT	Microbiological profile of bacterial infections in patients with cirrhosis over time: a 20-year territory-wide study	Jie Cai	Received

2301-SAT	Understanding the Impact of Cirrhosis Etiology on Risks of Complication, Regional Patterns, and Trends Over Time in the United States	Arun Jesudian	Received

2303-SAT	Development of a New Model to Predict Hospitalization for Liver-Related Events: The SOLIDARITY-DAM (Diabetes, Albumin, aMmonia) Score.	Gayathry Morvil	Received

2305-SAT	Stage-specific drivers of clinical progression in advanced chronic liver disease	Mattias Mandorfer	Received

2306-SAT	Impaired Cognition and a History of Hepatic Encephalopathy are Associated with Disordered Sleep as Measured by Short Term Monitoring with Commercial Wearable Technology	Jessica Siguencia	Received

2309-SAT	Real-World Treatment Patterns and Utilization of Albumin Among Patients with Cirrhosis and Ascites in the United States	Cristina Coll-Ortega	Received

2310-SAT	Hepatic Recompensation and Predictive Factors After EUS-Guided Therapy or TIPS in Patients With Decompensated Cirrhosis	Chenyue Zhang	Received

2311-SAT	Contemporary Natural History of Compensated Cirrhosis: Results from the Population-Based Indiana Cirrhosis Cohort	Maaz Arif	Received

2312-SAT	Comparison of standard-dose repeated bolus injection vs. low-dose continuous intravenous infusion of terlipressin for acute esophageal variceal bleeding in patients with liver cirrhosis: A prospective multicenter randomized trial	Hyung Joon Yim	Received

2314-SAT	Coagulation parameters with Albumin in decompensated cirrhosis (CoPA-D): An open-label randomized control trial	Omkar Rudra	Received

2315-SAT	Correlation of Race-Neutral Glomerular Filtration Rate Assessment in Liver Disease (GRAIL 2.0) With Hepatorenal Syndrome-Acute Kidney Injury Reversal in Patients Receiving Terlipressin	R. Todd Frederick	Received

2316-SAT	Characterization and prognostic implications of biomarkers of systemic inflammation and portal hypertension across distinct stages of cirrhosis.	Georg Kramer	Received

2317-SAT	Cachexia is an independent predictor of mortality in patients with cirrhosis	Takao Miwa	Received

2318-SAT	Predicting Cardiovascular Outcomes after Transjugular Intrahepatic Portosystemic Shunt (TIPS) Using Machine Learning: An ALTA Group Study	Shoma Bommena	Received

2319-SAT	Training and validation of the Phase Angle (PA)/C-reactive protein (CRP) index (PAC-I) as a novel non-invasive tool accurately predicting sarcopenia and further decompensation events requiring hospitalizations in MASLD-related decompensated cirrhosis.	Mario Romeo	Received

2320-SAT	Systematic Literature Review and Meta-analysis of the Cardiovascular Effects of Transjugular Intrahepatic Portosystemic Shunt Creation	Wali Badar	Received

2321-SAT	SARCIRAM: A Pilot Study on the Impact of Hydroxiram D Supplementation on Sarcopenia in Patients with Liver Cirrhosis	Dafne Marcelli	Received

2322-SAT	Development and Validation of a Nomogram Incorporating Nutritional Factors for Predicting Prognosis in Cirrhosis Patients	Jianchun Shen	Received

2323-SAT	Higher risk of first acute variceal bleeding (AVB) in MASLD decompensated advanced chronic liver disease patients (dACLD) receiving carvedilol-based primary prophylaxis: a matter of insulin resistance. Is it time to personalize prevention strategies o	Fiammetta Di Nardo	Received

2324-SAT	A machine learning model to reduce unnecessary paracentesis for SBP exclusion has excellent performance in a recent nationwide cirrhosis cohort	Jasmohan Bajaj	Received

2326-SAT	Olfactory and Gustatory Impairment in Cirrhosis correlates with renal insufficiency and cognitive impairment and negatively impacts perceived ability to eat	Jasmohan Bajaj	Received

2327-SAT	Development and Validation of an Ambulatory Administrative Frailty Index for Patients with Cirrhosis	Jennifer Lai	Received

2329-SAT	Pathomechanistic biomarkers link bacterial translocation to endothelial dysfunction and hepatic fibrogenesis across different stages of cirrhosis	Vlad Taru	Received

2330-SAT	Bioelectrical Impedance Analysis Provides Novel Insights into Factors Associated with Sarcopenia in Decompensated Cirrhosis	Somaya Albhaisi	Received

2335-SAT	Impact of Frailty on Clinical Outcomes Among Hospitalized Patients With Hepatorenal Syndrome: A Nationwide Analysis from 2018-2022	Daniel Gonzalez Mosquera	Received

2336-SAT	Aetiology-specific patterns of hepatic recompensation in alcohol-related and viral hepatitis B and C cirrhosis: a Baveno multicentre study	Benedikt Hofer	Received

2337-SAT	Readmission Rates for Patients with Cirrhosis in Saskatoon	Sushila Pathak	Received

2338-SAT	Measured Sleep Quality and Consistency are Associated with Impaired QoL and Sleep Function in Patients with Cirrhosis	Olivia Blocker	Received

2339-SAT	Direct Oral Anticoagulants versus Enoxaparin for Portal Vein Thrombosis in Cirrhosis without HCC:A Real-World Comparative Study	Mohamed Nadeem	Received

2342-SAT	Higher platelet counts define a low-risk subgroup among recompensated HBV cirrhosis: a propensity-matched cohort study	Bingqiong Wang	Received

2343-SAT	Spleen and Liver SSI-shear wave elastography accurately assess the risk for clinically significant portal hypertension - the prospective AIXPLORE study	Christian Sebesta	Received

2344-SAT	Prognostic performance of the enhanced liver fibrosis (ELF) test in patients with advanced chronic liver disease.	Georg Kramer	Received

2345-SAT	Prognostication of liver disease patients via ARFI-based Liver Stiffness Measurement using the WFUMB ´Rule-of-4´ algorithm	Christian Sebesta	Received

2346-SAT	Novel Therapeutic Strategy for Portopulmonary Hypertension Targeting Portosystemic Shunts	Tsuyoshi Ishikawa	Received

2347-SAT	Rifaximin Monotherapy Is Superior to Lactulose Monotherapy in Reducing the Risk of Hepatic Encephalopathy Recurrence: Insights From a Subgroup Analysis by Baseline Characteristics	Jasmohan Bajaj	Received

2348-SAT	The Effect of Hepatic Encephalopathy Serum on the Firing Patterns of Primary Rat Neurons	David Yardeni	Received

2349-SAT	High-fidelity natural language processing model for automated extraction of radiologic biomarkers to study cirrhosis outcomes	Peiyun Ni	Received

2351-SAT	Predictors and Significance of Elevated Lipase in Patients Undergoing Expedited Liver Transplant Evaluation	Peyton Crest	Received

2352-SAT	Elective TIPS and Kidney Function: Prospective Assessment of eGFR Trajectories and Impact on Clinical Outcomes in the Advancing Liver Therapeutic Approaches (ALTA) Study Group	Giuseppe Cullaro	Received

2353-SAT	Necrotizing Fasciitis in Cirrhosis: A Prospective Study of Clinical Features and Outcomes Compared to Non-Cirrhotic Patients	Mallikarjun Patil	Received

2355-SAT	Pre-admission rifaximin use is not associated with Infection with Drug Resistant Organisms in a Global Cohort of Inpatients with Cirrhosis	Jasmohan Bajaj	Received

2356-SAT	Prevalence and clinical outcomes of recompensation in decompensated cirrhosis: a systematic review and meta-analysis	May Xuan Goh	Received

2357-SAT	Efficacy of Intravenous Albumin for Management of Cellulitis Among Patients with Liver Cirrhosis	Akash Shukla	Received

2358-SAT	A simple score of sarcopenic obesity predicts all-cause mortality in patients with cirrhosis	Rui Huang	Received

2359-SAT	Statin Use in Liver Transplant Candidates with Decompensated Cirrhosis: A Multicenter Safety Analysis	Rishaan Sharma	Received

2360-SAT	Evaluation of sarcopenia-related muscle decline in patients with liver cirrhosis for rehabilitation	Hiroyuki Abe	Received

2361-SAT	Incidence, risk factors, and outcomes of major adverse kidney events in patients with decompensated cirrhosis	Rakhi Maiwall	Received

2363-SAT	Real-World Comparative Outcomes of Terlipressin Use in Hepatorenal Syndrome: A Propensity Score-Matched Analysis of U.S. Hospitalized Patients	Romelia Barba	Received

2364-SAT	Plasma ammonia levels over the course of a hospitalisation for overt hepatic encephalopathy	Davide Erminelli	Received

2365-SAT	Ultrasound muscular thickness-based model to identify sarcopenia in patients with portal hypertension (PH): a cross-sectional single-center observational study	Martina Lucà	Received

2366-SAT	Interpreting Spleen Stiffness Measurement: The Role of Technical Reliability Criteria in Clinical Decision-Making	Elizabeth Williams	Received

2368-SAT	Underutilization of Statins in Younger Cirrhotic Patients Despite Hepatoprotective Benefits: A Propensity-Matched Real-World Study	Mohammad Adam	Received

2371-SAT	Rifaximin Use is Associated with Reduced Mortality and Hospitalizations in Cirrhotic Patients: A Global Cohort Study	Mohamad Mahdi Osman	Received

2373-SAT	Point-of-Care Ultrasound-Based Volume Status Metrics as Predictors of Hepatorenal Syndrome-Acute Kidney Injury in Hospitalized Patients with Cirrhosis: A Prospective Cohort Study	Daniel Alvarez	Received

2374-SAT	Cirrhosis as an Independent Risk Factor for Mortality in Hospitalized Patients with Aspiration Pneumonia: A Nationwide Inpatient Sample (NIS) Study	Angelin Raju	Received

2375-SAT	Belapectin Maintains a Favorable Trend in Reducing Variceal Development Over 36 Months in MASH Cirrhosis: Results from the NAVIGATE Trial	Eric Lawitz	Received

2376-SAT	Micronutrient deficiencies in patients with cirrhosis: a contemporary evaluation	Jennifer Lai	Received

2378-SAT	Liver Stiffness as a Predictor of Myopenia and Functional Muscle Decline in Advanced Liver Disease: A Call for Refined Diagnostic Cutoffs	Lourianne Cavalcante	Received

2380-SAT	Incidence of Hepatorenal Syndrome in the Hospitalized U.S. Pediatric Population (2019-2023): A Retrospective Real-World Healthcare Database Analysis	Xingyue Huang	Received

2381-SAT	It is cost-effective to screen and treat patients with dementia for undiagnosed hepatic encephalopathy	Vinay Jahagirdar	Received

2382-SAT	Recombinant human ADAMTS13 attenuates LPS-induced acute kidney injury and renal microangiopathy in mice with liver cirrhosis via cleavage of vWF	Kosuke Kaji	Received

2383-SAT	When the Mind Meets the Liver: A Real-World Look at Mood and Mortality in Cirrhosis	Muhammad Ali Ibrahim Kazi	Received

2384-SAT	Muscle Composition Matters: MRI-Based Myosteatosis Strongly Correlates with Physical Function in Cirrhosis	Maria Rydfjord	Received

2385-SAT	The Role of Liver Stiffness in Assessing the Severity of Portal Hypertension and Stratifying Long-Term Prognosis: A Comparison of Viral and Non-Viral Etiologies	Tatsuro Nishimura	Received

2386-SAT	Predictors of Ascites Resolution in Patients with Hepatitis C Cirrhosis after Etiological Cure	Daniela Goyes	Received

2387-SAT	Impact of Chronic Kidney Disease on Outcomes of Acute Kidney Injury in Decompensated Cirrhosis: A Post-Hoc Analysis of the International Club of Ascites GLOBAL-AKI Study	Kavish Patidar	Received

2388-SAT	Sex-specific effect of estradiol on cholestatic liver cirrhosis and portal hypertension	Fabian Schachteli	Received

2389-SAT	Albumin in the Management of Hepatorenal Syndrome-Acute kidney Injury (HRS-AKI): Is There Ever Too Much?	Florence Wong	Received

2390-SAT	Ascitic Neutrophil Count at Initial Paracentesis Is Associated with Adverse Outcomes in Cirrhosis	Alp Kahveci	Received

2391-SAT	Impact of intravenous albumin administration on clinical outcomes after variceal hemorrhage in patients with cirrhosis: A randomized controlled trial	Sagnik Biswas	Received

2392-SAT	Endoscopic Variceal Ligation Alone or in Combination with Non-Selective Beta Blockers for Secondary Prophylaxis in Children with Non-Cirrhotic Portal Hypertension- A Randomized Control Trial	Srinivas Srinidhi Vadlapudi	Received

2393-SAT	Terlipressin Use Leads to a Significantly Reduced Creatinine Among Hospitalized Patient with Hepatorenal Syndrome When Compared with Midodrine/Octreotide in a Real-World Experience	Tanvi Goyal	Received

2395-SAT	Hepatologists´ Experience in Using Terlipressin for Treatment of Hepatorenal Syndrome-Acute Kidney Injury	Rachel White	Received

2396-SAT	Post-Polypectomy Bleeding in Patients with Cirrhosis: A Systematic Review of Risk, Predictors, and Procedure-Related Factors	Talal Bhatti	Received

2397-SAT	Enhanced Rifaximin Drug Release Across Gastrointestinal Tract pH Conditions With Soluble Solid Dispersion (SSD) Immediate-Release (IR) Tablets: A Comparative in Vitro Study Versus Rifaximin 550 mg Tablet Formulation	Christopher Allen	Received

2399-SAT	Risk of serious infection and mortality in patients with compensated cirrhosis and decompensated cirrhosis	Kyoung A Ko	Received

2400-SAT	Real-World Outcomes Following Terlipressin Use in Hepatorenal Syndrome: A Multi-Center U.S. EHR Analysis	Romelia Barba	Received

2401-SAT	Real-world Treatment Patterns and Outcomes Among Hospitalized U.S. Adults with Hepatorenal Syndrome-Acute Kidney Injury Treated with Terlipressin	Alfred Barritt IV	Received

2403-SAT	TIPS-Attributable Mortality Is Predicted by MELD Variants, Not Non-TIPS Deaths: Evidence from the ALTA Study Group	Heesoo Yoo	Received

2405-SAT	Bariatric Surgery Is Associated With Reduced Risk of Hepatic Decompensation and Improved Survival in Obese Patients With Cirrhosis: A Propensity-Matched TriNetX Study	Archana Kharel	Received

2406-SAT	Targeting the Hidden Risk: Rifaximin Lowers the Risk of New Onset of Hepatic Encephalopathy in Patients with Hepatocellular Carcinoma and Splenorenal Shunt Receiving Lenvatinib	Takumi Kawaguchi	Received

2407-SAT	Timing Matters: Comparative Analysis of Early vs. Late TIPS in Variceal Bleed Management	Het Patel	Received

2408-SAT	Epidemiology and Outcomes of Systemic Mycoses in Hospitalized Patients with Cirrhosis: A 5-Year National Inpatient Sample Analysis	David Maundu	Received

2409-SAT	Validating the urinary chloride dipstick as a potential biomarker for predicting decompensation in patients with cirrhosis	Susan Fischer	Received

2410-SAT	Comparative Outcomes Following AKI versus Non-AKI Hospitalizations in Patients with Decompensated Cirrhosis: An Analysis of Post-Discharge Trajectories	Chip Bowman	Received

2411-SAT	In-Hospital Outcomes After PCI in Patients With Cirrhosis: A Contemporary Nationwide Inpatient Sample Analysis (2016-2022)	Abdullah Hafeez	Received

2412-SAT	Recompensation improve survival and reduces further decompensation in a nationwide cohort of patients with acute variceal bleeding	May Xuan Goh	Received

2413-SAT	Concordance Between Baveno VII Recommendations and Real-World Practice in the Management of Portal Hypertension in Cirrhosis: A Nationwide Auditew Submission	LUCY MEUNIER	Received

2414-SAT	Impact of Cirrhosis on Outcomes in Acute Cholecystitis: A Nationwide Analysis	Angelin Raju	Received

2415-SAT	Secondary Spontaneous Bacterial Peritonitis prophylaxis is associated with a higher rate of SBP recurrence in Non-Cirrhotic Patients: A Propensity-Matched Analysis Using a Nationwide EMR Database	Mohammed Aloqaily	Received

2416-SAT	Non-Invasive Prediction Models of First Hepatic Decompensation in Compensated Advanced Chronic Liver Disease - A Systematic Review and Meta Analysis	Angus Jeffrey	Received

2418-SAT	Ascites Pressure Accounts for Patient Reported Measures and is a MELD-independent Predictor of One Year Outcomes After Paracentesis	Nikhilesh Mazumder	Received

2419-SAT	Splenic stiffness measurement as a noninvasive marker for monitoring dose of carvedilol in cirrhotic patients with high risk varices	Virendra Singh	Received

2422-SAT	The performance of shear wave elastography-based liver and spleen stiffness measurement in predicting high-risk varices and hepatic decompensation in patients with hepatocellular carcinoma	Kessarin Thanapirom	Received

2423-SAT	Lower BMI and Snare Polypectomy are Associated with a Higher Rate of Postpolypectomy Bleeding in Patients with Cirrhosis	Brian Yan	Received

2424-SAT	Vibration-Controlled Transient Elastography as a Non-Invasive Predictor of Sarcopenia in Cirrhosis: Establishing a Threshold for Risk Stratification	Lourianne Cavalcante	Received

2425-SAT	Using FIB-4 to Uncover Undiagnosed Cirrhosis in Patients with Dementia: A Quality Improvement Initiative	Vinay Jahagirdar	Received

2426-SAT	Real World Multi-Center Evaluation of the Use of Terlipressin for HRS-AKI in the United States	Prutha Shah	Received

2427-SAT	Is Time Liver? Comparing Outcomes of Early versus Late Paracentesis in Patients with Advanced Chronic Liver Disease (ACLD)	Nisha Sanghani	Received

2428-SAT	A Large Language Model (LLM) Approach for Screening Literature and Drafting Systematic Reviews and Meta-Analyses Using the Efficacy of Carvedilol on Decompensation and Mortality Compensated Cirrhosis as a Motivating Example	Yuntao Zou	Received

2429-SAT	Endoscopic Ultrasound (EUS)-guided portal pressure gradient measurement: clinical usefulness including assessment of acute response to propranolol	Rafael Romero-Castro	Received

2430-SAT	Enhanced Early Detection of Hepatocellular Carcinoma Using the GALAD Score in Vietnamese Cirrhotic Patients: A Prospective-Retrospective Cohort Study	Thong Vo	Received

2431-SAT	Predictive Accuracy of MELD 3.0 and MELD-Na scores for Mortality and Rebleeding After Endoscopic Hemostasis in Cirrhosis-Associated Variceal Hemorrhage: A Multicenter Study	Shinya Yokoyama	Received

2432-SAT	Safety of Testosterone Supplementation in Men with Cirrhosis and Hypogonadism: A Propensity Score-Matched Study from a Multinetwork Study	Tinsae Tsegaye Anebo	Received

2433-SAT	Baseline Characteristics and in-hospital outcomes of patients with cirrhosis undergoing coronary artery bypass grafting (CABG): A Seven-Year Analysis from the National Inpatient Sample	Omar Alkasabrah	Received

2434-SAT	Efficacy and safety of recombinant human thrombopietin injection in patients with chronic liver disease-related thrombocytopenia scheduled for invasive surgery: a multicenter, randomized, double-blind, parallel-group, placebo-controlled study	Yifan Han	Received

2436-SAT	Comparative Outcomes of Respiratory Syncytial Virus Vaccination and Infection in Hospitalized Patients with Advanced Liver Disease	Adil Fazir	Received

2437-SAT	Oral Cholate Challenge Test Characterizes Functional Differences between Child-Pugh A5 and A6	Naga Chalasani	Received

2439-SAT	Finerenone in the Management of Portal Hypertension and Ascites	Butros Fakhoury	Received

2441-SAT	Efficacy and safety of oral Ibandronate in patients of liver cirrhosis with hepatic osteodystrophy: A randomized, double blind, placebo-controlled trial[NCT06022237]	Sudhir Verma	Received

2442-SAT	Visceral adiposity area (VAT)-based sarcopenic obesity significantly increases cirrhotic patients´ risk of liver disease-related mortality	Guo Feng	Received

2443-SAT	Use of piperacillin-tazobactam in patients hospitalised with complications of cirrhosis in ATTIRE was associated with increased mortality	Alastair O´Brien	Received

2444-SAT	The ALBI score, a prognostic marker in advanced hepatic fibrosis: a prospective single-center study.	Bénédicte Delire	Received

2446-SAT	Sarcopenia is an independent predictor of further decompensation and mortality after endoscopic and endovascular interventions for secondary prophylaxis of gastric varices in patients with cirrhosis: A multicentre, real-world study	Sagnik Biswas	Received

2447-SAT	Clinical Perspectives on Long-Term Albumin Therapy in Decompensated Cirrhosis: A Nationwide Delphi Survey in Spain (The ALBA Study)	Elsa Solà	Received

2448-SAT	Sarcopenia is Associated with Worse Inpatient Outcomes and Increased Procedure Utilization in Hospitalized Cirrhotic Patients: A Nationwide Analysis	Mohamed Omar	Received

2449-SAT	Efficacy and Safety of Avatrombopag in Chronic Liver Disease Patients with Thrombocytopenia Undergoing Elective Surgery	Weihua Cao	Received

2453-SAT	Operationalizing a walking exercise prescription based on 6-minute walk test results	Joshua Sepic	Received

2454-SAT	Dynamic Lactate Clearance Predicts Mortality in Decompensated Cirrhosis: A Prospective Mexican Cohort	Emilio Sandoval-Gonzalez	Received

2455-SAT	Priority outpatient paracentesis prevents unplanned presentations	Janis Fernandes	Received

2456-SAT	Impact of Helicobacter pylori on liver outcomes in cirrhotic patients: a retrospective cohort	Mohammed Al-Aquily	Received

2460-SAT	Splenic stiffness and size differentiates Non Cirrhotic Portal Fibrosis and Extra Hepatic Portal Vein Obstruction in children: Prospective Observation Study.	Sanjeev Verma	Received

2461-SAT	Warning Notice for a Short-Term Elevation of Ammonia Levels Following Splenic Artery Embolization	Tsuyoshi Ishikawa	Received

2462-SAT	Fluid in the Lungs: Exploring the Association between B-line Burden on Point-of-Care Ultrasound and Markers of Right-sided Pressure Overload in Hospitalized Patients with Cirrhosis.	Daniel Alvarez	Received

2463-SAT	Is Substituting Serum Creatinine for Serum Cystatin C in Calculating MELD Scores More Appropriate for Assessing the Severity of Chronic Liver Disease?	Jeff Angelo Taclob	Received

2464-SAT	The safety of ACEi/ARBs in patients with cirrhosis	Nirmal Desai	Received

2465-SAT	Impact of Guideline-Based Acute Kidney Injury Care Processes on Outcomes in Hospitalized Patients with Decompensated Cirrhosis	Kavish Patidar	Received

2466-SAT	Non-Invasive Diagnostic Model for High-Risk Gastroesophageal Varices in Cirrhotic Patients Using Spleen Volume, Platelet Count, and Serum Albumin	Wenjun Wang	Received

2468-SAT	Experience and Confidence of Gastroenterology Faculty and Fellows in Placement of Balloon Tamponade Devices in Acute Variceal Hemorrhage	Jessica Vadaketh	Received

2469-SAT	Comparative Risks of Respiratory Syncytial Virus, COVID-19 and Influenza A in in Hospitalized Patients with Advanced Liver Disease	Adil Fazir	Received

2470-SAT	Patients With Decompensated Cirrhosis Have Reduced Fat and Muscle Volumes Compared to Compensated Cirrhosis: A Whole-Body MRI Study	Maria Rydfjord	Received

2471-SAT	Predictors of In-Hospital Mortality in Patients with Cirrhosis: A Multicenter Retrospective Study from Ethiopia	Tamrat Petros Elias	Received

2472-SAT	The Association of Liver Frailty Index and Cardiac Dysfunction in Patients Undergoing Transplant Evaluation	Hannah Laird	Received

2475-SAT	Dynamic Risk Modeling of Hepatocellular Carcinoma from Markov Chain Analysis with Curative Intent	Glenn Ho	Received

2476-SAT	Hernia Incarceration Is a Common Complication After TIPS: An Analysis of Incidence and Associated Risk Factors	Anand Vissa	Received

2477-SAT	Involvement of the ADAMTS13/von Willebrand factor axis in acute kidney injury in mice with advanced fibrotic liver	NORIHISA NISHIMURA	Received

2479-SAT	Risk factors and prediction model for sarcopenia in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt	Xinxing Tantai	Received

2480-SAT	Lean Patients with Metabolic Dysfunction Associated Steatotic Liver Disease Have Higher Liver-Related Events and Mortality	Abdellatif Ismail	Received

2481-SAT	Prediction and prognostic utility of a cirrhosis risk score in Chinese adults: derivation and validation cohort study	Xinyu Wang	Received

2482-SAT	Favorable trends in transient elastography and metabolic parameters in cystic fibrosis patients after two years of Elexacaftor/tezacaftor/ivacaftor therapy.	Souhir Hendis	Received

2483-SAT	Type 2 diabetes is associated with higher risk of incident liver fibrosis and lower likelihood of fibrosis regression in the general population: Longitudinal results from the LiverScreen consortium.	Jesse Pustjens	Received

2484-SAT	Risk Factors for Drug-Related Hepatic Steatosis: A Pharmacovigilance Study from the FDA Adverse Event Reporting System (FAERS)	Yanjie Lin	Received

2485-SAT	Optimal hemoglobin A1c (HbA1c) target for preventing liver-related complications in individuals with type 2 diabetes mellitus (T2DM) with and without cirrhosis: a territory-wide retrospective cohort study from 2000 to 2023 of 1,130,282 individuals	Mary Yue Wang	Received

2487-SAT	Effect of Hypertension on Long-term Adverse Clinical Outcomes and Liver Fibrosis Progression in Metabolic Dysfunction-Associated Steatotic Liver Disease	Ming-Hua Zheng	Received

2489-SAT	Evaluating the association of patient characteristics on hospitalizations among a cohort of Canadian MASLD patients in primary care	Elizabeth Baguley	Received

2490-SAT	Elevated Risk of Gastrointestinal Cancers in Lean MASLD: A Propensity-Matched Cohort Study	Omar Al Ta´ani	Received

2491-SAT	Risk Factors and Definition of Early Onset Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Cirrhosis	Veeral Ajmera	Received

2492-SAT	Tamoxifen is Associated MASLD Progression in Women with ER+ Breast Cancer: A Multicenter Retrospective Cohort Study	Emma Leipsner	Received

2493-SAT	Hypothyroidism and risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)	Xinrui Jin	Received

2494-SAT	IMPACT OF FIRST AND FURTHER DECOMPENSATION IN METABOLIC-DYSFUNCTION ASSOCIATED COMPENSATED ADVANCED CHRONIC LIVER DISEASE	Grazia Pennisi	Received

2495-SAT	Longitudinal Changes in Steatotic Liver Disease Subtype Classification and Subsequent Risk of Major Adverse Liver Outcomes: A Landmark Analysis	Pedro Ochoa-Allemant	Received

2496-SAT	Association of End-Stage Liver Disease with Steatotic Liver Disease Among People with and without HIV Infection	Jessie Torgersen	Received

2497-SAT	Refined indicators for MASLD-induced fibrosis detection safely reduce the need for screening by more than 50% in clinical care pathways	Laurens van Kleef	Received

2498-SAT	Machine Learning Models Accurately Predict Changes in FIB-4 Category for Patients with Diabetes Managed in Primary Care - An Analysis of 59,872 Cases	Chloe Yitian Guo	Received

2499-SAT	Semaglutide Discontinuation Among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)	Francis Lobo	Received

2500-SAT	Impact of protein and energy intake and physical activity on sarcopenia in chronic liver disease: A population-based study	Xinxing Tantai	Received

2501-SAT	Natural History of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Hispanic Patients: A Real-World Cohort Study Stratified by Fibrosis Severity	Robert Matson	Received

2502-SAT	Dynamics of LiverRisk Score and MAF-5 predict persistent liver stiffness elevation and normalization in the general population: Longitudinal results from the European LiverScreen project	Jesse Pustjens	Received

2503-SAT	Real-world use of PEth in a MASLD Clinic	Timothy Daugherty	Received

2504-SAT	Nationwide Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Prevalence in Saudi Arabia: Insights from the GENESIS Population-Based Cohort Study	Saleh Alqahtani	Received

2505-SAT	Corrected T1 value in liver MRI is associated with all-cause, cardiovascular-related mortality and liver-related outcome with lower cut-off value of 700ms.	Ju Dong Yang	Received

2506-SAT	Frequency and significance of variants in lysosomal acid lipase (LAL) gene in a large cohort of individuals with metabolic dysfunction associated steatotic liver disease (MASLD)	Chaowapong Jarasvaraparn	Received

2507-SAT	Metabolic dysfunction is associated with the development of hepatocellular carcinoma, hepatic decompensation, and reduced survival, independent of liver disease etiology	Ming-Lun Yeh	Received

2508-SAT	Different cardiovascular risk identified by the KASL/EASL two-step pathway according to diabetes status in individuals with MASLD	Jaehong Jeong	Received

2509-SAT	Hepatic Fibrosis is Associated with Diastolic Dysfunction in the Absence of Overt Heart Failure in Metabolic Dysfunction-Associated Steatotic Liver Disease	Rabab Ali	Received

2510-SAT	Trends in Premature Mortality and Leading Causes of Death in the Spectrum of Steatotic Liver Disease (SLD) Including Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Alcohol-Related Liver Disease (ALD), and Metabolic Dysfunction and	Dana Ivancovsky Wajcman	Received

2511-SAT	Sex Disparities and Epidemiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Globally in 2021 with Forecasting to 2050.	Charles Levesley	Received

2512-SAT	The genetic architecture of metabolic syndrome suggests common underlying biology and genetic predisposition with MASLD: Insights from enhanced polygenic risk scores	Carlos Pirola	Received

2513-SAT	Rate of Increase in Apolipoprotein B (apoB) during Early Adulthood and Prevalent MASLD in Mid-life: The Coronary Artery Risk Development in Young Adults (CARDIA) Study	Seong Park	Received

2514-SAT	Women´s Health and MASLD: The Critical Role of HDL Cholesterol in Both Obese and Non-Obese Women	Tsubasa Tsutsumi	Received

2515-SAT	A systematic review and meta-analysis: does liver disease represent an independent risk factor for cardiovascular disease in patients with metabolic dysfunction-associated steatotic liver disease?	Alexander Hung	Received

2516-SAT	Steatotic Liver Disease Phenotypes in Inflammatory Bowel Disease: A Screening Study Identifying MASLD as the Primary Driver of Liver Fibrosis	Dana Kablawi	Received

2517-SAT	Influence of Cardiometabolic Risk Factors and Alcohol Consumption on Liver Stiffness in Patients with MASLD: A Multicenter Study in Colombia Influence of Cardiometabolic Risk Factors and Alcohol Consumption on Liver Stiffness in Patients with MASLD: A M	ISMAEL YEPES	Received

2519-SAT	Independent Association Between Vitamin D Insufficiency and Liver Fibrosis in People with HIV, regardless of Metabolic Dysfunction-associated Steatotic Liver Di	Francesca Farina	Received

2520-SAT	Steatosis-associated fibrosis estimator (SAFE) outperforms other blood-based biomarkers for predicting major adverse liver outcomes in the community	Vincent Chen	Received

2521-SAT	Spleen, liver, muscle, and fat traits are associated with major adverse liver outcomes and liver-related mortality in metabolic dysfunction-associated steatotic liver disease	Vincent Chen	Received

2522-SAT	Screening for Fibrotic MASH in Subjects with Diabetes in the Population: Optimizing the Strategy using Imperfect Tools	Thuy-Duyen Nguyen	Received

2523-SAT	Key Diagnostic Factors in Steatotic Liver Disease and Their Longitudinal Impact on Overall Mortality	Do Han Kim	Received

2524-SAT	Comprehensive risk assessment of gastrointestinal cancer in patients with MASLD, MetALD, and ALD	Nobuharu Tamaki	Received

2527-SAT	Semaglutide Titration Patterns Among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)	Francis Lobo	Received

2528-SAT	Monitoring Liver Disease Progression Using Serial Transient Elastography Assessments in a Large Real-World Cohort of Patients with Type 2 Diabetes and MASLD	Laurent Castera	Received

2529-SAT	Implications of Expanded Advanced Fibrosis Screening Strategies for MASLD in Primary Care	Kush Patel	Received

2531-SAT	Trends in Mortality from Metabolic Dysfunction-Associated Steatotic Liver Disease, Chronic Kidney Disease, and Diabetes Mellitus in the United States, 1999-2020	Yash Hegde	Received

2532-SAT	Multiomics Signatures of Adiposity and Adverse Liver Outcomes: A Prospective Cohort Study	Longgang Zhao	Received

2534-SAT	Evaluating the association of patient characteristics on emergency department use among a cohort of Canadian MASLD patients in primary care	Elizabeth Baguley	Received

2535-SAT	An Innovative Screening and Treatment Pathway for Metabolic Dysfunction-Associated Steatotic Liver Disease: The UK-CURES Approach	Lindsey Sheehan	Received

2536-SAT	GLP-1 Receptor Agonists Use is Associated with Lower Liver- and Cardiac-Related Events in Patients with MASH Cirrhosis with Type 2 Diabetes: A Multinational Analysis	Do Han Kim	Received

2537-SAT	Increasing prevalence of chronic liver disease in the U.S.: a state-level and liver disease etiology-specific modeling study	Michael Le	Received

2541-SAT	Cost-effectiveness of semiannual hepatocellular carcinoma surveillance (HCC) in patients with metabolic dysfunction associated steatotic liver disease (MASLD) without cirrhosis: a Markov modeling study	Joanne Liu	Received

2542-SAT	Determinants of Hepatic Steatosis Among Baltimore PWID	Redeat Assefa	Received

2543-SAT	Racial Disparities in MAESTRO-NAFLD-1: A Geographic and Demographic Analysis of a Phase 3 Trial for Resmetirom	Rahul Thakkar	Received

2544-SAT	Impact of Cirrhosis Etiology on Outcomes After TIPS: A National Cohort Study	Gurmehr Brar	Received

2545-SAT	Risk of microvascular and macrovascular complications in patients with type 2 diabetes and cirrhotic metabolic dysfunction-associated steatohepatitis: a retrospective cohort study	Semiu Gbadamosi	Received

2547-SAT	Hispanic or Latino Patients with Compensated MASH Cirrhosis Have a Higher Rate of Adverse Outcomes Compared to Non-Hispanics or Non-Latino	Aryan Ayati	Received

2548-SAT	Metabolic dysfunction-associated steatotic liver disease (MASLD) in individuals with Obstructive sleep apnea (OSA): A meta-analysis	Tanya Gupta	Received

2549-SAT	Unveiling the Prognostic Burden of MetALD: A Multicenter Biopsy-Based Study: A Nationwide Biopsy-Based Study of 2,131 Patients	Takuma Nakatsuka	Received

2550-SAT	Prevalence of Liver Fibrosis in Relatives of Patients with MASLD-Related Cirrhosis: A Study on Degree of Kinship	ISMAEL YEPES	Received

2551-SAT	Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-Analysis	Faith Tan	Received

2552-SAT	Legacy Referral Bias: Reflexive Referral Behavior Limits the Effectiveness of FIB-4 Smart Tools in MASLD Triage	Ruona Ebiai	Received

2553-SAT	Predictors of Incident Hepatic Fibrosis and Steatotic Liver Disease-Associated Fibrosis Among Women with and Without HIV	Maria Duarte	Received

2556-SAT	Any amount of alcohol intake increases the risk of significant fibrosis and fibrotic MASH in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) - Insights from 7189 patients from Indian Consortium on MASLD (ICOM-D).	Ajay Duseja	Received

2557-SAT	Prognostic Nutritional Index (PNI) as a prognostic factor for HCC patients stratified by status of MASLD	Chun-Ting Ho	Received

2558-SAT	Cardiovascular Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Fatty Liver Disease: Results from Two Nationwide Cohort	Moon Haeng Hur	Received

2559-SAT	Interacting effect of alcohol, adiposity and genetic risk on steatotic liver disease in young adults	Eduardo Vilar-Gomez	Received

2561-SAT	Associations of Device-Measured Sedentary Behavior with Health-Related Quality of Life in Metabolic Dysfunction-Associated Steatotic Liver Disease patients	Hadeel Saad	Received

2562-SAT	Genetic risk of steatotic liver disease and its severity among people living with HIV	Eduardo Vilar-Gomez	Received

2563-SAT	Statin use reduces liver fibrosis progression in patients with low-risk chronic liver disease	Vy Nguyen	Received

2564-SAT	Lean MASLD: reclassification discrepancies, characteristics, and adverse liver outcomes across diverse populations	Terry Cheuk-Fung Yip	Received

2565-SAT	Global Prevalence and Risk of High-Risk Genetic Polymorphisms in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review and Meta-analysis	Kaanthi Rama	Received

2566-SAT	BMI and Dietary Intake as Modifiable Predictors of Postpartum Steatotic Liver Disease: Results from the Prospective Fatty Liver in Pregnancy (FLIP) Cohort	Cecilia Katzenstein	Received

2569-SAT	Sex-based differences in liver fibrosis progression among adults aged 55 and older with MASLD: an analysis of a national database	Kate Solpari	Received

2570-SAT	Comparing the risk of major adverse cardiovascular and liver outcomes in patients with probable MASH to those with diagnosed MASH and without MASH	Caichen Zhong	Received

2571-SAT	The Impact of High Fructose Corn Syrup on Liver Injury and Glucose Metabolism: A Systematic Review	Maimuna Marenah	Received

2572-SAT	Enhancing Metabolic Dysfunction Associated Steatotic Liver Disease Screening and Documentation: The Impact of an Educational Intervention in a Primary Care Clinic	Nadera Altork	Received

2573-SAT	Transjugular Intrahepatic Portosystemic Shunt Yields Similar Clinical Outcomes in MASH and Alcoholic Cirrhosis: A Multinational Analysis	Donghyun Ko	Received

2574-SAT	Assessing MASLD and Liver Fibrosis with Transient Elastography: Findings from a Multicenter Population-Based Study in Mexico	Luis Enrique Gutiérrez Rosas	Received

2575-SAT	From Hotspots to Blindspots: A Global View of MASH Research Disparities Over Time	Renan Prado	Received

2577-SAT	PNPLA3 p.I148M Polymorphism is associated with the Risk of Liver Fibrosis in Patients with Breast Cancer receiving Long-term Tamoxifen Therapy	Wonseok Kang	Received

2578-SAT	Integrating FIB-4 Scoring into Primary Care to Detect Advanced Fibrosis in Patients with Metabolic Risk: A Multicenter Pilot Implementation Study	Noor Albusta	Received

2579-SAT	Disparities in outcomes and complications of alcohol-related and NASH-related cirrhosis: A nationwide perspective	Abdelhaleem Sideeg	Received

2580-SAT	Associations of Cardiovascular Health with Hepatic Fibrosis, MASLD and MetALD in the Framingham Heart Study	Alejandro Campos	Received

2581-SAT	Muscle Function Correlates with Disease Severity in Patients with MASLD. A Prospective Study	Mary Olayiwola	Received

2582-SAT	MASLD vs MetALD: Distinct Clinical Phenotypes in a Central European Cohort	Jerzy Jaroszewicz	Received

2584-SAT	Longitudinal Association Between Change in Cardiovascular Health and Incident Hepatic Steatosis	Alejandro Campos	Received

2585-SAT	METABOLIC MATCHUP: COMPARING SGLT2, GLP-1, AND DUAL AGONISTS IN NASH/MASLD RISK AMONG DIABETICS	Muhammad Ali Ibrahim Kazi	Received

2586-SAT	Acculturation Is Associated with Improved Liver Measurements Among Mexican Americans with Metabolic Dysfunction-Associated Steatotic Liver Disease	Sharan Poonja	Received

2587-SAT	Distinct Phenotypic and Comorbidity Profiles of Lean versus Non-Lean Young Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Study from ´All of Us´ Research Program	Thanathip Suenghataiphorn	Received

2588-SAT	Long-Term Health and Economic Impact of Cigarette Taxation on Smoking-Attributable Burden of Metabolic dysfunction-associated fatty liver disease (MAFLD) in the United States: A GBD Lifetime Simulation Study	Thanathip Suenghataiphorn	Received

2589-SAT	Steatotic Liver Disease Subtypes and Colorectal Cancer: A Large-Scale Risk Analysis Including Fibrosis	takefumi kimura	Received

2591-SAT	Mortality by Cardiometabolic Risk Factor and Alcohol Consumption in Steatotic Liver Disease: A Nationwide Cohort Study	Yewan Park	Received

2592-SAT	Shifting Trends in U.S. Steatotic Liver Disease Care: Patient-Reported Insights from the 2022-2025 SLD Care Survey	Tiffany Mensah	Received

2593-SAT	Significant Differences in Dietary Patterns between Rural versus Urban Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: A Prospective Study	Swetha Tummala	Received

2594-SAT	Demographic and Metabolic Disparities in Steatotic Liver Disease Progression during COVID using the National Health and Nutrition Examination Survey (NHANES) 2021-2023	Kimberly Ho	Received

2595-SAT	High Burden of MASLD and Risk of Fibrosis in Type 1 Diabetes: Preliminary results from FibroScan-Based Screening	Khalid Alswat	Received

2596-SAT	Primary Care Perspectives on Diagnosis and Management of MASLD: Identifying Gaps and Opportunities in the Dallas-Fort Worth Area	Jeevin Sandhu	Received

2597-SAT	High prevalence of Portosinusoidal Vascular Disease in early stage Metabolic Dysfunction Associated Steatotic Liver Disease	Diederick van Doorn	Received

2598-SAT	The Impact of Statin Therapy on MASLD Prevalence and Severity: Analysis of a Community-Based, Prospective Cohort of 717 Adults with Overweight and Obesity	Monica Tincopa	Received

2599-SAT	Type 2 Diabetes Mellitus is Associated with Accelerated Progression to Cirrhosis and Chronic Kidney Disease in Patients with MASLD: A Real-World Multi-Center Cohort Study	Vaishnavi Modi	Received

2600-SAT	Cardiometabolic Burden Increases the Risk of Kidney Failure in a Dose-Dependent Manner Among Patients with Steatotic Liver Disease	Han-Tse Cheng	Received

2601-SAT	Unrecognized Fibrosis Risk in MASLD: A Real-World Analysis and the Case for AI-Augmented Stratification	Ruona Ebiai	Received

2602-SAT	Association of Pulmonary Hypertension with Hepatic Outcomes in Patients Undergoing Right Heart Catheterization: A Propensity-Matched Cohort Study	Akshay Sharma	Received

2603-SAT	Low Fat and Low Carbohydrate Diets Are Associated with Worse Survival in Subjects with Metabolic Dysfunction and Alcohol Associated Steatotic Liver Diseases.	Nicholas Dunn	Received

2604-SAT	Decoupling of hepatic steatosis and liver disease among Baltimore PWID	Jacqueline Rudolph	Received

2605-SAT	Sedentary lifestyle is associated with steatotic liver disease (SLD): results from three large US prospective cohorts.	Prooksa Ananchuensook	Received

2606-SAT	GCKR polymorphisms increase the risks of low bone mineral density in young and non-obese patients with MASLD and hyperuricemia	Ying-Ying Yang	Received

2607-SAT	Real-World Observational Data on MASLD in a Diverse Cohort from a Single Hepatology Clinic in Southern California: Racial and Ethnic Disparities and Impact of the Metabolic Syndrome on Fibrosis	Sabrina Alff	Received

2608-SAT	METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN INFLAMMATORY BOWEL DISEASE: PREVALENCE AND PROGRESSION	Grazia Pennisi	Received

2609-SAT	The Obesity-MASH-Sarcopenia Cascade: Metabolic Paradox in Advanced Liver Disease	ATSUSHI NAKAMURA	Received

2610-SAT	Greater Contribution of Alcohol to Steatotic Liver Disease Epidemiology than Previously Estimated Among Veterans in the United States	Robert Wong	Received

2611-SAT	Female sex hormones are negatively associated with metabolic dysfunction-associated steatotic liver disease in children with overweight and obesity	Judith Lubrecht	Received

2612-SAT	Clinical and Genetic Predictors of Cryptogenic Steatotic Liver Disease as compared to Metabolic-Associated Steatotic Liver Disease in lean individuals	Angela Sato Espinoza	Received

2613-SAT	Semaglutide Use Among Individuals Diagnosed with Metabolic-dysfunction Associated Steatotic Liver Disease in a Medicare Advantage Population.	Francis Lobo	Received

2614-SAT	Demographic and Metabolic Predictors of MASLD Progression in Saudi Arabia: A Retrospective Cross-Sectional Analysis	Amani Alsadoon	Received

2615-SAT	The usefulness of non-invasive scoring systems for hepatocarcinogenesis, extrahepatic malignancies and cerebrocardiovascular disease in MASLD patients	Takashi Nishimura	Received

2616-SAT	Steatotic Liver Disease: A Key Upstream Risk Factor in the Emergence of Metabolic Syndrome-Related Disorder	Yoshihiro Kamada	Received

2617-SAT	Ramadan Fasting Enhances Hepatic and Cardiometabolic Profiles in MASLD: A Prospective Real-World Study	Khalid Alswat	Received

2618-SAT	Clinical characteristics and outcomes of patients with presumed MASLD who meet MetALD criteria in the TARGET-NASH cohort	Alfred Barritt IV	Received

2619-SAT	Patient experience of compensated and decompensated liver cirrhosis: a patient interview study	Preety Gautam	Received

2620-SAT	Liver fibrosis is more prevalent in MASLD patients with acute myocardial infarction and significant coronary heart disease.	Geert Robaeys	Received

2621-SAT	Health-Related Quality of Life (HRQoL) in Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Findings from the GENESIS Study in Saudi Arabia	Saleh Alqahtani	Received

2622-SAT	Evaluating the Impact of Cardiometabolic Risk Factors on Non-Invasive Testing and Histological Findings in MASH: A Tertiary Center Experience in North Texas	Jeevin Sandhu	Received

2623-SAT	Sex-Based Disparities in Advanced Liver Disease Outcomes Among Metabolic dysfunction-associated steatotic liver disease (MASLD) Patients: A 5-Year Real-World Multicenter Analysis	Rishi Chowdhary	Received

2625-SAT	Real-world prevalence of diagnosed metabolic dysfunction-associated steatohepatitis among Medicare beneficiaries	Husam Albarmawi	Received

2626-SAT	Erosive Esophagitis and MASLD: A Nationwide Cross-Sectional Analysis of Hospitalized Adults in the United States	Hima Varsha Voruganti	Received

2627-SAT	MASLD: Screening for Cardiovascular Disease	Sindhu Chadalawada	Received

2628-SAT	Exploring the Link Between Eosinophilic Esophagitis and MASLD in U.S. Hospitalized Adults	Hima Varsha Voruganti	Received

2629-SAT	Prevalence and Characteristics of Steatotic Liver Disease According to the New Nomenclature in a Japanese Health Checkup Population	Satoko Tajirika	Received

2630-SAT	MASLD etiology independently predicts 3-month hospital readmission in decompensated cirrhosis - A single-center study	Rohit Mehtani	Received

2631-SAT	Mind the gap: the disconnect between perceived and actual lifestyle in MASLD	Lorenzo Ciocca	Received

2632-SAT	Spontaneous Progression and Regression of Fibrosis in Metabolic Dysfunction Associated Steatohepatitis (MASH)	Zobair Younossi	Received

2634-SAT	Temporal Trends in Hepatic Steatosis and Its Risk Factors Among Young Adults: A Comparative Cohort Study	Abdullah Alsaeed	Received

2635-SAT	Hypertension Associated with the Risk of Female Reproductive System Cancers in MASLD population	Xinyue Zhao	Received

2636-SAT	Phenotypic and Metabolic Features of MASLD in Central Asian Populations Living in Moderate-Altitude Hypoxia	Nurgul Toktogulova	Received

2637-SAT	Prevalence of at-risk MASLD in patients with Type 2 Diabetes mellitus	Martin Kluge	Received

2638-SAT	Phenotypic Differences Between ALD and MASLD: Insights from a Veteran Cohort Using Revised SLD Criteria- A Retrospective Study	Thanita Thongtan	Received

2639-SAT	Role of metabolic dysfunction-associated steatohepatitis (MASH) as a risk factor for hepatocellular carcinoma (HCC) development	Robert Gish	Received

2640-SAT	Racial Disparity in MASLD/MASH Using a Predominantly African American Academic Medical Center	Paul Naylor	Received

2641-SAT	High Risk of Obstructive Sleep Apnea (OSA) Among Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Insights from the GENESIS Study Using the Berlin Questionnaire	Waleed Alhazzani	Received

2642-SAT	Muscle quality, defined by low muscle volume and muscle fat index on MRI, is worse in decompensated NASH cirrhosis, but not in compensated MASH cirrhosis	Niharika Samala	Received

2643-SAT	Implementation of a WeChat mini-program-driven lifestyle intervention among overweight or obese individuals with metabolic dysfunction-associated fatty liver disease	CHAO SUN	Received

2645-SAT	Impact of Liver Histology and MASLD-Associated Genetic Variants on Insufficient Weight Loss After Bariatric Surgery	Felice Cinque	Received

2646-SAT	A systematic review of the effectiveness of lifestyle interventions in improving liver health for patients with steatotic liver disease	Laura Temperley	Received

2647-SAT	MARS: A Simple, Readily Available, Non-Invasive Score to Assess Treatment Response in Patients with MASH	Jérôme Boursier	Received

2648-SAT	In Treatment of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD), Patient´s Choice Matters	Sandeep Khurana	Received

2649-SAT	The Importance of Weight Reduction in MASH Management	Ayse Levent	Received

2651-SAT	Effect of Bariatric Surgery on Major Adverse Cardiovascular and Cerebrovascular Events in MASLD Patients: Insights from the National Inpatient Sample Data (2016-2022)	Omar Alkasabrah	Received

2652-SAT	Impact of Body Weight Changes on New-Onset Diabetes in Individuals with Non-Diabetic Metabolic Dysfunction-Associated Steatotic Liver Disease	Aryoung Kim	Received

2653-SAT	Intermittent Calorie Restriction Modulates Gut Microbiota in patients with MASLD: A Differential Impact on Megamonas, Lachnospira, and Enterobacter in Obese and Non-Obese Patients	Hanah Lee	Received

2654-SAT	Yoga is non inferior to exercise in improving hepatic steatosis in MASLD - An open label, non-inferiority, randomised controlled trial	Sunil Taneja	Received

2655-SAT	A Traditional Mexican Diet against Viral Hepatitis B and C, and MASLD: An Integrative Bioinformatic Analysis	Sonia Roman	Received

3002-SUN	Baseline symptom burden and network analysis in adults with PSC, PBC, and cirrhosis enrolled in the eMPower RCT	Emily Johnson	Received

3003-SUN	EXPLORE B post hoc analysis of chronic symptoms in patients with acute hepatic porphyria	Susana Monroy	Received

3004-SUN	Assessing the environmental impact of patient travel to a liver transplant clinic: can we make the liver transplant outpatient service more sustainable?	Mhairi Donnelly	Received

3005-SUN	EUS-Shear Wave Elastography Effectively Excludes Advanced Chronic Liver Disease During Routine EUS Procedures	Umang Arora	Received

3007-SUN	Development and feasibility of a patient-reported experience survey for outpatients with liver disease	Oliver Tavabie	Received

3008-SUN	Hepatitis C Detection to Prevent Liver Disease: Implementation of Opt-Out Screening within a South Texas Emergency Department	Makayla Tey	Received

3009-SUN	Large-Language-Model-Assisted Validation of ICD-10-CM Codes for Liver Disease in 865,079 Documentations	Yichen Wang	Received

3010-SUN	Reducing Routine Consultation Wait Times at a Large Tertiary Care Outpatient Hepatology Clinic	Ofodile Joe-Uzuegbu	Received

3011-SUN	Burden of Chronic Liver Disease and Cirrhosis by Etiology in U.S. Veterans	Akshatha Kiran	Received

3012-SUN	Social Risk Phenotypes Predict Stage, Treatment, and Mortality in Hepatocellular Carcinoma: A Latent Class Analysis	Lauren Nephew	Received

3014-SUN	Persistent Use of Medications for Alcohol Use Disorder in All of Us participants	Phuc Le	Received

3017-SUN	Automated Screening of Bloodborne Viruses in Health Systems: Regional Model for Syndemic Testing	Su Wang	Received

3018-SUN	Impact of prior awareness of chronic liver disease on the risk of further decompensation in patients with hepatic decompensation	Junlong DAI	Received

3019-SUN	Chinese physicians´perspectives on human albumin for the treatment of cirrhosis complications: Insights from a nationwide questionnaire study	Zhan Zeng	Received

3020-SUN	A Pocket of Untapped Potential: A Novel Approach to Ensuring Timely Paracentesis	Joseph Abraham	Received

3021-SUN	Comprehensive Hepatitis B Perinatal Prevention Interventions in Delta State, Nigeria	Catherine Freeland	Received

3022-SUN	Health-related quality of life (HRQoL) of patients with Liver Disease: A cross-sectional analysis by disease severity and aetiology	Stephanie Landi	Received

3023-SUN	A hospital-based HCV elimination model based on multidisciplinary collaboration.	Xuehua Yan	Received

3024-SUN	How Can Gen AI Empower Liver Patients?	Mustafa Behan	Received

3025-SUN	Clinician Adherence to an Electrocardiogram-enabled Artificial Intelligence Model for Detection of Liver Disease in Primary Care: Insights from the DULCE Trial	Alberto Calleri	Received

3026-SUN	Hepatitis C Treatment Exposure in Pregnancy: Three-year Experience from the ´TiP-HepC´ Clinical Case Registry	Neil Gupta	Received

3027-SUN	AVATAR: AI Virtual Assistant for Triage and Referrals in an Academic Hepatology Practice	Anubhav Shankar	Received

3029-SUN	Effect of the COVID-19 Pandemic on Overall Survival among Patients with Hepatocellular Carcinoma in the United States	Ju Dong Yang	Received

3030-SUN	Real-world ascites treatment patterns diverge from AASLD recommendations: an analysis of over 200,000 patients with cirrhosis and ascites	Kate Solpari	Received

3031-SUN	Hospital at Home for acute care patients with decompensated cirrhosis provides comparable clinical outcomes to hospital-based care while improving patient-centeredness: A prospective study.	Miranda Stovall	Received

3032-SUN	Dimension analysis of ENVISION study EQ-5D data to assess relationship between annualized attack rate and chronic symptoms in patients with acute hepatic porphyria	Manisha Balwani	Received

3033-SUN	Adolescent Lived Experiences with Hepatitis B	Catherine Freeland	Received

3034-SUN	Prospective Implementation and Evaluation of a Real-World FIB-4 Screening Pathway for MASLD with Significant Fibrosis in Primary Care Patients with Diabetes, Obesity, or Both	Mohsen Merati	Received

3035-SUN	Epidemiology of At-Risk Clinically Significant Portal Hypertension in the United States	Ritik Mahaveer Goyal	Received

3036-SUN	Treatment Delays and Survival in Patients with Hepatocellular Carcinoma: A Multicenter Cohort Study	Mohammad Jarrah	Received

3037-SUN	Surveillance for Hepatocellular Carcinoma in Alaska Native Peoples with Chronic Hepatitis BLesleigh Kowalski Frank, Brian J McMahon, Chriss Homan, Mary Snowball, Lisa Townshend-Bulson	Lesleigh Kowalski Frank	Received

3038-SUN	MASLD/MASH Care Pathway Adherence Identifies Patients with Advanced Fibrosis	Anna Mageras	Received

3039-SUN	Long-Term Follow-up and Factors Influencing Follow-up Adherence After DAAs Therapy: A Multicenter Study of SVR 3,704 Patients in Nationwide survey	Masatsugu Ohara	Received

3040-SUN	Optimizing workflows for providers using large language models to respond to patient messages in the electronic portal	Hersh Shroff	Received

3041-SUN	Determinants of health-related quality of life among chronic hepatitis B patients in France	Clotilde Lepers	Received

3042-SUN	Predictors of Specialty Referral among Resettled Refugees Living with Hepatitis B	Jose Debes	Received

3043-SUN	Early detection of hepatic fibrosis and hepatocellular cancer in vulnerable adults in community settings: A pilot service evaluation project in SE England	James Ryley	Received

3044-SUN	Liver disease-specific large language models (LLMs) drafted hepatology ´e-consult´ responses are not equivalent to human responses	Debra Yen	Received

3047-SUN	Hepatology Clinician Perceptions of Addiction Treatment Importance for Patients with Liver Disease Across the Continuum of Transplant Care	Dylan Balter	Received

3050-SUN	Meaningful Engagement of Patients with Cirrhosis and Their Care Partners: Strategies from the LIVE-SMART study	Jacqueline Theroux	Received

3051-SUN	Using the Integrated Palliative Care Outcome Scale (IPOS) for Symptom Assessment: A Prospective Study in a Liver Supportive Care Program in Singapore	Cheryl Huang	Received

3053-SUN	Outreach Clinics Improve Access and Reduce Mortality in Liver Transplant Candidates	Sanad Dawod	Received

3054-SUN	Exploring Factors Associated with Being ´Too Early´ for Liver Transplantation: A California Liver Network Study	Jasleen Singh	Received

3056-SUN	Palliative Care Involvement in Inpatient Liver Transplant Evaluations: An Opportunity for Growth	Kathy Nguyen	Received

3057-SUN	Technology Utilization and (Health) Literacy Assessment for Patients with Chronic Liver Disease (TULAP-CLD)	Jonathan Day	Received

3059-SUN	Impact of liver-related clinical complications at first hospitalization on the outcome of patients with liver cirrhosis and hepatocellular carcinoma: a 13-year national study	Claire DELACOTE	Received

3062-SUN	Assessing need for hepatitis B vaccination in adults aged 18-59 across health system enterprise	Jonathan Fenkel	Received

3063-SUN	Oophorectomy is Associated with Hepatic Decompensation in Women with Pre-Existing Cirrhosis: A Multicenter Retrospective Cohort Study	Emma Leipsner	Received

3064-SUN	Evaluating Short-Term and Long-Term Patient Reported Symptoms Following COVID-19 Exposure in Cirrhosis: Implications for Quality Patient Care Management	Dhweeja Dasarathy	Received

3065-SUN	Prospective evaluation of a fast-track treatment pathway for individuals with chronic hepatitis B under primary care	Jimmy Che-To Lai	Received

3066-SUN	´FIB-4 More´: Improving MASLD Screening and Management in Patients with Type 2 Diabetes in an Urban Diverse Endocrinology Clinic	Melina Manolas	Received

3067-SUN	Using Community Partnerships to Achieve HCV Micro-elimination in Vancouver´s Inner-city	Christina Wiesmann	Received

3068-SUN	Appropriate Interventions Help to Reduce 30-Day Hospital Readmissions for Cirrhosis: A Scoping Review	Jawaid Shaw	Received

3069-SUN	Designing for Adoption: A Qualitative Study of Clinician Perspectives on Risk Prediction Tools in Cirrhosis	Kinza Khan	Received

3070-SUN	Race and Ethnicity Influence Pregnancy Outcomes in Women with Chronic Liver Disease and Cirrhosis	Katherine Cooper	Received

3071-SUN	Strategies for reducing the time from HCV diagnosis to treatment initiation: Lessons from Vancouver, BC, Canada	Christina Wiesmann	Received

3072-SUN	Barriers and Proposed Interventions to Improve Hepatocellular Carcinoma Surveillance Adherence in Patients with Hepatitis C Virus Post-Sustained Virologic Response: A Qualitative Survey Assessment of Hepatology Experts	Seren Gedallovich	Received

3073-SUN	The Rising Global Clinical and Economic Burden of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Driven by Type 2 Diabetes (T2D): A 20-Year Modeling Study Across Nine Countries	Zobair Younossi	Received

3074-SUN	Rural-Urban Trends in Liver-Related Mortality Post-Pandemic Differ by Etiology and Age	Tiange ´Philip´ Zhang	Received

3075-SUN	Maternal and Perinatal Outcomes in Pregnant Patients with Comorbid Inflammatory Bowel Disease and Chronic Liver Disease: A National Inpatient Sample Study	Jessica Lee	Received

3076-SUN	Timing is Everything: Economic Implications of Immediate Versus Delayed Hepatitis C Care	Mark Sulkowski	Received

3078-SUN	Hospitalization Patterns and Resource Utilization in Liver Cirrhosis	Paola Barrios	Received

3080-SUN	Characterizing Healthcare Costs in Medicare Beneficiaries with a New Diagnosis of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Compensated Cirrhosis	Nipun Atreja	Received

3082-SUN	Missed Opportunities in HCV Elimination: Insights from Italy´s National Screening and Equity Gaps	Loreta Kondili	Received

3083-SUN	Liver and splenic stiffness in clinically significant portal hypertension.	KABIR KANG	Received

3084-SUN	Long term antibody response following ChAdOx1-nCOV (Covishield) vaccine in patients with cirrhosis: A cross-sectional observational study	Simrat Kaur Parmar	Received

3085-SUN	Balancing Quality Training for Primary Surgeons and Improved Patient Outcomes: The Art of Fluorescence Navigation in Difficult Laparoscopic Cholecystectomy – Results from an Ongoing Open-label Randomized Clinical Trial	Baojia Zou	Received

3086-SUN	A qualitative study exploring the experiences and unmet needs of patients living with metabolic dysfunction-associated steatohepatitis	Ahsan Shoeb	Received

3088-SUN	Trends in Hepatitis C Virus (HCV) Antibody Screening and Positivity Rates, 2020-2024: Analysis of >35 million US adults using real-world data	Isabelle Winer	Received

3089-SUN	Liver disease elimination: Wuwei Medical consortium of liver disease specialists model.	Fengmei Wang	Received

3090-SUN	Accessibility and Effectiveness of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists for Primary Biliary Cholangitis (PBC): A Real-World Experience at a Tertiary Academic Medical Center Hepatology Clinic	Jane Giang	Received

3091-SUN	ChatGPT for Clinical Data Extraction: A Comparison with Manual Review of Hepatology Referral Packets	Vinathi Polamraju	Received

3092-SUN	Characterizing Healthcare Costs in Medicare Beneficiaries with a New Diagnosis of Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis	Nipun Atreja	Received

3093-SUN	Shifting Patterns in Liver Biopsy Indications and Diagnoses: A Retrospective Comparison Between Two Time Periods	Emmanouil Sinakos	Received

3094-SUN	Avoiding the Impact of Inaction: How to Maximize Progress to HCV Elimination in the United States	Nancy Reau	Received

3095-SUN	Insights from the ELPA European Liver Screening Week 2024	Milan Mishkovikj	Received

3097-SUN	Cost-effectiveness of Emergency Department opt-out BBV testing to advance elimination targets for Viral Hepatitis and HIV transmission: Tales from opposite corners of the world	James Jarrett	Received

3098-SUN	Trends in 1-Year Post-Liver Transplant Over Two Decades: A National Cohort Study Using the UNOS Registry	Sangmin Lee	Received

3100-SUN	RE-LIVE Study (Re-Linkage to Pan-Viral Hepatitis): Interim Results from a Multicenter Observational Study on Care Engagement in Chronic Viral Hepatitis	Jae hyun Yoon	Received

3101-SUN	Evaluating the agreement between patient self-administered questionnaires vs. transplant team psychosocial assessments in liver transplant candidacy screening.	Hyundam (Dami) Gu	Received

3102-SUN	Impact of COVID-19 Infection on Outcomes in Hospitalized Patients with Liver Cirrhosis: A Nationwide Analysis	Ritik Mahaveer Goyal	Received

3104-SUN	Establishing Baseline Quality Metrics for Paracentesis in Patients with Cirrhosis in Alberta, Canada	Leona Chan	Received

3105-SUN	Improving Tobacco Cessation in Liver Transplant Candidates Through a Multidisciplinary Quality Improvement InitiativeBrandon Shore, Susan Trout, Kim Shoenbill, Hersh Shroff	Brandon Shore	Received

3108-SUN	Does the Pay-for-Performance Program (P4P) for Type 2 Diabetes Patients Reduce the Incidence of Primary Liver Cancer?	Chao-Yi Lai	Received

3110-SUN	Development of the Palliate End-stage and Advanced Cirrhotics Early (PEACE) Liver Supportive Care Programme: Lessons and early outcomes from a multidisciplinary approach to providing palliation for liver cirrhosis patients in Singapore	Marianne De Roza	Received

3111-SUN	Conflicting Expert Opinions on Hospital Readmission Prevention in Advanced Liver Disease	Eric Orman	Received

3112-SUN	Longitudinal Monitoring with Commercial Wearable Technology is Feasible Across Sociodemographic and Disease Severity Spectrum in Cirrhosis	Adam Buckholz	Received

3113-SUN	Global Burden of Liver Cancer from 1990 to 2021 and 20-Year Projections: Findings from the Global Burden of Disease Study 2021	Yikai Wang	Received

3114-SUN	A modified nominal group technique consensus to define implementation priorities for a chronic hepatitis B functional cure treatment pathway	Carla Coffin	Received

3115-SUN	US Health Care Spending on Cirrhosis and Other Chronic Liver Diseases	Wenjun Wang	Received

3116-SUN	Temporal Changes in Screening for Esophageal Varices in Patients with Cirrhosis	Tanvi Goyal	Received

3119-SUN	Global burden of primary liver cancer: A population-based analysis from 1990 to 2021 with projections to 2050	Xinrong Zhang	Received

3120-SUN	Visualization quality and effectiveness of noncontrast-abbreviated magnetic resonance imaging for hepatocellular carcinoma surveillance in cirrhotic patients with prior ultrasound visualization score C	Sunyoung Lee	Received

3121-SUN	The efficacy of dexamethasone versus N-acetylcysteine in prevention of post-embolization syndrome in hepatocellular carcinoma patients: A multicenter randomized, double-blind, double-dummy, non-inferiority trial	Padungkeat Karasin	Received

3122-SUN	Advancing HCC Diagnostics: Outperformance of Novel Biomarker LC-SPIK in Detection of HCC in Early-Stage, AFP-Negative and Non-Viral Cirrhosis Cases	karteek kadimisetty	Received

3123-SUN	Diagnostic Performance of GALAD and GAAD vs. Ultrasound for HCC Detection in Patients with Non-Viral Liver Disease	Mohammad Jarrah	Received

3124-SUN	´Comparison of Dexamethasone and N-Acetylcysteine versus N-Acetylcysteine alone in prevention of Post-Embolization Syndrome in patients with Hepatocellular Carcinoma following Transarterial Chemoembolization - Randomized Controlled Trial.´	Phool Chand	Received

3128-SUN	Morphological signatures and spatial biology in HCC: Focus on macrotrabecular and vessels-encapsulating tumor clusters patterns	Jun Akiba	Received

3129-SUN	Arid1a is Decisive for Initiating Hepatocyte-Derived Intrahepatic Cholangiocarcinoma via Notch Pathway Activation	Jinqiang Zhang	Received

3130-SUN	The stage-dependent, divergent, and contrasting effect of concurrent MASLD on the prognosis of patients with hepatocellular carcinoma (HCC): A nationwide cohort study	Chun-Ting Ho	Received

3131-SUN	Healthcare utility and disease burden in advanced hepatocellular carcinoma patients receiving systemic therapy	Rex Wan-Hin Hui	Received

3132-SUN	A Markov model for cost-effectiveness analysis comparing the novel blood-based HelioLiver test vs liver ultrasound semiannually for early detection of hepatocellular carcinoma	Jim C. Huang	Received

3134-SUN	Disparities in Outcomes in Patients with Hepatocellular Carcinoma Treated with Liver Transplantation	Imran Qureshi	Received

3135-SUN	A real-world study of hepatocellular carcinoma surveillance over 4 decades - Is the current surveillance strategy adequate?	Wei-Lun Liou	Received

3136-SUN	Association of concomitant MASLD and hepatitis B virus with clinical outcomes in hepatocellular carcinoma following curative resection	Chih Wen Lin	Received

3137-SUN	Child-Pugh Score 7 with Mild Ascites and Hypoalbuminemia Demonstrates Comparable Outcomes to Child-Pugh Score 6 in HCC Patients Treated with Atezolizumab/Bevacizumab	Soon Kyu Lee	Received

3138-SUN	Development and Validation of a Risk Prediction Model for Patients with Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab	Heechul Nam	Received

3139-SUN	Poly(I:C) could be an efficient cancer adjuvant for immunotherapy in hepatocellular carcinoma by activating cytotoxic CD8+ T cells	yichun ji	Received

3140-SUN	NON-ADHERENCE TO SURVEILLANCE PROTOCOL OF HEPATOCELLULAR CANCER IN PATIENTS WITH LIVER CIRRHOSIS: PREVALENCE AND REASONS	Akash Shukla	Received

3142-SUN	Hormone-Replacement Therapy Reduces the Risk of Hepatocellular Carcinoma and Slows Chronic Liver-Disease Progression in Post-Menopausal Women: A Propensity-Matched TriNetX Analysis	Prabhat Kumar	Received

3143-SUN	Extratumoral HSC-Derived CXCL12 Promotes Liver Metastasis in MASLD Through the CXCR4/YAP Axis and Immune-Fibrotic Remodeling	Jieun Kim	Received

3144-SUN	Accurate diagnosis of hepatocellular carcinoma with a high-throughput test for plasma DNA methylation signatures	Rex Wan-Hin Hui	Received

3145-SUN	Under-utilization of antiviral therapies in patients with hepatocellular carcinoma (HCC) and viral hepatitis B (HBV) or C (HCV): a multinational real-world study	Taotao Yan	Received

3146-SUN	A Prospective Study of Cytology, FISH, and Methylated DNA Markers in Bile and Biliary Lavage for Pancreatobiliary Cancer Detection	Shuji Mitsuhashi	Received

3147-SUN	Real-World Insights into the Treatment Landscape of Hepatocellular Carcinoma and Its Adherence with Guideline Recommendations: A 5-Year Nationwide Prospective Study in the Netherlands	Minneke Coenraad	Received

3148-SUN	Multi-center validation of Elecsys GAAD digital algorithm performance in Chinese population.	Yujuan Guan	Received

3149-SUN	Patients with cirrhosis living in rural areas are less likely to receive hepatocellular carcinoma surveillance: a population-based study involving 43,207 patients with cirrhosis	Paul Karre	Received

3150-SUN	CA9 functions both as a biomarker of resistance to Atez/Bev therapy in hepatocellular carcinoma and as a promising therapeutic target	Yu Sato	Received

3152-SUN	Next-generation Plasmonic Imaging Platform for Hepatocellular Carcinoma Detection	Mohammad Sadman Mallick	Received

3155-SUN	SMYD2 inhibition reduces tumor growth and synergizes with anti-PD1 therapy in murine HCC	Barbara Bueloni	Received

3156-SUN	Pre-diagnostic Plasma Metabolites and Risk of Hepatocellular Carcinoma in a Multiethnic Cohort	Sihao Han	Received

3157-SUN	Efficacy and safety of SBRT combined with atezolizumab plus bevacizumab vs atezolizumab plus bevacizumab in treating unresectable advanced hepatocellular carcinoma (SAB -An Observational Study)	Phool Chand	Received

3158-SUN	Hepatocellular Carcinoma Risk in Metabolic Dysfunction Associated Steatotic Liver Disease with Increased Alcohol Intake (MetALD)	Binu John	Received

3159-SUN	PIVKA-II Monitoring to Predict Response of The First Transarterial Chemoembolization (TACE) in Intermediate Stage of Hepatocellular Carcinoma	Napapong Nitiwaranggoon	Received

3160-SUN	Risk factors for incidental hepatocellular carcinoma at time of liver transplantation	Mahip Grewal	Received

3163-SUN	UBE2D3 functions as a novel tumor suppressor in hepatocarcinogenesis by modulating the p62-SHP2-STAT3 signaling axis.	Hideharu Nagasawa	Received

3164-SUN	Hepatocellular Carcinoma (HCC): Gankyrin and miRNA Expression Profiling as Potential Markers for Diagnosis and Monitoring	Levan Gogichaishvili	Received

3165-SUN	Re-evaluation of serum amyloid A-positive hepatocellular neoplasm/inflammatory hepatocellular adenoma (HCA) by expression pattern of glutamine synthetase for detection of associated β-catenin activated HCA.	Motoko Sasaki	Received

3166-SUN	Advanced Blood Plasma Spectroscopy Improves Diagnostic Accuracy for Liver Cancer According to BCLC Stage	Petr Hríbek	Received

3167-SUN	US Health Care Spending on Liver Cancer	Wenjun Wang	Received

3168-SUN	Tumor biomarkers added to BCLC score ameliorate significantly hepatocellular carcinoma staging	Francesco Damone	Received

3170-SUN	Artificial Intelligence for HCC Risk Prediction in MASLD: Development and Validation of a Predictive Model in 306 Patients	Mario Pessoa	Received

3171-SUN	Induction of Cuproptosis and Immunogenic Cell Death by a Novel Copper Carrier A3 in hepatocellular carcinoma: Synergistic Enhancement with PX-478	Yu-Lan Li	Received

3172-SUN	Preoperative prediction of microvascular invasion in intrahepatic cholangiocarcinoma and its prognostic implications: A multicenter study	Dong Hwan Kim	Received

3173-SUN	Investigation of tumor heterogeneity in liver using histological analysis and spatial lipidomics in myristoylated AKT-TAZ (myrAKT-TAZ S89A)-driven murine model	Jee Won Jennifer Shin	Received

3174-SUN	Interim Short-Term Feasibility and Safety Analysis of Single-session Yttrium-90 Transarterial Radioembolization for Small Hepatocellular Carcinoma: One & Done Trial	Nima Kokabi	Received

3176-SUN	Unravelling Stemness Dynamics in Intrahepatic Cholangiocarcinoma: Insights into Primary and Metastatic Stem-like Cell Evolution	Chiara Raggi	Received

3177-SUN	Outcome Prediction in HCC After Liver Transplant: How Much Can We Trust Imaging?	Natalia Marcos Carrasco	Received

3181-SUN	A Phase II Study of Dual VEGF/PD-L1 Blockade in the Neoadjuvant Setting in Patients with Resectable HCC	Joe Eid	Received

3184-SUN	Prognostic Impact of Diabetes and Hypertension on Hepatocellular Carcinoma Survival: A 15-Year Registry-Based Analysis	Jonggi Choi	Received

3185-SUN	Geranylgeranyl pyrophosphate regulates human hepatic stellate cell function via Yes-Associated Protein and Rho GTPases.	Courtney Labrecque	Received

3186-SUN	Target-Specific Locked Nucleic Acid Gapmer Decreases Growth of Hepatocellular Carcinoma	Keyue ZHANG	Received

3187-SUN	Plasma TWEAK levels as a predictive biomarker for tremelimumab plus durvalumab in patients with advanced hepatocellular carcinoma	Takeru Hirao	Received

3188-SUN	Synergistic Tumor Immunotherapy via Cuproptosis, Apoptosis and Chemodynamic Therapy: Functional Copper(II) Complexes Combined with HIF-1α Inhibition	Yu-Lan Li	Received

3189-SUN	Diagnostic accuracy of the GAAD score in non-cirrhotic patients with focal liver lesions	Mohamed Moussa	Received

3191-SUN	Loss of phospholipase Cγ1 suppresses hepatocellular carcinogenesis through blockade of STAT3-mediated cancer development	Eun-Bi Seo	Received

3192-SUN	Prognostic and Functional Study of SLC27A2 in Hepatocellular Carcinoma	Zhan Zeng	Received

3193-SUN	Predictors of Curative Treatment in Patients with Early-Stage Hepatocellular Carcinoma	Ashwini Arvind	Received

3194-SUN	Association of TGF-β Molecules in Circulating Tumor Cells with Drug Resistance in Systemic Therapy for Unresectable Hepatocellular Carcinoma.	Yosuke Murata	Received

3195-SUN	Impact of prior oncological treatment on immunotherapy responses in patients with hepatocellular carcinoma	SHING HIN CHUNG	Received

3196-SUN	Immune checkpoint inhibitor-induced rapid decline in HBV markers improves the prognosis of HBV-related hepatocellular carcinoma patients	Yujie Ran	Received

3197-SUN	Tumor Response Patterns of Second-Line Tyrosine Kinase Inhibitors Following Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Proportional Meta-analysis	Ronald Blanco Montecino	Received

3199-SUN	Age-dependent development of hepatocellular carcinoma in liver-specific betaine homocysteine methyltransferase (BHMT) knockout mice	Kusum Kharbanda	Received

3201-SUN	Physiologic and Social Stress Predict Mortality in Hepatocellular Carcinoma: Independent Contributions of Allostatic Load and Health Literacy	Sebastian Abad	Received

3202-SUN	Predicting Mortality in Patients with Hepatocellular Carcinoma: Insights from a Multicenter Cohort	JIHYE LIM	Received

3204-SUN	NRF2-COX2-PGE2 Axis Drives Immune Cold Tumors and Predicts Resistance to Atezolizumab and Bevacizumab Therapy in Hepatocellular Carcinoma	Shuhei Yamamoto	Received

3206-SUN	A NOVEL ROLE OF SECRETED METHIONINE ADESNOSYLTRANSFERASE α2 IN THE DEVELOPMENT OF COLORECTAL LIVER METASTASES	Monica Justo	Received

3207-SUN	Recent Trends in Surveillance-Detected HCC in the United States	Naomy Kim	Received

3209-SUN	Frailty Is Associated With Adverse Inpatient Outcomes in Hepatocellular Carcinoma: A Nationwide Study From 2018 to 2022	Daniel Gonzalez Mosquera	Received

3211-SUN	Comparative Outcomes of Transradial (TRA) Versus Transfemoral (TFA) Access in Locoregional Therapies for Hepatocellular Carcinoma: Systematic Review and Meta-analysis in TARE, TACE, and HAIC	Renan Prado	Received

3213-SUN	Hepatic fibrosis as predictor of cancer-associated thrombosis in patients with intrahepatic cholangiocarcinomaNew Submission	Luca Fabris	Received

3214-SUN	Predictors of Outcomes Following Transarterial Embolization Therapies in Unresectable Hepatocellular Carcinoma: A Multicenter Analysis	Faisal Sanai	Received

3216-SUN	Enhanced antitumor activity of programmed cell death-1 antibody/regorafenib combined with dipeptidyl peptidase-4 inhibition in hepatocellular carcinoma organoid model	Heejoon Jang	Received

3217-SUN	The effect of circulating inflammatory biomarkers on the risk of non-viral related hepatocellular carcinoma development	Mazen Elsheikh	Received

3218-SUN	Novel approaches for the early detection of hepatocellular carcinoma: A systematic review of diagnostic accuracy studies	Melissa Barlow	Received

3219-SUN	Serum tyrosine level is an independent factor for hepatocellular carcinoma development and mortality in patients with chronic liver disease	Mikita Oi	Received

3220-SUN	Novel Risk Prediction Score for Acute Care Utilization after Locoregional Therapy for Hepatocellular Carcinoma	Andrew Moon	Received

3222-SUN	Serum metabolomic signatures predict tumor recurrence after resection or ablation in patients with hepatocellular carcinoma	Ashwini Arvind	Received

3223-SUN	Temporal Trends and Regional Variations in Hepatocellular Carcinoma Etiology and Associated Clinical Features: A Multinational-APASL Hepatology/Oncology Consortium (A-HOC)- Study Across Asia	YASUTO TAKEUCHI	Received

3224-SUN	Hepatocellular Carcinoma Screening Adherence Is Associated with Higher Curative Intent Surgical Resection Rate	Rachel McNulty	Received

3225-SUN	Clinico-pathological differences and Key Genomic Alterations in MASLD-Related Hepatocellular Carcinoma with and Without Cirrhosis: Integrating Whole-Exome and Sanger Sequencing	Ajay Duseja	Received

3228-SUN	The Impact of Long-Term Prednisone Use on Hepatocellular Carcinoma Risk in Autoimmune Hepatitis and Cirrhosis: A Retrospective Cohort Study with Literature Review	Jessica Liu	Received

3229-SUN	Increased Liver-Related Morbidity in Autoimmune Hepatitis-Primary Sclerosing Cholangitis Overlap Syndrome Compared to Autoimmune Hepatitis Alone: A Retrospective Multicenter Analysis	Muhammad Hassaan Arif Maan	Received

3231-SUN	Platelets from patients with hepatocellular carcinoma promote disease progression by enhancing tumor cell migration and invasion	Meng Zhang	Received

3232-SUN	Prognostic value of TERT promoter-mutated cfDNA after curative ablation in early-stage hepatocellular carcinoma	Masaru Muraoka	Received

3233-SUN	Radiation as an Immunologic Primer: Scoping the Emerging Landscape of Multimodal Strategies in Hepatocellular Carcinoma	Eric Welwin	Received

3234-SUN	Association between Tumor Burden and Frailty in Liver Transplant Candidates with Hepatocellular Carcinoma	Gabrielle Jutras	Received

3235-SUN	Evaluation of Factors Affecting Alpha Fetoprotein Levels in Patients with Hepatocellular Carcinoma in a Large Multicentre Cohort?	Ethan Kai Jun Tham	Received

3237-SUN	Proteinuria and Its Clinical Implications in HCC Patients Treated with Atezolizumab/Bevacizumab: A Multicenter Real-World study	Yu Rim Lee	Received

3238-SUN	Bleeding Complications and Survival Outcomes in HCC Patients Treated with Atezolizumab/Bevacizumab: Multicenter Real-World study	Yu Rim Lee	Received

3239-SUN	Circulating Serum Proteins as Predictive Biomarkers for Immunotherapy Efficacy in Advanced HC	Young-Sun Lee	Received

3242-SUN	SMART-HCC Outperforms PLEASE Score in Stratifying HCC and Liver-related Events Risk in Advanced Chronic Liver Disease Patients	Kessarin Thanapirom	Received

3243-SUN	Utility of Tyrosine Kinase Inhibitors after Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis	Ronald Blanco Montecino	Received

3244-SUN	N-Acetylcysteine Slows down Liver Carcinogenesis: Mechanistic Insights from a Preclinical Hepatocellular Carcinoma Model	Fernando Caloca-Camarena	Received

3245-SUN	N6-Methyladenosine-Mediated Up-Regulation of ARRB2 Regulates Intrahepatic Cholangiocarcinoma malignant progression and Pemigatinib Resistance Through MAPK and Hippo Signaling Pathways	qiwei yang	Received

3246-SUN	Intratumoral Fibrosis and Aggressive Features in Treatment-naïve Advanced Hepatocellular Carcinoma	Makoto Fujiya	Received

3247-SUN	Chemopreventive effect of fibrate as an add-on to statin on the risk of hepatocellular carcinoma: a nationwide-population based study	Won Sohn	Received

3249-SUN	Prognostic Impact of Etiologies on Intrahepatic Cholangiocarcinoma: An Analysis of a Nationwide Registry in Japan	Kazuya Okushin	Received

3250-SUN	Predicting and managing hepatocellular carcinoma recurrence after liver transplant: a single center experience 2012-2024	Jesse Civan	Received

3251-SUN	Incidence and Survival Outcomes of Liver Cancer: Analysis of the SEER database	Chawin Lopimpisuth	Received

3253-SUN	Characteristics and clinical course of Fontan-associated liver disease (FALD)	Sumire Takano	Received

3254-SUN	Histotripsy to Achieve Local Tumor Control for Liver Tumors: A National Multi-Center Study	Chase Wehrle	Received

3255-SUN	Clinically Significant Portal Hypertension as a Prognostic Factor in Cholangiocarcinoma: A Cohort Study	Yingfan Chen	Received

3256-SUN	Barriers and Facilitators to Hepatocellular Carcinoma Care Coordination Among Hispanic Patients at a Multidisciplinary ClinicJanan	Janan Leppo	Received

3257-SUN	Efficacy and Safety of Bintrafusp Alfa in Biliary Tract Cancer: A Review of the Clinical Trials	MANASA SINDHURA NAGINENI	Received

3259-SUN	Baseline von Willebrand Factor as a Predictive Biomarker for Response to Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma	Tadashi Namisaki	Received

3260-SUN	Therapeutic efficacy and safety of lenvatinib as a second-line therapy after first-line therapy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma	Chinatsu Nishioka	Received

3261-SUN	Genetic Predisposition in Metabolic-Driven Hepatocellular Carcinoma: PNPLA3/GCKR Polymorphisms and Their Differential Association Patterns Compared to Viral Etiology	Tao Liu	Received

3262-SUN	Performance of HCC risk scores in patients with advanced chronic liver disease in the Netherlands	Mohamed Moussa	Received

3263-SUN	Utility of Contrast-enhanced Ultrasound in HCC surveillance in Fontan Associated Liver Disease	Amanda Pirola	Received

3264-SUN	TP53 alterations predict poor response to immune checkpoint inhibitor-based chemotherapy in intrahepatic cholangiocarcinoma.	Hiroki Inada	Received

3265-SUN	Liver Tumor Burden Independently Predicts Risk of Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Immunotherapy.	Erica Storm	Received

3266-SUN	Metabolic Dysfunction-Associated Steatohepatitis Predicted Poor Prognosis in Hepatocellular Carcinoma Patients with Concurrent MASLD	Chien-Wei Su	Received

3267-SUN	A novel mouse model of intrahepatic cholangiocarcinoma and effects of SGLT2 inhibitors on the malignancy	Yohei Shirakami	Received

3268-SUN	Differential impact of antibiotics on anti-PD-1 versus anti-PD-L1 therapy in hepatocellular carcinoma	Cheng-Hao Kuo	Received

3270-SUN	Malignant Liver Neoplasm Related Mortality Trends Due to Infective vs Non-Infective Association: CDC WONDER analysis (1999-2020)	Jayasree Rajapandian	Received

3271-SUN	Identification of Uric Acid-Related Genes as Potential Biomarkers in Hepatocellular Carcinoma	Fengsheng Dai	Received

3273-SUN	Impact of Cardiometabolic Risk on Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Retrospective Study	Apichat Kaewdech	Received

3275-SUN	Adverse Event Profile of Second-Line Tyrosine Kinase Inhibitors After Atezolizumab/Bevacizumab in Advanced HCC: A Meta-analysis of Treatment-Related Toxicity	Ronald Blanco Montecino	Received

3276-SUN	Risk Stratification for Hepatocellular Carcinoma in Autoimmune Liver Diseases Using the ADRESS-HCC Model: U.S. Single-Center Validation	Ana Marenco-Flores	Received

3277-SUN	Tumor-Derived CXCL2 Suppresses Hepatocellular Carcinoma through Promoting Neutrophil N1 Polarization via the YBX1/SREBP2 Axis	Xin Liu	Received

3279-SUN	Clinical Characteristics and One-Year Survival of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Hepatocellular Carcinoma (HCC): Insights from a Large Institutional Registry	Saleh Alqahtani	Received

3282-SUN	TEAD Inhibition by IAG933 as a Novel Therapeutic Strategy for Cholangiocarcinoma	Hidemi Nishi	Received

3283-SUN	The prognostic significance of AAA Scoring system in BCLC stage 0/A ruptured hepatocellular carcinoma	Chao Wang	Received

3285-SUN	Oncologic Outcomes Following Liver Transplantation for Cholangiocarcinoma: A National Cohort Analysis (2009-2022)	Andrew Caddell	Received

3286-SUN	Non-Invasive Histotripsy for Liver Tumors: Links to ctDNA Tumor Mutational Burden, Tumor Viability, and Radiologic Outcome.	Ahmed Sayed Ahmed	Received

3290-SUN	´Hot´ Immune Microenvironment of AFPlow Hepatocellular Carcinoma Patients Harbours Proliferative Natural Killer Cells	Pushpa Yadav	Received

3291-SUN	Association between Air Quality Index and Risk of Hepatocellular Carcinoma: a nationwide population-based study	Chun-Ying Wu	Received

3292-SUN	Cancer-related death in individuals with alcohol-associated liver disease	Pojsakorn Danpanichkul	Received

3293-SUN	MECHANISTIC INSIGHTS INTO PROGLUMIDE´S ROLE IN IMMUNE CELL EFFICACY AND RESISTANCE TO IMMUNE CHECKPOINT INHIBITOR THERAPY FOR HEPATOCELLULAR CARCINOMA	Priyanka Doneparthi	Received

3294-SUN	Sintilimab plus bevacizumab as systemic therapy in patients with Child-Pugh A and Child-Pugh B advanced hepatocellular carcinoma: a multi-institutional cohort study	Yuanxu Zhang	Received

3297-SUN	Performance of GALAD, GAAD, and ASAP for early HCC detection in chronic liver disease: A systematic review and meta-analysis	Mohammad Jarrah	Received

3298-SUN	IL-1β Induced by ER Stress in Hepatic Stellate Cells Facilitates the Progression of Hepatocellular Carcinoma	Makoto Morita	Received

3300-SUN	Two Decades of Intrahepatic Cholangiocarcinoma: A Mixed-Effects Analysis of Age, Sex, Tumor Stage and Demographics	Ivan Mogollon	Received

3301-SUN	SPP1 Promotes Hepatocellular Carcinoma Progression Through Regulation of m6A Methyltransferases METTL3 and METTL14	Yanqiu Li	Received

3303-SUN	Influence of Histotripsy on Patient-Reported Quality of Life: A Retrospective Cohort Study	Ahmed Sayed Ahmed	Received

3305-SUN	Growth Hormone (GH) pathway as a Prognostic and Therapeutic Biomarker in Patients with Unresectable Hepatocellular Carcinoma treated with Radiotherapy	Joe Eid	Received

3306-SUN	Presentation and clinical outcomes of patients with hepatocellular carcinoma differ by type of steatotic liver disease	Ashwini Arvind	Received

3308-SUN	KDM5A-Driven Reprogramming of IL-1β? CD14+ Monocytes Mediates Resistance to Anti-PD-1 Therapy in Advanced Hepatocellular Carcinoma by Suppressing T Cell-Mediated Antitumor Immunity	Wenying Qiao	Received

3310-SUN	Associations between deprivation index and post-locoregional therapy mortality and acute care utilization among patients with hepatocellular carcinoma	Merete Lund	Received

3311-SUN	Expression and function of miR-1297 and its target thymosin-β10 in hypoxia-induced lenvatinib resistance in hepatocellular carcinoma	Takayuki Kogure	Received

3313-SUN	Exosomal miR-30a-5p Decision Tree Distinguishes Responders to Atezolizumab-Bevacizumab Therapy in Advanced Hepatocellular Carcinoma	Young-Sun Lee	Received

3314-SUN	Clinical Insights into Mucinous Cystic Neoplasm of the Liver: A Single-Center Case Series	Cong-Tian Wang	Received

3315-SUN	Medical Specialty Treatment Patterns in the Multidisciplinary Management of Hepatocellular Carcinoma: The Mayo Clinic Experience	Fatima Islam	Received

3316-SUN	Characteristics and Treatment of Primary Hepatic Perivascular Epithelioid Cell Tumor (PEComa) in adults: a Systematic Review	Christos Triantos	Received

3319-SUN	Healthcare costs of steatotic liver disease-associated hepatocellular carcinoma	Catherine Mezzacappa	Received

3322-SUN	TBX15 regulates sorafenib resistance in hepatocellular carcinoma through cGAS/STING pathway	Hui Yuan	Received

3323-SUN	Distinct Recurrence Patterns and Inferior Postoperative Outcomes of Combined Hepatocellular-Cholangiocarcinoma Compared with Hepatocellular Carcinoma	Yeongseok Hwang	Received

3324-SUN	Breaking Resistance and Rewriting the Systemic Playbook: A Scoping Review of Combination Targeted Therapies in Advanced Hepatocellular Carcinoma	Taseen Tanzil	Received

3325-SUN	Evolving trends in therapy for hepatocellular carcinoma and the impact of multidisciplinary management - A real-world study of 1,627 cases over 5 decades	Chee-Kiat Tan	Received

3326-SUN	Trends and factors associated with hepatocellular carcinoma diagnosis, stage, treatment and survival	George Ioannou	Received

3327-SUN	Prognostic impact of proteinuria in patients with advanced HCC treated with atezolizumab plus bevacizumab	Young Mi Hong	Received

3329-SUN	Clinical Outcomes of Immunotherapy for Unresectable Hepatocellular Carcinoma in Patients with Coexisting Malignancies	Haruhiko Takeda	Received

3331-SUN	Tyrosine Kinase Inhibitor Sequencing in Unresectable Hepatocellular Carcinoma: A Real-World Dual-Center Retrospective Analysis	Khalid Abumelha	Received

3332-SUN	Use of Non-steroidal Anti-inflammatory Drugs, Aspirin, Ibuprofen, and Acetaminophen in Relation to Biliary Tract Cancers in the Biliary Tract Cancers Pooling Project (BiTCaPP)	Jill Koshiol	Received

3333-SUN	Influence of Metabolic Syndrome on Post-Ablation Outcomes in Early-Stage Hepatocellular Carcinoma	Jason Chiang	Received

3334-SUN	Hypoxia-inducible factor 1α knockout enhances the antitumor efficacy of tyrosine kinase inhibitors in an orthotopic hepatocellular carcinoma mouse model	Francisco Jorquera	Received

3335-SUN	Absence of miR-122 in mice triggers pathological regeneration and liver failure in fibrotic conditions	Anna Cardona-Simó	Received

3336-SUN	Inhibition of neutrophil extracellular trap formation by anticoagulation attenuates liver fibrosis and identifies Cystatin B as a potential target for antifibrotic therapies	Yingjie Ai	Received

3337-SUN	Machine Learning identifies Proteo-Transcriptomics modules associated with fibrogenesis in advance fibrosis in a Japanese MASH Cohort	Ali Ebrahimi	Received

3338-SUN	Non-Invasive Estimation of Portal Pressure Using Machine Learning: Development and Validation in 670 Cirrhotic Patients	Seul Ki Han	Received

3339-SUN	Fibroblastic activity is prognostic for further decompensation after TIPS in patients with liver cirrhosis	Alejandro Mayorca Guiliani	Received

3340-SUN	Rap1a Modulates LSEC Capillarization to Drive Hepatic Fibrosis Progression	Xiaobo Cai	Received

3341-SUN	Single cell fixed RNA-sequencing analysis revealed HSCsLMCD1+ is a driver of liver fibrosis by modulating AKT-PRAS40-4EBP1	Thi Thanh Thuy Le	Received

3342-SUN	Continuous Digital Pathology Scoring Reveals Fibrosis Reversal and Treatment Benefit of Lanifibranor: Insights from a Preclinical Rodent Model.	Guillaume Wettstein	Received

3345-SUN	Fibrosis microenvironment after HBsAg clearance is associated with HCC recurrence in HBV patients.	Michitaka Matsuda	Received

3346-SUN	Dynamic Cellular Changes in a Precision Cut Liver Slice Model	Denisse Rubio Cruz	Received

3347-SUN	Combining Digital Pathology and Biomarkers Offer a Translational Framework to Quantify Fibrosis and Lanifibranor Treatment Response in a TAA-Induced Cirrhosis Model.	reethika Chokkakula	Received

3348-SUN	High-Resolution Digital Pathology Demonstrates Antifibrotic and Anti-inflammatory Effects of Lanifibranor in Therapeutic Interventions Using TAA-induced Cirrhotic Rodent Models.	Guillaume Wettstein	Received

3349-SUN	Laboratory and Elastography Characteristics of At-Risk Clinically Significant Portal Hypertension (CSPH) in the United States	Ritik Mahaveer Goyal	Received

3356-SUN	Machine Learning-Based Fusion of Contrast-Enhanced Upper Abdominal MRI Signatures and Clinical Scores Improves Prediction of 1-Year Mortality in Acutely Decompensated Cirrhosis	Qingren Cao	Received

3357-SUN	Clinical utility of a 50% relative decline in MRI-PDFF in predicting fibrosis improvement in metabolic dysfunction-associated steatohepatitis	Daniel Huang	Received

3358-SUN	Spatial Transcriptomics Reveals GPNMB-Positive Macrophages as Drivers of Fibrotic Niches and Prognostic Indicators in Chronic Liver Disease	Kenji Fukumoto	Received

3359-SUN	Regulation of DDX5 by FL118 and Its Association with Cellular Senescence During Hepatic Stellate Cell Activation	Thi Nga Ha	Received

3360-SUN	Multimodal Assessment of Fontan-Associated Liver Disease in a Novel Ovine Model using Ultrasound and Histological Quantification	Jennifer Kievert	Received

3361-SUN	ALKBH5 ameliorates hepatic fibrosis by regulating the PI3K-AKT-FOXO3A signaling axis	lingyu kong	Received

3362-SUN	Baicalein induces hepatic stellate cell senescence via inhibiting glycolysis by CEBPZ/p53/HK2 signaling pathway to inhibit liver fibrosis	Shuling Chen	Received

3363-SUN	Single-Cell Analysis of Heterogeneity in Reverted Human Hepatic Stellate Cells	Xinjia Wang	Received

3364-SUN	Functional role of Nicotinamide N-methyltransferase in hepatic stellate cell activation and liver fibrosis	Ji Hyun LEE	Received

3368-SUN	Liver stiffness response and heterogeneity assessed via magnetic resonance elastography in alpha-1 antitrypsin deficiency-associated liver disease: results from phase 2 studies of fazirsiran	Rohit Loomba	Received

3369-SUN	Development of a Fibrosis Index Using Machine Learning to Predict Liver Fibrosis Progression in Chronic Liver Disease	David Zhang	Received

3370-SUN	Early Tissue Damage-Derived Cells Orchestrate the Formation of Age-Related Senescent Microenvironments	Kwon Yong Tak	Received

3371-SUN	Potent antifibrotic effects of oncolytic reovirus on liver fibrosis via restoration of activated hepatic stellate cells to quiescent status following intravenous administration	Ikuho Ishigami	Received

3372-SUN	The mechanism of hydroxynidone in the treatment of liver fibrosis by targeting CTSL-SirT1 to regulate lipid metabolism reprogramming of hepatic stellate cells.	Hanjing Zhangdi	Received

3374-SUN	A Gene Expression Signature Correlates with Fibrosis Severity in Patients with MASH, Alcohol-Associated Liver Disease, and Viral Hepatitis	Jennifer Chen	Received

3375-SUN	Resolving fibrosis by stimulating HSC-dependent extracellular matrix remodeling	Sachin Sharma	Received

3376-SUN	Medication Adherence in Wilson Disease Patients Treated with Trientine Tetrahydrochloride Supplied by a Single Source Specialty Pharmacy	Veronica Tomor	Received

3379-SUN	Identification of Tbx20 as a mediator of hepatic stellate cell memory and plasticity	Alvaro Gonzalez Dominguez	Received

3380-SUN	Activation of the integrin αV-YAP-CTGF axis in LSECs promotes liver fibrogenesis in congestive hepatopathy	Seiya Kato	Received

3382-SUN	Identification of novel drivers of HSC activation and fibrogenesis through leveraging complementary proteomic analysis	Jessica Maiers	Received

3384-SUN	Effect of mesenchymal stromal cell-derived extracellular vesicles purified by phosphatidylserine affinity method on a murine model of liver fibrosis	Ryo Jimbo	Received

3385-SUN	CT-Based Liver Morphology Scoring as a Tool for Stratifying Age-Related Liver Disease Risk	Nobuyuki Matsumoto	Received

3386-SUN	PKHD1 mutation promote hepatic stellate cell activate via SPP1 in bile duct cell	Mengfan Jiao	Received

3391-SUN	Assessment of regenerative macrophage therapy pharmacology supports anti-inflammatory and anti-fibrotic effects in preclinical models of liver fibrosis	Lara Campana	Received

3392-SUN	Repurposing Pimozide to Reverse Hepatic Fibrosis via AMPK-YAP/TAZ Signaling in Hepatic Stellate Cells	Vijaya Prathigudupu	Received

3393-SUN	Digital Pathology Quantification Reveals Fibrotic Signatures Linked to Early Recurrence in patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma	Li Chen	Received

3394-SUN	Constitutive MAS1 G protein-coupled receptor participates in the pathogenesis of liver fibrosis	Sabine Klein	Received

3395-SUN	Does IQR/median of liver stiffness measurement impact the accuracy of predicting of advanced fibrosis in MASLD?	Michael Eiswerth	Received

3396-SUN	Gene Expression Profiling Reveals THBS2 as a Candidate Mediator of Periductal Fibrosis in Primary Sclerosing Cholangitis	Tomohiro Katsumi	Received

3399-SUN	The Role of Iron in Hepatic Fibrosis Severity in Black and White Patients	Michael Attanasi	Received

3400-SUN	Study on the degree of liver fibrosis by FIB-4 index and ARFI technique in patients with non-alcoholic fatty liver disease and non-diabetes	Trung Huynh	Received

3401-SUN	HIV coinfection exacerbates HBV-induced liver fibrogenesis via an exosomal miR-103a-3p dependent pathway	Min Xu	Received

3403-SUN	From Trials to Targets: Hydronidone´s Mechanistic Role in Reversing Hepatic Fibrosis	Qichao Ge	Received

3404-SUN	Five anti-fibrotic microRNAs enriched in extracellular vesicles derived from mesenchymal stem cells suppress hepatic stellate cell fibrogenesis via downregulation of RhoA signaling	Daiki Kawamoto	Received

3408-SUN	Discovery of a Novel Acid Ceramidase Inhibitor to Reverse Hepatic Fibrosis	Vijaya Prathigudupu	Received

3409-SUN	Impact of Extracellular Matrix Stiffness on Temporal Dynamics of Hepatic Stellate Cell Activation in vitro	Kento Inada	Received

3411-SUN	Verification of the efficacy and safety of Kehuang capsule in treating the hepatic fibrosis induced by chronic hepatitis B, a multicentric, randomized, double-blind, placebo-controlled study	Yifan Han	Received

3412-SUN	Hydronidone Activates the PTEN-ATG7 Axis to Restore Mitophagy and Curb Oxidative Stress in Hepatocytes during Experimental Liver Fibrosis	Yuecheng Guo	Received

3413-SUN	Mitochondrial uncoupler promotes hepatic stellate cell activation and liver fibrosis by impairing mitochondria and lysosome function	Ji Hyun LEE	Received

3414-SUN	Functional Evaluation of BM-MSC-EVs on LSEC Normalization and Hepatic Progenitor Cell Induction	Seul Ki Han	Received

3416-SUN	Liver transcriptomic signatures in patients with alpha-1 antitrypsin deficiency-associated liver disease with a Pi*ZZ genotype are similar to those in other fibrotic liver diseases	Pavel Strnad	Received

3418-SUN	Analysis of clinical characteristics and long-term prognosis in young hepatitis B cirrhosis: a propensity score matching study	Zhenhua Zhang	Received

3419-SUN	Thyroid Dysfunction Reflects Disease Severity and Is Associated with Short-Term Mortality in Hospitalized Cirrhotic Patients	Christos Triantos	Received

3421-SUN	Interleukin-22 Promotes Liver Regeneration by Reprogramming Glycolytic Metabolism in a Mouse ALPPS Model	sheng wang	Received

3424-SUN	The Impact of Combined Heart-Liver Allocation on High-Acuity Liver Transplant Candidates in the United States: Intention-To-Treat Analysis	Toshihiro Nakayama	Received

3425-SUN	CleVER-LG: A Multimodal Machine Learning Biomarker for Non-Invasive Diagnosis of Liver Graft Injury	Soumita Ghosh	Received

3427-SUN	Older recipients transplanted with hepatocellular carcinoma have worse survival despite lower severity of illness and fewer post-transplant complications	Therese Bittermann	Received

3430-SUN	Finite human hepatocyte expansion in chimeric mouse livers is not overcome by TERT overexpression	Viktoriia Iakovleva	Received

3431-SUN	Preoperative exercise therapy alleviates surgical stress-promoted colorectal cancer liver metastases by shifting Kupffer cells to an anti-tumor phenotype	Janice Oh	Received

3433-SUN	Digital Twin Trajectory Matching Reveals Equipoise Between Simultaneous Liver-Kidney Transplantation and Liver Transplant Alone: A Deep Learning Analysis of 11,152 UNOS Registry Patients	Eytan Palte	Received

3434-SUN	Risk Stratification for Waitlist Dropout in HCC Patients Beyond UCSF Criteria: A Competing-Risks Analysis	Butros Fakhoury	Received

3435-SUN	Platelet-Rich Plasma Perfusion During Static Cold Storage Reduces Ischemia-Reperfusion Injury in Liver Transplantation	Catherine Anosova	Received

3436-SUN	Low Bile Output During Normothermic Machine Perfusion Is Not Predictive of Poor Graft Outcomes	Stephanie Ohara	Received

3441-SUN	Loss of Liver Sympathetic Innervation Exacerbates Hepatic Injury and Metabolic Dysregulation	Sadam Bhat	Received

3442-SUN	THE IMPACT OF GLP-1 AGONIST UTILIZATION ON POST LIVER TRANSPLANT OUTCOMES: A RETROSPECTIVE REVIEW	Taylor Seacor	Received

3444-SUN	Quantitative MRCP accurately detects the presence of non-anastomotic strictures in patients after liver transplantation	Andrea Dennis	Received

3445-SUN	Liver Frailty Index predicts poor physical activity volume and intensity (GENEActiv? accelerometer) in advanced chronic liver disease: UK prospective case-control study	Felicity Williams	Received

3447-SUN	Longer Driving Distance and Time to Transplant Center Are Associated with Increased Waitlist Removal and Lower Transplant Probability in Patients with Low MELD at Listing	John Esli Medina Morales	Received

3449-SUN	Evaluating the Role of Frailty in Extubation Timing and Recovery Following Liver Transplantation	Ishan Antony	Received

3451-SUN	Long-term Outcomes of Liver Transplantation for Alcohol-associated Hepatitis	Gene Im	Received

3452-SUN	Development and International Validation of the Living-Donor Liver Allograft Dysfunction Score for Early Graft Loss Prediction: Multicenter Analysis of 1,034 Cases	Jiro Kusakabe	Received

3454-SUN	Results and updated data of the Notable-HCC phase 1b trial: Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma	Lei Zhao	Received

3459-SUN	Psychological Symptom Burden Before and After Liver Transplantation: Patterns and Predictors in a Single-Center Cohort	Kishore Botla	Received

3460-SUN	Molecular patterns associated with recurrence and survival in intrahepatic cholangiocarcinoma (iCCA) / hepatocholangiocarcinoma (HCC-CCA) after liver transplantation	Maarouf Hoteit	Received

3461-SUN	Multimodal multiphasic image-based deep transfer learning for prediction of hepatocellular carcinoma recurrence after liver transplant	Rex Wan-Hin Hui	Received

3462-SUN	Cytomegalovirus-RNA accurately identifies clinically significant infection needing preemptive therapy in liver transplanted children: a proof-of-concept study	Emanuele Nicastro	Received

3465-SUN	COVID-19 and Post-Transplant and Biliary Outcomes Among Liver-Transplant Recipients: A Propensity Score Matched Analysis	Iqra Arshad	Received

3466-SUN	Examining the Impact of Inflammatory Bowel Disease Regarding Post-Transplant Outcomes in Primary Sclerosing Cholangitis	Yashasavi Sachar	Received

3467-SUN	Steatotic Liver Disease Phenotypes and Risk of Simultaneous Liver-Kidney Transplantation Eligibility: A Competing Risk Analysis of National Registry Data	Roy Wang	Received

3471-SUN	Platelet Recovery After Liver Transplantation: A New Look at Timing and Risk Factors	Jamie Yang	Received

3474-SUN	Trends and Regional Variation in Utilization of U.S. Living Liver Donors with Class II/III Obesity and Associated Recipient Survival, 2002-2023	Leandro Sierra	Received

3479-SUN	Efficacy and Safety of Tenofovir Alafenamide for HBV Prophylaxis in HBV-negative Liver Transplant Recipients with HBcAb-positive Donors:Updated 24-Week Interim Analysis	Aiwei Zhou	Received

3481-SUN	Temporal Trends in Median Wait Time for Liver Transplantation and Waitlist Outcomes in the U.S.	Ha Tran	Received

3482-SUN	PUMP-SOFT Score: Machine Perfusion as a Predictor of Short-Term Postoperative Mortality in Liver Transplantation	Gwendolyn Henry	Received

3483-SUN	A Randomized Multi-center Trial of a Telemetric Intervention to Prevent Rejection in Adolescents at Risk after Liver Transplantation (iMALT)	Emily Perito	Received

3484-SUN	Risk-Adapted Protocol for Coronary Artery Disease Assessment in Liver Transplant Candidates: Impact of Pre-Transplant Cardiac Catheterization Findings on Post-Transplant Outcomes - A Retrospective Cohort Analysis	Bandar Aljudaibi	Received

3485-SUN	The Profile and Outcomes of Liver Transplantation in the United States and 30 European Countries	Zobair Younossi	Received

3486-SUN	Anti-thymocyte globulin-based induction immunosuppression in liver transplant recipients with non-immune chronic liver diseases	Alexander Scherer	Received

3487-SUN	Non-ABO Antibodies and Their Impact on Liver Transplant Rejection: A Retrospective Study	Nino Gudushauri	Received

3488-SUN	CAD-LT Score Predicts Cardiac Mortality and Graft Survival in Liver Transplant Recipients: A Retrospective Cohort Analysis	Bandar Aljudaibi	Received

3489-SUN	An Increase in Regulatory B Cells and a Reduction in T Helper 17 Cells Play a Crucial Role in Achieving Tolerance in Liver Transplantation	Soon Kyu Lee	Received

3490-SUN	Consequences of MELD Cutoffs and Score Trajectories in Liver Transplantation	Tomohiro Tanaka	Received

3492-SUN	Sex Mismatch and Body Size Mismatch in Deceased Donor Liver Transplantation in the United States: Mismatching Is Associated With Worse Outcomes	Nolberto Jaramillo	Received

3494-SUN	Severe actigraphy-measured sleep dysfunction is associated with disease severity and poor quality of life in advanced chronic liver disease: UK prospective case-control study.	Felicity Williams	Received

3495-SUN	Superior Bioavailability of Tacrolimus in Liver Transplant Recipients Treated with Extended-release LCP-Tacrolimus (Envarsus) Compared to Prolonged-release Tacrolimus (Advagraf) after 12 (´EnGraft´)	Hans Schlitt	Received

3498-SUN	Subjective sleep disturbance, objective sleep quality, and patient reported quality of life: Interim results from the multi-center LivCog cohort study	Jacqueline Theroux	Received

3504-SUN	Arrb2 in hepatocytes promote M2 macrophage polarization ameliorates hepatic ischemia-reperfusion injury through upregulating metabolite 6-ketoLCA	genshu wang	Received

3505-SUN	Impact of Obesity on Pre- and Post-Liver Transplantation Outcomes: A Comparative Analysis Across BMI Classes	Nazli Begum Ozturk	Received

3506-SUN	Pre-Transplant Lipase Elevation and Its Prognostic Implications: Differentiating Biochemical Abnormalities from Clinically Significant Pancreatitis in Patients Undergoing Liver Transplantation	Peyton Crest	Received

3508-SUN	A meta-analysis of the effect of cirrhosis on mortality after heart transplant alone in those with a Fontan	Christopher Danford	Received

3509-SUN	A Multi-Stage-Resolved Flux Platform Quantifies Substrate-Specific Modulation of Hepatic Metabolism During Ex Vivo Liver Perfusion	Amin Amin	Received

3511-SUN	Liver transplantation in individuals with HIV - changes in indications and outcomes after the advent of direct-acting antivirals for hepatitis C virus	Ewan Glassey	Received

3512-SUN	Assessing kidney dysfunction in inpatients with decompensated cirrhosis: A Global-AKI cohort study	Kavish Patidar	Received

3514-SUN	Comparison of MELD, MELD-Na, and MELD 3.0 Scoring Systems in Transplant Prioritization in the Turkish Population: A Multicenter Study	Kenan Moral	Received

3515-SUN	Risk Factors for Seven-Day Graft Loss in Pediatric Liver Transplantation: A Retrospective Analysis of the SRTR Database	Louis Borsellino	Received

3517-SUN	Tricuspid Annular Plane Systolic Excursion (TAPSE) to Right Ventricular Systolic Pressure (RVSP) Ratio: A Novel Tool to Predict Cardiac Outcomes in Liver Transplant Recipients	Hong Lin	Received

3521-SUN	Outcomes of Low-Dose Valganciclovir in Treatment of Post Liver Transplant Cytomegalovirus Viraemia: A Retrospective, Single-Centre Study	Alison Rowley	Received

3522-SUN	The Natural History of Spur Cell Anemia after Liver Transplantation and its Impact on Survival	Hasan Alroobi	Received

3523-SUN	Disparities in Screening for and Prevalence of Low Bone Mineral Density Following Liver Transplant	Katherine Cooper	Received

3524-SUN	Plasma Cell-Rich Rejection After Liver Transplantation: New Insights into Evolving Risk Factors and Etiologies	Thuy-Duyen Nguyen	Received

3526-SUN	Delisting due to Clinical Improvement (DCI) as a Surrogate for Recompensation in the Era of Effective Treatments for Several Etiologies of Decompensated Cirrhosis: Analysis of UNOS Data	Alexandra McCullough	Received

3527-SUN	Association between Pre-Liver Transplant Coronary Artery Disease Risk and All-Cause Mortality After Liver Transplant: A Single Center Experience.	Alexander Dile	Received

3528-SUN	LONG TERM OUTCOME AND TIPS PLACEMENT FOR THE TREATMENT OF VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE	Michela Triolo	Received

3529-SUN	Pre-Transplant Echocardiographic Predictors of Post-Transplant Cardiac Events	Ali Albenmousa	Received

3530-SUN	From Bench to Computational Modeling: Integrating Mitochondrial Stress Data from a Rat Hepatic Ischemia-Reperfusion Injury Model into a Preclinical and Human Quantitative Systems Toxicology Platform	Joohyun Kim	Received

3531-SUN	Hepatic Reserve and Regeneration in Living Donors after Right Hepatic Lobectomy: a Pilot Study of the Oral Cholate Challenge Test	Joanne Imperial	Received

3533-SUN	Survival Benefit of Liver Transplantation in Alcohol-associated Liver Disease: Insights from a National Claims Database	Samer Gawrieh	Received

3534-SUN	Mechanistic target of rapamycin inhibitors (mTORi) utilization among U.S. liver transplant recipients is largely driven by center preference	Therese Bittermann	Received

3535-SUN	Using the Rochester Experience in Living Donor Liver Transplantation (LDLT) for Unresectable Colorectal Liver Metastasis (CRLM) to Evaluate the Utility of Circulating Tumor DNA (ctDNA) in Surveillance for Disease Recurrence	Roberto Hernandez-Alejandro	Received

3537-SUN	New Submission: Institutional Approaches to Liver Transplant Evaluation for Alcohol-Associated Liver Disease (ALD): A Protocol-Based Comparison	Esra Alagoz	Received

3538-SUN	Psychological, Sociodemographic and Sex-related Predictors for Waitlist Enrollment, Liver Transplantation and Survival	Maria Rosina Troppmair	Received

3539-SUN	Trends and Demographic Differences in Reasons for Removal from the Liver Transplant Waitlist: A Nationwide OPTN Analysis from 1988 to 2025	Razan Aburumman	Received

3541-SUN	Sex-Specific Performance of Non-Invasive Biomarkers for Predicting Graft Loss and Mortality among Liver Transplant Recipients	Thierry Fotsing Tadjo	Received

3545-SUN	Expanded utilization of liver transplantation in critically ill candidates with chronic liver disease does not threaten center-based outcome metrics	Laura Barr	Received

3546-SUN	One Year Post Transplant Outcomes in HCV Positive Donor to HCV Negative Recipient Liver Transplantation: A Descriptive Analysis of An Arizona Transplant Center´s Experience	Raha Sadjadi	Received

3549-SUN	Biologic Use and Risk of Acute Cellular and Antibody-Mediated Rejection in Liver Transplant Recipients With Inflammatory Bowel Disease	Ishan Antony	Received

3551-SUN	Proton Pump Inhibitor Use Is Associated with a Two-Fold Increased Risk of Liver Transplant Complications: A Propensity-Matched Analysis of 48,192 Recipients	Kate Solpari	Received

3553-SUN	Differential Overall Mortality and Healthcare Utilization for Liver Transplant Recipients by Regional, Hospital and Insurance Characteristics	Monica Tincopa	Received

3554-SUN	EARLY EXTUBATION FOLLOWING LIVER TRANSPLANTATION: AN UPDATED ANALYSIS OF A PROSPECTIVE COHORT	Justin Lin	Received

3555-SUN	Incidence and Predictors of Post-Transplant Malignancy in Liver Transplant Recipients: A Single-Centre Cohort Study	Francisco Idalsoaga	Received

3556-SUN	Fibrosis and Steatosis Progression After Liver Transplantation Differs Based on the Pretransplant Etiology of Liver Disease	Michael Attanasi	Received

3557-SUN	Grading ChatGPT´s Responses to Questions About Living Donor Liver Transplant	Russell Rosenblatt	Received

3558-SUN	Should Acute Pancreatitis Delay Liver Transplantation? Insights From a Propensity-Matched Cohort Study	Sameer Rao	Received

3560-SUN	Early Post-Transplant Enteral Nutrition Shortens Hospitalization and Prevents ICU Readmission After Liver Transplantation	Ali Shaat	Received

3562-SUN	Outcomes of Retransplantation for Autoimmune Liver Diseases: A National Retrospective Cohort Study	Justin Ong	Received

3563-SUN	Impact of Pre-existing Diabetes on Post-Transplant Infections and Mortality in Liver Recipients: A Time-Interval Propensity-Matched Analysis	Mohammad Abuassi	Received

3565-SUN	Few patients with alcohol-associated liver disease initially declined for liver transplantation receive transplant and have high 3-year mortality	Jennifer Flemming	Received

3566-SUN	Impact of switch from Standard-Release Tacrolimus (Prograf, Advagraf) to MeltDose Tacrolimus (LCPT) (Envarsus) on headaches/migraines: the E-MIG study	LUCY MEUNIER	Received

3567-SUN	Validation of GEMA-Na and GEMA-AI in an American Cohort of Patients on the Liver Transplant Waiting List	Austin Halupnik	Received

3568-SUN	Dynamic changes of spleen stiffness in liver transplanted patients: preliminary findings from a single-centre study	Sofia Ridolfo	Received

3570-SUN	Echoing Risk: The Role of Right Ventricular Systolic Pressure (RVSP) in Liver Transplant Outcomes	Hong Lin	Received

3571-SUN	Impact of Transjugular Intrahepatic Portosystemic Shunt on Waitlist and Post-Transplant Outcomes in Liver Transplant Candidates	Shyna Gunalan	Received

3572-SUN	Risk of Liver Transplant Rejection After COVID-19 Vaccination	Jordan Voss	Received

3573-SUN	Is it better to have one committed donor or many potential living liver donors?	Lauren Callans	Received

3574-SUN	Outcomes of Liver Transplantation from HCV-NAT-positive donors in HCV-NAT-negative recipients: A Systematic Review and Single-Arm Meta-Analysis	Mariana Del Col	Received

3577-SUN	Characterizing Outcomes and Donor Characteristics of Liver Transplant Recipients with High Number of Donor Inquiries	Nicole Ng	Received

3579-SUN	Liver Frailty Index Is Associated with Increased Intra-operative Blood Product Requirements during Liver Transplantation	Jade Pace	Received

3580-SUN	Expedited LT evaluation in the age of the COVID-19 pandemic and beyond: A comparative study investigating waitlist decisions in patients with and without alcoholic liver disease	Claire Maher	Received

3581-SUN	Mortality, Intensive Care Unit and Hospital Length of Stay in Patients Undergoing Simultaneous Liver-Kidney Transplantation Compared to Liver Transplantation Alone	Nazli Begum Ozturk	Received

3582-SUN	A 10-year Retrospective Single-Center Study on Vaccination Status of Pediatric Liver Transplant Recipients	Stephanie Chau Nguyen	Received

3583-SUN	Impact of Liver Diseases on De-Novo Allogeneic Liver Transplant Outcomes	Renuka Verma	Received

3585-SUN	Epidemiologic differences in high-risk cytomegalovirus mismatch between adult and pediatric liver transplant (LT) recipients	Vikram Raghu	Received

3586-SUN	Expanding the Donor Pool: Safe Recovery in Living Liver Donors Over Age 50	Hojung Park	Received

3587-SUN	Direct Bilirubin-Based MELD Score: Impact of Hepatic vs. Extra-Hepatic Hyperbilirubinemia on Staging of Cirrhosis	mete ucdal	Received

3588-SUN	Relationship between post-liver transplant relapse identified with phosphatidylethanol (PEth) testing and mortality among patients with alcohol use disorder	Humberto Gonzalez	Received

3590-SUN	Liver Transplantation Scholarly Works: A Focused Bibliometric Analysis Using the LENS Database	Hussam Almasri	Received

3591-SUN	Robotic Caudate Lobe Resection: A Systematic Review and Meta-analysis of Perioperative and Postoperative Outcomes	Mohammad Abuassi	Received

3592-SUN	De Novo Malignancy After Liver Transplantation in Patients With and Without Hepatocellular Carcinoma: A Propensity-Matched Analysis	Mohammad Abuassi	Received

3593-SUN	Liver Frailty Index: A vital Sign in a Transplant Hepatology Clinic	Sahak Hovsepian	Received

3594-SUN	External validation of MELD 3.0 performance in a Latin American liver transplant cohort.	Josefina Pages	Received

3597-SUN	Defining Weight Trajectory After Liver Transplantation Using Generative Artificial Intelligence	Alexis Kim	Received

3598-SUN	Pre-Liver Transplant Coronary Artery Disease Risk Is Associated with Incidence of Adverse Cardiovascular Events After Liver Transplant: A Single Center Experience.	Tanner Thornsberry	Received

3599-SUN	Patients Transplanted for MetALD Cirrhosis Have Rates of Metabolic Disorders Post-Transplant That Are Intermediate Between MASLD and Alcohol Cirrhosis	Mohammed Abourahma	Received

3600-SUN	Impact of pre-transplant treatments modalities on transplantable HCC aggressiveness	Francois Faitot	Received

3602-SUN	Liver Graft Characteristics of Low-MELD (6-9) Versus High-MELD (35+) Recipients: Insights from the UNOS Database	Mason Lai	Received

3603-SUN	Comorbidities and Survival in Liver Transplant Recipients	Lama Amer	Received

3604-SUN	Infections in the Immediate Post-Liver Transplant Period: Incidence, Microbial Profile, and Impact on Early Mortality	Radhika Nittala	Received

3605-SUN	The AI Agent in the Room: Informing Objective Decision Making at the Transplant Selection Committee	Bima Hasjim	Received

3606-SUN	Association between Recipient/Donor Characteristics and Liver Stiffness Measurement in the First Year Post-Liver Transplantation	Clara Dibenedetto	Received

3608-SUN	Sepsis as a Leading Cause of Mortality in Liver Transplant Recipients: A Single-Center Experience	Abdullah Alfhaid	Received

3609-SUN	SHOULD HBA1C LEVELS IMPACT CANDIDACY FOR LIVER TRANSPLANTATION? EVALUATING HBA1C CUTOFFS ON POST-LT OUTCOMES	Taylor Seacor	Received

3610-SUN	Safety and Feasibility of Immunotherapy Post Liver Transplantation- Prospective Multicentered Study of a Standardized Clinical Practice Protocol	Kymberly Watt	Received

3611-SUN	Application of New Steatotic Liver Disease Nomenclature to Liver Transplant Recipients	Nicole Lulkin	Received

3612-SUN	Sleeve Gastrectomy in Liver Transplant Recipients is safe and effective: A Paired Analysis	Jacob Bornstein	Received

3615-SUN	Intent-To-Treat Analysis of Liver Transplant (Living Donor Vs Deceased Donor) For Hepatocellular Carcinoma in the United States	Madeleine Wong	Received

3616-SUN	Prognostic Impact Of Combined Diastolic And Systolic Dysfunction With Global Longitudinal Strain On Outcomes In Liver Transplant Recipients	Ebehiwele Ebhohon	Received

3617-SUN	MELD-Na Score Stratification and Post-Liver Transplant OutcomesBackground	Ahmad Alissa	Received

3619-SUN	Direct Percutaneous Transhepatic Cholangioscopy Visualization for Safe and Radiation-Free Removal of Biliary Foreign Body: A Migrated Non-Absorbable Hemostatic Clip	Tianhao Chen	Received

3622-SUN	In vivo Gene Editing Therapy as a Treatment for Alpha-1 Antitrypsin Deficiency	Jeff An	Received

3623-SUN	Copper Overload Reshapes the Hepatic Immune Landscape in Wilson´s Disease	Mugagga Kalyesubula	Received

3625-SUN	CRISPR-Corrected Urine-Derived Stem Cells Reverse Wilson´s Disease Phenotypes:A Patient-Tailored Treatment Strategy	Pengfei Yu	Received

3626-SUN	Metabolic risk factors promote alpha-1 antitrypsin deficiency-associated liver disease	Malin Fromme	Received

3628-SUN	Cognitive function in patients with Wilson disease: prospective analysis from the Wilson Disease Registry study.	Michael Schilsky	Received

3629-SUN	Performance of vibration-controlled transient elastography relative to biopsy for liver fibrosis staging in patients with alpha-1 antitrypsin deficiency-associated liver disease and a Pi*ZZ genotype	Virginia Clark	Received

3630-SUN	Liver disease progression in patients with metabolic dysfunction-associated steatohepatitis with and without alpha-1 antitrypsin deficiency: results from a retrospective cohort study in the USA	George Marek	Received

3631-SUN	Serum microRNA sequencing identified fazirsiran treatment-responsive microRNAs in patients with alpha-1 antitrypsin deficiency-associated liver disease and a Pi*ZZ genotype	Pavel Strnad	Received

3633-SUN	Understanding the Real-World Burden of Wilson´s Disease: A Decade of Data From a Multinational Analysis	Do Han Kim	Received

3634-SUN	Tracking iron in the brain: The impact of Ceruloplasmin variants on Neurodegeneration	Marlene Panzer	Received

3635-SUN	TMED10 is a novel ATZ cargo receptor and therapeutic target for lowering ATZ accumulation in Alpha-1 Antitrypsin Deficiency.	Fabian Suri-Payer	Received

3636-SUN	Predictors of Testing and Test Positivity for Alpha-1 Antitrypsin Deficiency in Patients with Cirrhosis in a U.S. National Cohort	Binu John	Received

3637-SUN	Interim results of the international phase I/II GATEWAY gene therapy trial with VTX-801 conducted in adult patients with Wilson disease	Michael Schilsky	Received

3638-SUN	Intestinal-Failure Associated Liver Disease and Hepatic Manifestations of Short Bowel Syndrome: Exploring Predictors of Disease and Nationwide Outcomes	Michael Gianarakis	Received

3640-SUN	Genetic drivers of liver cirrhosis: the role of SERPINA1 and PNPLA3 variants in disease onset and progression	Jan Šperl	Received

3642-SUN	A Novel Nomogram Based on Common Clinical Indicators for Differential Diagnosis of Inherited Unconjugated Hyperbilirubinemia with Hemolytic Diseases	Haitian Yu	Received

3643-SUN	Alpha-1 Foundation Research Registry: Comparison of Liver-Affected Alpha-1 Antitrypsin Deficiency Patients with PiZZ and PiMZ Genotypes in a United States Cohort	Nadine Nuchovich	Received

3646-SUN	Longitudinal study of psychiatric features and disease outcomes in Wilson disease at the largest UK psychiatric center	Aftab Ala	Received

3648-SUN	Liver disease progression in individuals with alpha-1 antitrypsin deficiency-associated genotypes: insights from a large genetic database linked to electronic medical records in the USA	Virginia Clark	Received

3649-SUN	Diurnal Variation in Blood Ammonia Levels in Patients with Adult-Onset Type II Citrullinemia	Hiroaki Haga	Received

3650-SUN	Liver-humanized mice repopulated with hepatocytes from a hemophilia B donor exhibit delayed blood clotting and have a physiologic response to gene therapy correction of human FIX	Devorah Goldman	Received

3652-SUN	Understanding the Experience of Adults with Alpha-1 Antitrypsin Deficiency Liver Disease: A Concept Elicitation Interview Study	Hafiz Oko-osi	Received

3653-SUN	Metformin treatment to improve mitochondrial morphology and function in a mouse model of Wilson disease	Valentina Medici	Received

3654-SUN	Evaluation of Noninvasive testing for hepatic steatosis: results from the multicenter Wilson Disease Registry including Yale, Aarhus and Barcelona cohorts.	Frederik Kirk	Received

3655-SUN	A clinical decision support tool for the identification of patients at risk of developing alpha-1 antitrypsin deficiency-associated liver disease: interim results	Jeffrey Teckman	Received

4001-MON	Major Cardiovascular Event Reduction in MASLD: Tirzepatide vs. Semaglutide; A Propensity-Matched Real-World Study	Himsikhar Khataniar	Received

4002-MON	Efficacy and safety of time-restricted eating in metabolic dysfunction-associated steatotic liver disease	Hyo Young Lee	Received

4005-MON	Combination Therapy in Metabolic Dysfunction-associated Steatohepatitis: GLP-1R Agonist with Others	Hui Li	Received

4006-MON	Jamun-Derived Extracellular Vesicles Restore Intestinal Histidine-Adiponectin Signaling and Hepatic Lipid Metabolism to Attenuate High Carb-High Fat-Induced MASLD	P. Debishree Subudhi	Received

4008-MON	Efficacy of Saroglitazar in real world patients with Metabolic dysfunction associated steatotic liver disease with compensated advanced chronic liver disease	Rashmeet Brar	Received

4009-MON	Obese Patients On Glucagon-like Peptide-1 Inhibitors (GLP-1) Have Lower Rates Of Liver Related Morbidity Compared To Bariatric Surgery Patients- A Nationwide Retrospective Analysis	Rama Nanah	Received

4010-MON	SAMARA: SemAglutide treatMent in the reAl-woRld for fibrotic MASH in obesity and T2DMSemaglutide versus placebo in NIT-assessed MASH: A real world pragmatic multicenter randomized placebo-controlled trial (SAMARA)	Rohit Loomba	Received

4012-MON	DA-1241, a GPR119 agonist, demonstrates hepatoprotective effects through improving inflammation and metabolism in the liver: A 16-week randomized placebo-controlled trial in presumed metabolic dysfunction-associated steatohepatitis (MASH) patients	Rohit Loomba	Received

4014-MON	Comparative Risk of Hepatic Decompensation and Hepatocellular Carcinoma Among Antidiabetic Therapies in Patients with Type 2 Diabetes and Chronic Liver Disease	Ana Verma	Received

4015-MON	Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease: A randomized-placebo controlled trial	Srinivasan Dasarathy	Received

4016-MON	SGLT2 Inhibitors Suppressed the Onset of Extrahepatic Cancer Compared to DPP4 Inhibitors in Type 2 Diabetic Patients with MASLD: A Nationwide Medical Claims Database Study in Japan	Takumi Kawaguchi	Received

4017-MON	Effect of Bariatric Surgery, GLP-1 RA, and SGLT2i on Composite Liver Events in Non-Cirrhotic MASLD Patients: A Retrospective Cohort Study	Diwanshu Soni	Received

4018-MON	Preclinical Characterization of CVI-2742: A Highly Selective, Liver-Targeted THR-β Full Agonist with Robust Efficacy and Safety in MASH Models	Jingwen Liu	Received

4019-MON	A 5-week treatment with retatrutide strongly reduces liver fat content and shows multiple metabolic benefits in diet-induced obese MASH mouse and hamster models	Francois Briand	Received

4020-MON	Saroglitazar treatment reduced severity of MASLD phenotypes by lipidomic-based test OWLiver in subjects with MASLD in a 16-week phase 2 trial	Samer Gawrieh	Received

4021-MON	Cardiometabolic Risk Factors Are Highly Prevalent and Undertreated in MASLD With Advanced Liver Fibrosis- Analysis of a Large Regional Veterans´ Affairs Cohort	Suria Devarapalli	Received

4023-MON	Incretin Mimetic Therapy in Patients with MASLD is Associated with Early Body Composition Changes with Blunting of Differences with Longer-term Treatment	Oscar Shaver	Received

4024-MON	Antisense-Mediated Upregulation of HNF4α as a Potential Therapeutic Strategy for Liver Fibrosis	Lingdi Zhang	Received

4027-MON	Lower Liver Stiffness Among Adults with Type II Diabetes at Risk of MASLD is Independently Associated with Statin Use: Analysis of a Prospective Cohort of 548 Individuals	Monica Tincopa	Received

4029-MON	Prescribing Patterns of Statins in Decompensated Cirrhosis: A Multi-Center Cohort Study	Rishaan Sharma	Received

4031-MON	Variation in placebo response of randomised controlled trials evaluating GLP-1 receptor agonist activity on Metabolic-dysfunction Associated Steatotic Liver Disease	Katie Denver	Received

4032-MON	Decreased serum concentrations of pro-inflammatory oxylipins in MASH patients treated with icosabutate (ICONA study)	David Fraser	Received

4034-MON	SGLT2 Inhibitors and Risk of Liver Fibrosis Progression in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes	Daniel Fulop	Received

4035-MON	Association of GLP-1 Receptor Agonist Use with Liver Fibrosis Progression in Patients With MASLD and Type 2 Diabetes	Tushar Kamath	Received

4036-MON	Semaglutide Improves Markers of Cardiovascular Risk in People with HIV and MASLD: The SLIM LIVER Study	Jordan Lake	Received

4038-MON	Therapeutic Failures with Semaglutide - Lessons Drawn from Obesity and Type 2 Diabetes Mellitus Trials	Donghyun Ko	Received

4040-MON	Targeting nuclear protein improves NAFLD Activity Score and shows antifibrotic and hepatoprotective effects superior to Lanifibranor in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH	Michael Feigh	Received

4041-MON	Tirzepatide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH-HCC with advanced fibrosis	Michael Feigh	Received

4042-MON	Efficacy response in subgroups of participants in ESSENCE demonstrate that semaglutide is effective in improving liver fibrosis across a diverse population	Mary Rinella	Received

4047-MON	Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Metabolic Dysfunction-associated Steatohepatitis and Hepatic fibrosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials with Trial Sequential Analysis	Eliabe Abreu	Received

4049-MON	Fibrosis Regression with Resmetirom: Early Observations in Reducing Fibrosis in Patients with Metabolic Dysfunction-Associated Steatohepatitis	Rachel Patel	Received

4050-MON	Beyond Body Weight Control: Transcriptomic Analysis Reveals Additional Beneficial Effect of GIPR/GLP-1R Agonists in Metabolic Dysfunction-associated Steatohepatitis Therapy	Hui Li	Received

4051-MON	Real world resmetirom 6-month follow up data	Nadia Blessing	Received

4052-MON	RESMETIROM IMPROVES MORTALITY, LIVER AND CARDIO-RENAL-METABOLIC (CRM) OUTCOMES IN INDIVIDUALS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IN ROUTINE CLINICAL PRACTICE	Vinay Jahagirdar	Received

4053-MON	Harnessing the peripheral serotonin signaling: non-psychedelic psilocin analogues designed for the treatment of MASLD	Sara De Martin	Received

4055-MON	Effects of Pemafibrate on Improvement and Recurrence in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)	Takamasa Ohki	Received

4057-MON	Impact of levothyroxine on progression to and complications of cirrhosis in MASH	Abhinav Rao	Received

4058-MON	Realworld use patterns of resmetiron in patients with MASH: analysis of a national cohort	Tatyana Kushner	Received

4060-MON	Key Interaction Between Aspirin, Mediterranean Diet and Mortality in High-Risk MASLD: Analysis of NHANES 2011-2018	Tsubasa Tsutsumi	Received

4061-MON	Luseogliflozin Reduced CVD Risk by Improving Blood Pressure and HDL Cholesterol Levels in Diabetic Patients with MASLD: A Pooled Meta-analysis of Phase III Clinical Trials using A Causal Inference Analysis	Takumi Kawaguchi	Received

4063-MON	Evaluating Antidepressant Choice: TCAs vs SSRIs in MASLD Patients with Comorbid Major Depressive Disorder	Saad Ahmed	Received

4064-MON	Superior hepatoprotective effects of OPK-88006, a novel GLP-1/Glucagon receptor dual agonist, to semaglutide and survodutide in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH	Michael Feigh	Received

4065-MON	Treatment with SGLT2 inhibitors is associated with a reduction in esophageal and gastric varices in patients with cirrhosis	Helena Katchman	Received

4067-MON	Patient characteristics and treatment patterns among patients using resmetirom in the real-world setting	Nipun Atreja	Received

4069-MON	Prescribing Patterns and Clinical Characteristics of Resmetirom Recipients: Real-world Insights	Vinay Jahagirdar	Received

4071-MON	Beyond the Liver,Impact of MASLD treatment on subclinical atherosclerosis and cardiometabolic risk: A Systemiatic review and Meta-analysis.	Eunice Omeludike	Received

4073-MON	Evaluating the early real-world impact of resmetirom in patients with metabolic dysfunction-associated steatohepatitis (MASH): A United States cohort study using electronic medical records	Yestle Kim	Received

4076-MON	Prescribing Patterns of GLP-1 RA Across Steatotic Liver Disease Phenotypes	Natalia Salinas Parra	Received

4084-MON	Combination Therapy with Resmetirom and GLP-1 Receptor Agonists Demonstrates Superior Efficacy in Reducing Liver Fibrosis in Patients with Metabolic Dysfunction-Associated Steatohepatitis: A Real-World Multi-Cohort Analysis	Kate Solpari	Received

4086-MON	A bispecific ANGPTL3-DGAT2 siRNA for concurrent treatment of both hepatic steatosis and atherosclerotic cardiovascular disease	Michael Khan	Received

4088-MON	Effects of Oral Semaglutide on FIB-4 score in Adults with Type 2 Diabetes in Real-World Clinical Practice: An Indian Observation Study	Ramakrishnan Santosh	Received

4089-MON	Real-World Experience with Resmetirom to Treat MASH in a University Hospital System	Arthi Thirumalai	Received

4090-MON	New SubmissionDemographic Variables and Co-Morbid Conditions Predict Prescribing of GLP-1 Receptor Agonists for Individuals with Metabolic Dysfunction	Emily Currier	Received

4091-MON	Comparative Analysis of Resmetirom and Tirzepatide in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease: Insights from a Large Database	Liza Bagashvili	Received

4092-MON	Long-term real-life experience of semaglutide in a monocentric Metabolic dysfuction-Associated Steatotic Liver Disease (MASLD) diabetic cohort	Giovanni Petralli	Received

4094-MON	Impact of Endoscopic Gastric Remodelling in Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review and Meta-Analysis	Yusuf Kagzi	Received

4095-MON	Exercise Partly Protects Against Semaglutide-Induced Muscle Loss in Obese Ldlr-/-.Leiden Mice	Eveline Gart	Received

4097-MON	APPLYING CLINICAL TRIAL RESULTS TO INDIVIDUAL PATIENT CARE: A GUIDE FOR CLINICIANS	Shobha Joshi	Received

4098-MON	Safety and efficacy of dual incretin receptor agonists for metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis of randomized controlled trials	Eliabe Abreu	Received

4099-MON	GSK4532990 PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) MODELING SUPPORTS QUARTERLY AND MONTHLY SIRNA DOSING FOR MASH IN THE HORIZON PHASE 2B STUDY	Brandon Swift	Received

4100-MON	Turning the Tide on Fatty Liver: Efficacy and Safety of GLP-1 Receptor Agonists in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis - a Systematic Review	Harika Dadigiri	Received

4101-MON	Effectiveness of Semaglutide in Non-Alcoholic Steatohepatitis resolution A meta-analysis and systematic review	Claudine Feliciano	Received

4103-MON	Fat, Fibrosis, and Fix: Transforming Cirrhotic Outcomes via multi-modality Weight Loss approaches	Yashowardhan Taparia	Received

4104-MON	Liver-targeted Delivery of Human Platelet Lysate-derived Hydrogels promote Hepatocyte Proliferation, Angiogenesis and Survival in Post-hepatectomy Liver Failure	Ashwini Vasudevan	Received

4106-MON	Lipopolysaccharide binding protein as a potential predictive biomarker for acute kidney injury onset in cirrhosis	Tadashi Namisaki	Received

4108-MON	Clinical profile, Prognostic Factors and Outcomes in Acute Liver Injury Due to Yellow Phosphorus/Metal Phosphide Poisoning: A Large Real-World Cohort Analysis	Arun Valsan	Received

4109-MON	Novel Predictors of 30-Day Mortality in Acute Liver Failure: A Multi-Center Acute Liver Failure Study Group (ALFSG) Cohort Analysis	Taranika Sarkar Das	Received

4110-MON	Treatment of Alcoholic Liver Disease and Liver Failure Using a Novel 3D-Printed PLG-Based Implantable Therapy	Regeant Panday	Received

4112-MON	Targeting RAC1 as a novel strategy to reduce inflammation and liver damage in acute liver failure.	Barbara Bueloni	Received

4113-MON	Indications and Outcomes for Patients Delisted for Emergency Liver Transplant in Acute Liver Failure - a single centre review over 30 years	Daniel Z	Received

4114-MON	Targeting Albumin Binding Function to Describe Removal of Protein-Bound Toxins in Personalized Extracorporeal Therapies	Stine Koball	Received

4116-MON	Combination with glucocorticoids during artificial liver support system treatment does not improve the survival rate of Acute-on-chronic liver failure patients: A retrospective cohort study	Fu-Xia Ta	Received

4118-MON	Factors contributing to technical success and its predictors in transjugular liver biopsy	NAOHIRO WADA	Received

4119-MON	Activation of a Tumor Suppressor p53 Drives Acute Liver Failure via Upregulation of Leukemia Inhibitory Factor (LIF)	Jihyun Sung	Received

4120-MON	Efficacy, safety and prognostic factors of Dual Plasma Molecular Adsorption System combined with Plasma Exchange on Acute-on-Chronic Liver Failure:A Single-Center Retrospective Cohort study	Wen-Juan Shi	Received

4121-MON	Beyond Acetaminophen: An umbrella review of N-Acetylcysteine in Non- Acetaminophen-Induced Liver Failure	Abdullah Sultany	Received

4122-MON	Spatiotemporal-omics reveals the role of Mlxipl+ hepatocytes in liver repair in acute liver injury mice	Bingqi Li	Received

4124-MON	Gut Microbial Succession and Escalating Antibiotic Resistance from Chronic Hepatitis B to Acute-on-Chronic Liver Failure: A Metagenomic Study	Jiyang Chen	Received

4125-MON	Secondary SBP Prophylaxis Worsens Survival Without Affecting Liver Transplant Rates in Veterans with Cirrhosis Followed After their First Decompensation	Jasmohan Bajaj	Received

4126-MON	Nutritional Support Intervention in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure at Nutritional Risk: A Randomized Controlled Clinical Trial	Liang Peng	Received

4129-MON	Empiric Versus Pre-emptive Antifungal in Acute-on-Chronic Liver Failure with Suspected Invasive Fungal Infections: A Pragmatic Randomized Controlled Trial with Machine Learning	Nipun Verma	Received

4131-MON	A simple machine learning model considering Serum bilirubin, PT-INR and age can accurately predicts the risk of early renal failure in patient of Acute on Chronic Liver Failure(ACLF).	Ashok Kumar Choudhury	Received

4132-MON	Liver Frailty Index Is Associated with Decreased Recovery in eGFR after Liver Transplantation	Ahmed Aboseria	Received

4133-MON	Dynamic changes in the A-TANGO organ failure score over 7-days accurately defines mortality and could be used as a surrogate end point in clinical trials	Nipun Verma	Received

4134-MON	Impact of Hepatic Encephalopathy on Prognosis in Cirrhotic Patients with Acute Decompensation: The Crucial Role of Underlying Liver Function and Coagulation Failure	Jung Hee Kim	Received

4136-MON	ESTABLISHING A RANK-ORDERED HEIRARCHY OF ACLF RELATED MORTALITY RISK ASSOCIATED WITH ORGAN SUPPORT IN REAL WORLD CLINICAL PRACTICE	Kavin Parmar	Received

4137-MON	Development and validation of the ATANGO organ failure score for diagnosis and prognosis of acute-on-chronic liver failure in global cohorts	Cornelius Engelmann	Received

4138-MON	Macrophage polarization mediated by the interactions of Hypoxia-inducible factor 1a and CBP/P300 interacting trans-activator plays an important role in disease progression of hepatitis B virus-related acute-on-chronic liver failure	Yubao Zheng	Received

4139-MON	Efficacy and Safety of Tenofovir Amibufenamide Fumarate in Patients with Acute-on-Chronic Liver Failure: a Multi-Center, Prospective Cohort Study	Wei Liu	Received

4140-MON	Direct Chemical Reprogramming of Urine-Derived Stem Cells from ACLF Patients into Functional Hepatocyte-Like Cells for Liver Injury Therapy	Pengfei Yu	Received

4141-MON	HDL-C, Cholesterol and the ALT/HDL-C ratio are predictors of survival in patients with acute-on-chronic liver failure	Georg Kramer	Received

4142-MON	New Submission The albumin-bilirubin (ALBI) score predicts kidney failure and mortality in patients with alcohol related acute on chronic liver failure- An analysis from the AARC	Rakhi Maiwall	Received

4143-MON	Dynamic changes in spleen stiffness predicts outcome of ACLF patients by day-7 - A prospective study[NCT06069284]	Sudhir Verma	Received

4144-MON	High Risk Readmission Following Discharge Home from Expedited Liver Transplant Evaluation	Katherine Cooper	Received

4145-MON	Window for Plasma exchange (PLEX) in Alcohol-related ACLF (Kyoto consensus): PSM analysis of 1-year survival with PLEX (with low dose steroid) vs Standard medical treatment.	Santhosh Kumar	Received

4147-MON	Development and Validation of an Explainable Machine Learning Model for Predicting Invasive Fungal Infection in Acute-on-Chronic Liver Failure within 28 Days	Qi Wang	Received

4148-MON	Performance of the China-CLIF framework in acute-on-chronic liver failure: A multi-cohort study across all aetiologies	Jun Li	Received

4149-MON	A HDL-based cirrhosis risk score improves the prediction of short-term mortality in acutely decompensated cirrhosis	Rudolf Stauber	Received

4150-MON	Anti-microbial Resistance Patterns in Acute-on-chronic liver failure and its impact on clinical outcome	Yaduvir Singh	Received

4151-MON	Impact of Liver Transplant and Therapeutic plasma exchange on Clinical Outcomes in ACLF Patients With and Without Infection: A Propensity Score-Matched Study from the AARC Database	Ajay Patwa	Received

4152-MON	Systemic and multi-organ inflammation patterns across the spectrum of experimental and human cirrhosis and acute-on-chronic liver failure	Vlad Taru	Received

4158-MON	From Colonization to Infection: Clinical Consequences of Multidrug-Resistant Organisms in Cirrhosis in the ICU	Iva Kosuta	Received

4160-MON	The linoleic acid-derived leukotoxin 9,10-DiHOME drives immunosuppression in patients with acute-on-chronic liver failure	Bryan Contreras	Received

4162-MON	Effect of VS-01 on systemic inflammation and liver injury in a rat model of endotoxemia	Marie Bobowski-Gerard	Received

4163-MON	Longitudinal single-cell multimodal analysis reveals the dynamic immune mechanisms underlying HBV-ACLF progression	Jun Li	Received

4164-MON	Identification of Plasma Extracellular Vesicle microRNA Profiles as Diagnostic and Prognostic Biomarkers for HBV-Associated Acute-on-Chronic Liver Failure	Wanying Tan	Received

4165-MON	Efficacy of nitazoxanide (NTZ) on systemic inflammation and organ function in disease models of acute-on-chronic liver failure (ACLF) when administered post-ACLF trigger	Marie Bobowski-Gerard	Received

4166-MON	AARC score predicts survival outcomes better than other scores in patients with acute on chronic liver failure patients having histopathologically-proven mild liver fibrosis	Rohit Wagh	Received

4167-MON	Treatment of Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) with Titratable Norepinephrine Outside of Intensive Care Unit (ICU): A Single Center Experience	Kyle Schneider	Received

4168-MON	Presence of sepsis is associated with increased risk of acute variceal bleeding and increased moratlity in patients with Acute-on-chronic Liver Failure: a propensity-matched multinational cohort of the APASL ACLF Research Consortium (AARC).	Madhumita Premkumar	Received

4169-MON	Timing Matters: Delayed Antibiotic Therapy Increases Mortality in Patients with ACLF. A single-center retrospective study	German Barrientos - Cabrera	Received

4170-MON	Elevated fibrin degradation product level predict poor outcomes in hepatitis B virus-related acute-on-chronic liver failure patients treated with artificial liver support system therapy	Xiaoqi Zhou	Received

4172-MON	Noncanonical inflammasome-triggered pyroptosis exacerbates coagulopathy in acute-on-chronic liver failure via releasing histone H3 and enhancing tissue factor activity	Xueyun Zhang	Received

4173-MON	Single-nucleus transcriptomics identifies a CD44? regenerative hepatocyte subpopulation in hepatitis B virus-related acute-on-chronic liver failure	Xiaohan Qian	Received

4174-MON	EVALUATION OF THE VALIDITY AND RELIABILITY OF THE GLIM CRITERIA IN DIAGNOSING MALNUTRITION AMONG OUTPATIENTS WITH LIVER CIRRHOSIS	Araceli López Nepomuceno	Received

4175-MON	Using machine learning to accurately predict the 90 day prognosis of Acute-on-chronic liver failure based on Liver reserve function and clinical features	Xia Zhu	Received

4176-MON	Combination of MELD score with neutrophil-to-lymphocyte ratio predicts in-hospital mortality in acute-on-chronic liver failure.	Nikos Viazis	Received

4177-MON	Impact of Frailty and Obesity on Hospital Length of Stay After Liver Transplantation	Ahmed Aboseria	Received

4181-MON	Real-world data on acute-on-chronic liver failure: Implications for clinical management and policy	Hidehiro Kamezaki	Received

4182-MON	Prognostic Models and Infection-Related Mortality in ACLF: A Prospective Mexican Cohort Study	Emilio Sandoval-Gonzalez	Received

4183-MON	OGA Induces Neuronal Necroptosis via Extracellular Vesicles Driving Perineural Invasion in Gallbladder Cancer	Danyang Shen	Received

4186-MON	The Clinical Efficacy of a PPARα Agonist on Murine Primary Biliary Cholangitis	Masahiro Umemura	Received

4191-MON	Cholangiocyte RUNX1 Orchestrates Fibrogenic and Inflammatory Signaling to Drive Biliary Fibrosis	Sayed Obaidullah Aseem	Received

4193-MON	Loss of DNMT1 disrupts liver regenerative pathways and progenitor cell activation in cholestatic liver disease	Juliana Marques Affonso	Received

4195-MON	Gene edited iPSC-derived biliary organoids reveal CFTR mutation-specific impacts on cholangiocyte function and provides pathophysiological insights relevant for treatment of CF-related liver disease	Romina Fiorotto	Received

4196-MON	TGFβ2 upregulation on reactive cholangiocytes limits the therapeutic efficacy of TGFβ trap RAP-1332 in mouse models of chronic biliary injury and fibrosis	Pinzhu Huang	Received

4198-MON	Does Cholangiocyte Ferroptosis Promote a Pro-fibrogenic Macrophage Phenotype in Cholestasis?	Maria Eugenia Guicciardi	Received

4201-MON	The Influence of Hydrophobic Bile Acids on the Onset of Primary Sclerosing Cholangitis via Cholehepatic and Enterohepatic Circulations	Teruo Miyazaki	Received

4203-MON	The NF-Y Heterotrimeric Transcription Factor Complex as a Regulator of the Cholangiocyte Proliferation-Associated Phenotype in a Model of Murine Cholestasis	Gregory Gores	Received

4206-MON	Distinct Bile Mycobiome Signature Identifies Fungal Peptide panel predictive for Gallbladder Carcinoma.	Sanju Yadav	Received

4209-MON	A New Class of Orally Available NTCP Inhibitors Demonstrates Potent Efficacy Against HBV and Cholestasis in Humanized Mice Models	Stan van de Graaf	Received

4210-MON	Combination of pharmacological IBAT inhibition and PPAR activation improves liver histopathology of sclerosing cholangitis in MDR2-/- mice	Manavi Singh	Received

4212-MON	Beta-catenin overexpression dampens hepatitis, fibrosis, and ductular proliferation in a mouse cholestatic liver disease model and coincides with increased hepatocyte-to-cholangiocyte transdifferentiation	Tony (Chun-Cheng) Chiang	Received

4214-MON	SC435, an Intestinal bile acid transporter inhibitor (IBAT), improves liver function in cholestatic Mdr2-/- mice but not in ARE-Del-/- Mice	James Boyer	Received

4215-MON	The histone deacetylase inhibitor MS-275 mitigates hepatobiliary injury by maintaining quiescence and metabolic reprogramming in a murine model of cholestatic liver disease	Tony (Chun-Cheng) Chiang	Received

4216-MON	Lipid-Immune Crosstalk in HCC: FXR Disrupts Sphingosine-1-Phosphate Signaling to Limit Treg Trafficking	Yasmeen Attia	Received

4221-MON	Distinct Morphological and Functional Characteristics of Peridroplet and Cytoplasmic Mitochondria in Human Liver Biopsies	Norihiro Imai	Received

4222-MON	Mechanisms of Gene Transcription Regulation by Nuclear Lipid Droplets in Liver Diseases	Norihiro Imai	Received

4224-MON	Immunosuppressive tumor microenvironment in hepatocellular carcinoma orchestrated by CD90-positive cancer stem cells	Kouki Nio	Received

4225-MON	Identification of a signaling microdomain in the hepatocyte nucleus that regulates cell proliferation and becomes disrupted in chronic liver disease.	Jittima Weerachayaphorn	Received

4226-MON	Dfna5-dependent hepatocyte death promotes Tnf production in Kupffer cells and contributes to hepatocarcinogenesis	Yoshinobu Saito	Received

4227-MON	Trained human bone marrow mesenchymal stem cells restore tissue immuno-microenvironment in fulminant hepatic failure mice	Bingqi Li	Received

4229-MON	Discovery of porcine greater omentum-derived stem cell and its therapeutic potential for liver regeneration	Min-Gyeong Seo	Received

4230-MON	Porcine greater omentum-extracts promote liver regeneration by stimulating cell cycle progression in mice after partial hepatectomy	Min-Gyeong Seo	Received

4235-MON	Development of an intrahepatic cholangiocyte-derived cholangiocarcinoma mouse model	Bin Wang	Received

4236-MON	ABAT Inhibits VEGFA-Driven Hepatocellular Carcinoma Progression by Promoting SerRS2 Nuclear Translocation	Baojia Zou	Received

4237-MON	Development and characterization of a novel long-term culture system for human iPSC-derived hepatic organoids	Taro Shimizu	Received

4240-MON	The XBP1 activator IXA4 regulates human bile acid and fatty acid synthesis genes in iPSC-hepatocytes	Moloud Aflaki Sooreshjani	Received

4241-MON	Etiology-specific chromosome 8q24 amplification associated with human intrahepatic cholangio- and hepatocellular carcinomas predicts MYC/ZEB1/MIZ1 transcriptional regulation and poor prognosis	Saniya Davis	Received

4242-MON	Nuclear receptor expression is dysregulated in adipose tissue in cirrhosis	Sanal Madhusudana Girija	Received

4245-MON	Rapid and versatile multiplex liver gene editing in mice using adeno-associated viral 8 or lipid nanoparticles	Dandan Wu	Received

4246-MON	Sensing of phosphatidic acid by mTORC1 in liver and development of MASLD	Chandrima Gain	Received

4247-MON	Discovery of a Novel DNA Aptamer to Facilitate In Vivo Targeted Gene Therapy in Cholangiocarcinoma	Enis Hikmet Ozmert	Received

4249-MON	Transceptor RhBG-dependent activation of inositol requiring enzyme-1 alpha (IRE1a) and X-box binding protein-1 (XBP1) splicing in skeletal muscle during hyperammonemic stress response causes sarcopenia of liver disease	Pugazhendhi Kannan	Received

4252-MON	Aging triggers alcohol-induced endotoxin tolerance by reprogramming monocyte responses in a niche-specific manner	Marti Ortega Ribera	Received

4255-MON	Albumin rescues endothelial cell mitochondrial morphology in patients with decompensated cirrhosis	Susan Fischer	Received

4257-MON	Suggested importance of the microenvironment surrounding cancer cells in the progression of hepatocellular carcinoma	Hirayuki Enomoto	Received

4258-MON	Polyenylphosphatidylcholine (PPC) Attenuates Oxidative Stress-Induced Liver Injury by Stabilizing Lysosomal Membrane Integrity	yongzhi li	Received

4260-MON	Zinc finger transcription factor FANIN is the upstream regulator of pioneer factors Foxa1 and Foxa2 in the liver.	Irina Bochkis	Received

4261-MON	Exosome-dependent mechanism of Liver Regeneration After Partial Hepatectomy	Vasily Yakovlev	Received

4262-MON	The caloric restriction mimetic, hydroxycitrate, is a promising supplemental dietary therapy to prevent alcohol-induced liver injury.	Oluwaseyi Okesooto	Received

4263-MON	Increasing matrix heterogeneity promotes cell-matrix interactions and the aggressiveness of liver cancer cells	Alexander Hayn	Received

4265-MON	Association of liver-specific miR-122 expression with COVID-19 severity	Nicoleta Mihai	Received

4267-MON	Hepatic Stellate Cell-derived HB-EGF suppressed hepatocyte apoptosis in acute liver injury	Yoichi Sasaki	Received

4270-MON	HEPATIC MITOCHONDRIAL METABOLISM ASSESSED IN VIVO BY HYPERPOLARIZED [1-13C]- and [2-13C]PYRUVATE WITH EX VIVO ISOTOPOMER ANALYSIS	Baljeet Seniwal	Received

4272-MON	Loss of BRCA2 Sensitizes Hepatocellular Carcinoma to PARP Inhibition	Salah Adlat	Received

4274-MON	Cancer-associated fibroblast (CAF) atlas in HCC and association with immunotherapy response	Guillem Cano Segarra	Received

4275-MON	Transcriptomic and Cellular Traits of Liver Fibrosis Regression in On-Treatment Chronic Hepatitis B Patients	Wei Chen	Received

4279-MON	AI Assisted Imaging Analysis Improving Risk Prognostication of Hepatocellular Carcinoma in Veterans with Chronic Liver Disease	Grace Su	Received

4280-MON	Targeted resequencing identifies predisposing genetic correlates in lean and obese MASH subtypes: Finding the missing heritability in Indian population	Pramod Gautam	Received

4281-MON	Clonal Hematopoiesis of Indeterminate Potential is associated with an increased risk of HCC in patients with MASLD	Gopanandan Parthasarathy	Received

4284-MON	Plasma Cell-Free DNA Fragmentomics and Methylomics Analysis of Individuals with Gallstones and Gallbladder Cancer from the Shanghai Biliary Tract Cancer Case-Control Study	Michael Daniels	Received

4285-MON	High-resolution spatial transcriptomics of HCC identifies distinct immune cell architectures linked to response and resistance to atezolizumab-bevacizumab therapy	Anna Vila	Received

4290-MON	The genomic mutation of hepatocellular carcinoma in Fontan-associated liver diseases characterized by chromosomal rearrangements	Taiji Yamazoe	Received

4291-MON	Clinico-radiomic features can stratify Clinically Significant Portal Hypertension (CSPH) in patients of Cirrhosis non-invasively.	Ashok Kumar Choudhury	Received

4296-MON	Towards a Human-Like Bile Acid Pool in Mice: dissecting the role of Cyp2c70 and Agxt in bile acid composition and conjugation	Dandan Wu	Received

4297-MON	Hepatocellular carcinoma microenvironment analysis using single-cell RNA-seq to explore novel therapeutic targets	Ryo Takahashi	Received

4299-MON	Electroporation in hepatocytes to evaluate a cell-based gene editing strategy for treating homozygous familial hypercholesterolemia	Renee Cottle	Received

4300-MON	Next generation whole exome sequencing of liver tissues in Indian Hepatocellular carcinoma patients to identify the actionable mutations	Baibaswata Nayak	Received

4301-MON	β-arrestin2 facilitates liver regeneration in cirrhosis by inhibiting Beclin1-mediated ferritinophagy-dependent ferroptosis	WenFeng Zhu	Received

4303-MON	Identification of Key Proteins in Cirrhosis Progression Via a Biological Network (Rich-Club) Analysis Approach	Paola Barrios	Received

4304-MON	Establishment of assay limits for differential gene expression and DNA methylation to characterize specificity of epigenetic editing	Erica Hildebrand	Received

4306-MON	Shared genetic variants between Long COVID and Viral Hepatitis B and C individuals: Association with polymorph in the PLXNA4 and DPP9 genes.	Manuel Romero-Gomez	Received

4309-MON	Fecal microbiota transplantation improves gut microbial diversity and reduces antimicrobial resistance in cirrhosis: results from a randomized controlled trial	. Shalimar	Received

4311-MON	Targeting the Gut-Liver Axis: Graphene Oxide Nanoparticles Restore Barrier Function, Rebalance Microbiota, and Suppress miR-203a-TLR4 Pathway in Alcohol associated liver disease.	Hiral Aghara	Received

4315-MON	Early shift in Gut Mycobiome Exacerbates Alcoholic Liver Disease Progression	Satya Priya Sharma	Received

4316-MON	´Bacteroidetes enrichment influences hepatocellular carcinoma progression and response to immunotherapy´	Marina Barcena Varela	Received

4318-MON	A gut metagenomic profile distinguishes compensated cirrhosis from healthy controls across multiple country cohorts.	Jasmohan Bajaj	Received

4319-MON	Modified Forms of Secondary Bile Acid Levels Could be Biomarkers of Hepatocellular Carcinoma Pathogenesis in Steatotic Liver Disease Patients	Yoshimi Yukawa-Muto	Received

4323-MON	Higher plasma Kynurenine-Tryptophan Ratio Predicts Incident Hepatic Fibrosis in Women With HIV	Maria Duarte	Received

4325-MON	C-C motif chemokine receptor 9 ablation worsens whereas therapeutic blocking protects mice from western diet-induced steatohepatitis.	Daniel Rossmiller	Received

4326-MON	Breaking Barriers and Triggering Death: Dual Bacterial Mechanisms of Junction Damage and Paraptosis in Spontaneous Bacterial Peritonitis	Noah Sendtner	Received

4328-MON	Lactulose Efficacy is Linked to Bifidobacterium and Short-Chain Fatty Acid Production	Patricia Bloom	Received

4329-MON	Characterizing the Gut Microbiome in Non-cirrhotic Portal Hypertension	Jenna Oringher	Received

4332-MON	Neonatal overfeeding accelerates age-related liver pathologies and metabolic dysfunction through gut microbiota	Jiangao Fan	Received

4339-MON	Dysbiosis in the Gut-Liver Axis Drives Bone Loss during Cholestatic Liver Disease	Matthew Carson	Received

4340-MON	THE MICROBIOME IN PATIENTS WITH CIRRHOSIS AND CLINICAL SIGNIFICANT PORTAL HYPERTENSION: A PILOT CASE-CONTROL STUDY	Giuseppe Colucci	Received

4341-MON	Cross-Kingdom Shifts in the Blood Microbiome During HCV-Associated Liver Fibrosis and Post-Viral Clearance.	Rownock Afruza	Received

4342-MON	MASLD-related oral microbes were associated with obesogenic metabolites and clinical parameters	Hyo Young Lee	Received

4343-MON	Carboxymethylcellulose and polysorbate 80: bridging ultraprocessed food and MASLD-associated hepatocarcinogenesis.	Gabriel Prata Bacil	Received

4345-MON	Kinase Inhibitor Induced Liver Injury	Lily Dara	Received

4347-MON	Identification of Novel Biomarkers for Cholestatic Drug-Induced Liver Injury	Kota Tsuruya	Received

4350-MON	Impact of acute kidney injury at the time of diagnosis of idiosyncratic drug-induced liver injury: comprehensive analysis of two large prospective cohorts	Raul Andrade	Received

4352-MON	Impact of Steroid Duration on Outcomes in Immune Checkpoint Inhibitor Hepatitis	Mohamed Nadeem	Received

4354-MON	Rule-of-Two and DILIscore for Drug-Induced Liver Injury Risk Assessment Are Associated with Risk Mitigation Actions in Drug Applications Evaluated at the FDA	Ifedayo Oye	Received

4355-MON	The high predictive power of the model of end-stage liver disease score in drug-induced liver injury	Sabine Weber	Received

4358-MON	A Limited Revised Electronic Causality Assessment Method (RECAM) Algorithm for DILI Case Prioritization in Clinical TrialsSubmission	Paul Hayashi	Received

4359-MON	The Effect of a Fixed Aminotransferase Upper Limit of Normal on eDISH Assessment of Liver Injury Risk in Clinical Trials	Paul Hayashi	Received

4360-MON	An PHD2-Targeted Intrabody Protects Acetaminophen-Induced Liver Injury by Improving Redox Homeostasis and Attenuating Ferroptosis	Guiying Li	Received

4361-MON	Hepatocyte-specific deletion of betaine homocysteine methyltransferase promotes age-dependent progression of liver disease through altering one-carbon metabolism	Kusum Kharbanda	Received

4362-MON	Drug induced Liver Injury in Patients with Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome	Neel Ravela	Received

4363-MON	Liver test pattern and histologic bile duct injury do not predict response to treatment of immunotherapy hepatotoxicity	Benjamin Rabin	Received

4364-MON	Efficacy of Plasma Exchange in Severe Immune Checkpoint Inhibitor-Induced Hepatitis (CHILI): plasmaCHILI study	LUCY MEUNIER	Received

4365-MON	Study on the Mediating Effect of Sleep Disorders Between Anxiety and Quality of Life in Patients with Liver Cirrhosis.	Guzainuer Yiliyaer	Received

4367-MON	ACR Score: A Novel Predictive Model for Drug-Induced Liver Injury Severity Assessment	Na Fu	Received

4369-MON	Hormonal Contraceptive-Associated Drug-Induced Liver Injury in the Modern Era: Insights from the Drug-Induced Liver Injury Network	Raj Vuppalanchi	Received

4370-MON	Drug-induced ductopenia in the Spanish and LATINDILI registries	Fernando Bessone	Received

4371-MON	Sentinel Surveillance for Herbal and Dietary Supplement Induced Liver Injury in the United States: A pilot initiative in DILIN	Victor Navarro	Received

4372-MON	Association of GLP-1RA Use with Lower Sepsis and Urinary Tract Infection in Alcohol-Associated Liver Disease	Pojsakorn Danpanichkul	Received

4373-MON	Uncovering two clinical patterns of immune-related liver injury: metabolic dysfunction as a key risk factor for the persistent type	Sae Yumita	Received

4378-MON	Analysis of the Prospective Turkish Drug-Induced Liver Injury Registry	Ali Riza Caliskan	Received

4379-MON	The impact immune-mediated hepatotoxicity onset on long-term prognosis in patients with advanced cancer who received immune checkpoint inhibitors	Daniel Zaldumbide	Received

4381-MON	Immune checkpoint inhibitor hepatitis in patients with hepatocellular carcinoma: diagnostic complexity, shorter onset, and delayed biochemical recovery	Isaac Benque	Received

4384-MON	Expression of IL-8, IL-10, and CXCL-14 in Liver Tissues of Patients with Drug-Induced Liver Injury and Their Association with Pathological Features	diandian Hao	Received

4385-MON	Enabling DILI Surveillance through Automated Medication Extraction from Clinical Notes: A Real-World LLM Validation Study	Thanathip Suenghataiphorn	Received

4386-MON	Drug induced granulomatous hepatitis - a disproportionality analysis using the FDA Adverse Event Reporting System (FAERS) database	Rohan Karkra	Received

4387-MON	Liver Injury Due to Medications for Mental Health: An Analysis of the Drug-Induced Liver Injury Network Prospective Study	Hersh Shroff	Received

4389-MON	Liver Injury from the Death Cap Mushroom: The Philadelphia Experience and Role for Silibinin	Stefanie Gallagher	Received

4390-MON	Characterisation of liver injury induced by trastuzumab within the French-speaking network for the study of hepatotoxicity in health products (REFHEPS).	Bénédicte Delire	Received

4391-MON	The impact of Cyp2e1 deletion in mouse liver	Jessica Hartman	Received

4392-MON	Unraveling the Paradox: Clinical Outcomes in Primary Biliary Cholangitis with Hyperlipidemia - A Multinetwork Cohort Study	Tinsae Tsegaye Anebo	Received

4393-MON	Reduction in interleukin (IL)-31 with linerixibat is associated with pruritus response in patients with primary biliary cholangitis (PBC) and cholestatic pruritus in the Phase 3 GLISTEN study	Christopher Bowlus	Received

4394-MON	Tofacitinib as a Steroid-free Induction therapy in Autoimmune Hepatitis: An initial experience	Sarthak Saxena	Received

4395-MON	Long-Term Bone Health in Obeticholic Acid-Treated Patients With Primary Biliary Cholangitis: A POISE Post Hoc Analysis	Kimberly Brown	Received

4396-MON	Safety and activity of nebokitug over 48 weeks in patients with primary sclerosing cholangitis: Open-label extension results from the SPRING Study	Christopher Bowlus	Received

4397-MON	Treatment with elafibranor leads to stabilization of PRO-C3, a marker of fibrosis, in patients with primary biliary cholangitis	Jörn Schattenberg	Received

4398-MON	Validation of Prognostic Models in Hispanic Patients with Primary Biliary Cholangitis: Results from the ELLA-PBC Cohort	Paul Yoon	Received

4400-MON	Nebokitug Targets Macrophage-Mediated Mechanisms in Primary Sclerosing Cholangitis with Potential Impact on Disease Progression	Adi Mor	Received

4401-MON	Targeting CCL24 Restores MST1 expression: A Mechanistic Insight from the SPRING Trial	Adi Mor	Received

4402-MON	Establishing the safety profile of linerixibat for the treatment of cholestatic pruritus in primary biliary cholangitis: Pooled safety analysis of GLIMMER and GLISTEN studies	Gideon Hirschfield	Received

4404-MON	Factors Associated with Recompensation and Criteria for Aetiological Control in Patients with Primary Biliary Cholangitis	Li Shen	Received

4406-MON	Odevixibat Treatment in Patients with Alagille Syndrome: Characterization of Outcomes by Serum Bile Acid Levels After 24 Weeks of Treatment in an Integrated Analysis from ASSERT and ASSERT-EXT	Nadia Ovchinsky	Received

4408-MON	Therapeutic effect of PPAR agonists on pruritus and quality of life in PBC: A systematic review and meta-analysis of placebo-controlled trials	ADRIELLY MARTINS	Received

4409-MON	Clinical course of Autoimmune Hepatitis and Recompensation rates in Decompensated Cirrhosis	Anand Kulkarni	Received

4410-MON	Bruton´s Tyrosine Kinase Regulates Inflammation and Fibrosis in Primary Biliary Cholangitis	Prashanth Thevkar Nagesh	Received

4413-MON	Association between pretreatment GLOBE score and histological cirrhosis in primary biliary cholangitis	Manabu Hayashi	Received

4414-MON	Correlation Between Opioid Ligands and Response to Opioid Antagonist in Cholestatic Patients with Pruritus	Nir Barak	Received

4416-MON	Non-invasive assessment of clinically significant portal hypertension risk in patients with compensated advanced primary biliary cholangitis	Giulia Francesca Manfredi	Received

4417-MON	Autoimmune disease clustering in autoimmune hepatitis: Patterns in a large multi-center cohort	Kate Solpari	Received

4423-MON	Research Without Borders? A Critical Look at Geographic and Temporal Disparities in PSC Publications	Renan Prado	Received

4424-MON	The Role of Killer Immunoglobulin-like Receptor (KIR) Gene Variants in Autoimmune Hepatitis and Primary Biliary Cholangitis: Association with Disease Severity and Deep Remission	mete ucdal	Received

4425-MON	Clinical Practice Patterns in the Management of Primary Biliary Cholangitis in Community Settings	Robert Gish	Received

4426-MON	Analysis of Circulating Biomarkers in the Randomized, Double-Blind, Placebo-Controlled PORTOLA Phase 2a Study Evaluating Zetomipzomib, a Selective Immunoproteasome Inhibitor, in Patients with Autoimmune Hepatitis	Janet Anderl	Received

4427-MON	A Diagnosis With Lasting Impact: Current Sex- and Age-Specific Epidemiological Trends in Primary Biliary Cholangitis	Kristel Leung	Received

4432-MON	Serum IgM Levels as a Prognostic Indicator of Liver-related Events in Primary Biliary Cholangitis	Taiki Okumura	Received

4433-MON	Protocolled thiopurine metabolite monitoring leads to better quality care outcomes in patients with autoimmune hepatitis	Ed Reece Ansaar	Received

4436-MON	A quantitative systems pharmacology (QSP) model to interrogate the underlying mechanisms of cholestatic pruritus (itch) in primary biliary cholangitis (PBC) and the impact of linerixibat treatment	Brandon Swift	Received

4439-MON	Real-World Adherence to Primary Biliary Cholangitis Care Guidelines: A U.S. Single-Center Cohort Study	Ana Marenco-Flores	Received

4440-MON	TREATMENT OUTCOMES AND UNDERUTILIZATION OF SECOND-LINE THERAPIES FOR PRIMARY BILIARY CHOLANGITIS IN LATIN AMERICA: A CALL TO BRIDGE THE GAP	Claudia Couto	Received

4441-MON	Primary Biliary Cholangitis: Analysis of Gender Differences in Disease Progression and Time to Hepatic Decompensation	Jade Pace	Received

4442-MON	Symptom Burden and Treatment Patterns in Primary Biliary Cholangitis: A Systematic Review and Meta-analysis	Hon Lam CHUNG	Received

4444-MON	EPIDEMIOLOGY OF PRIMARY BILIARY CHOLANGITIS IN LATIN AMERICA: INSIGHTS FROM THE ALLATIN COHORT	Claudia Couto	Received

4445-MON	Characterization of Prodromal Events Preceding the Diagnosis of Pediatric Autoimmune Hepatitis- A Retrospective Study	Forum Patel	Received

4446-MON	Bisphosphonate Treatment is Not Associated with Decreased Fracture Risk in Primary Biliary Cholangitis patients with Osteoporosis	Leandro Sierra	Received

4448-MON	Increased Fracture Burden in Primary Biliary Cholangitis compared to Post-menopausal Controls: a Retrospective Multicenter Study	Leandro Sierra	Received

4449-MON	Anti-IL-23p19 Autoantibody: A High-Sensitivity Diagnostic Biomarker for Antimitochondrial antibody-Negative Primary Biliary Cholangitis	Jia Zhou	Received

4450-MON	The PSC-DM: development and validation of a clinical diagnostic model to aid the diagnosis of primary vs. secondary sclerosing cholangitis in clinical practice	Miki Scaravaglio	Received

4451-MON	Machine Learning Predicts Response to Obeticholic Acid Therapy and Identifies Prognostic Pathways linked with Primary Biliary Cholangitis	Hussain Syed	Received

4452-MON	Treating itch in primary biliary cholangitis - what is a clinically meaningful change in the Worst Itch Numerical Rating Scale?	Brooke Currie	Received

4453-MON	Clinical and Pathological Characteristics of Acute-Onset and Chronic Autoimmune Hepatitis and the Significance of anti-PD-1 Autoantibodies	Takashi Oda	Received

4454-MON	The Limits of Anti-Mitochondrial Antibodies as a Diagnostic Tool for Primary Biliary Cholangitis: A Thirteen-Year Experience in a Large Healthcare System	Ananya Majumdar	Received

4455-MON	Decreased levels of alkaline phosphatase during bezafibrate therapy in primary biliary cholangitis are associated with better clinical outcome	Maria van Hooff	Received

4456-MON	Women with Autoimmune Hepatitis on Azathioprine have Similar Obstetric Outcomes Compared to those Not on Azathioprine: A Global Retrospective Cohort Study	Mikaela Nikkola Jara-Tantoco	Received

4458-MON	Mechanistic Insights into the Protective Effects of Faecalibacterium prausnitzii and Its Metabolite Short Chain Fatty Acids on Biliary Injury in Primary Biliary Cholangitis	Qi Wang	Received

4460-MON	Long-Term Safety of Combination Obeticholic Acid and Bezafibrate in Patients With Primary Biliary Cholangitis: Interim Data From Two Phase 2 Trials	Cynthia Levy	Received

4461-MON	Changes in fatigue and pruritus in patients with primary biliary cholangitis treated with elafibranor are largely independent from improvements in serum biomarkers	Andreas Kremer	Received

4462-MON	Therapeutic Silencing of an Undisclosed Target with a GalNAc siRNA Reverses Liver Injury and Fibrosis in a Humanized Mouse Model of Cholestatic Liver Disease	Walter Hunziker	Received

4463-MON	Anticholestatic Effects of Obeticholic Acid and Bezafibrate in Combination Compared With Elafibranor and Seladelpar in a Human Hepatocyte Model of Cholestasis	Sanjay Kansra	Received

4464-MON	Serum Anti-Integrin αvβ6 Autoantibodies as Non-Invasive Biomarkers for the Diagnosis of Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis	George Papatheodoridis	Received

4465-MON	Single-Cell Resolution Spatial Transcriptomic Atlas Reveals Distinct Pathogenic Landscapes in Autoimmune Hepatitis and AIH-PBC Overlap Syndrome	Ming-Qin Lu	Received

4467-MON	The Predictive Role of Smoking in Achieving Biochemical Remission in Autoimmune Hepatitis: A U.S.Single Center Study	Natalia Rojas-Amaris	Received

4469-MON	Distinct Prognostic Patterns of the Hepatic Transaminases in Primary Biliary Cholangitis: AST is the Stronger Predictor of Outcome	Gemma Weijsters	Received

4474-MON	Predictors of Response to Rituximab in Refractory Autoimmune Hepatitis and Variant Syndromes	Juliette Labelle	Received

4475-MON	Temporal trends in the epidemiology of primary biliary cholangitis in the public healthcare system of Brazil: preliminary data from a large population-based study	Guilherme Cancado	Received

4476-MON	Identifying Gaps in PSC Patient Education and Understanding of Cholangiocarcinoma Screening and Surveillance Practices: Results of a Multinational Patient Survey	Brian Thorsen	Received

4478-MON	Comparative effectiveness of peroxisome proliferator-activated receptor agonists as second-line therapies for Primary Biliary Cholangitis: A systematic review and network meta-analysis	ADRIELLY MARTINS	Received

4479-MON	´This is not normal´: Understanding cognitive impairment through qualitative interviews with adults with PSC to inform measure development	Donna Evon	Received

4481-MON	The impact of the MELD exception point policy change on application approval and waitlist outcomes for patients with primary sclerosing cholangitis	Isaac Benque	Received

4482-MON	Epidemiology, Treatment Response, and Genetic Characteristics of Autoimmune Liver Diseases: A Retrospective and Prospective Cohort Study	Young Chang	Received

4483-MON	Clinical Characteristics, Treatment Patterns, and Outcomes Among Autoimmune Hepatitis Patients with Later Hospitalizations	Chandni Kapoor	Received

4484-MON	Heterogeneity in liver fibro-inflammation assessed by MRI is associated with active disease in patients with autoimmune hepatitis	Maciej Janik	Received

4485-MON	Systemic metabolic remodeling and abnormal mitochondrial signaling in primary biliary cholangitis	Hussain Syed	Received

4487-MON	Characterization of young adults with autoimmune hepatitis and features of primary sclerosing cholangitis using multiparametric MRI	Maciej Janik	Received

4488-MON	Corticosteroid Use and Metabolic Complications in Autoimmune Hepatitis: Insights from a Multinational Patient Survey	Libby Bell	Received

4489-MON	Predictors of Death in Patients with Sarcoidosis and Elevated Liver Enzymes.	Neil Garg	Received

4491-MON	Oral Vancomycin in Adolescents and Adults with PSC-IBD: A Single-Center Study Demonstrating Safety and Clinical Benefit	Judah Kupferman	Received

4493-MON	6-Mercaptopurine and Mycophenolate Mofetil in Patients with Autoimmune Hepatitis and Azathioprine Intolerance: A Comparative Multicenter Retrospective Study	Ludwig Jesse Horst	Received

4495-MON	NK Cell Plasticity in Autoimmune Hepatitis: Acquisition of Gamma-Delta-Like Traits	Kiandokht Bashiri	Received

4496-MON	Autoimmune Hepatitis Patients with Variable Levels of Biochemical Response have Distinct Differences in Proteomic Profiles	Craig Lammert	Received

4497-MON	The Percentage Change of Alkaline Phosphatase Can Be Used to Evaluate Response to Ursodeoxycholic Acid but Not Prognosis in Patients With Primary Biliary Cholangitis	Ellen Werner	Received

4498-MON	The Short- and Long-Term Course of the Cholestatic Biochemical Parameters in Patients With Primary Biliary Cholangitis treated With Ursodeoxycholic Acid	Ellen Werner	Received

4499-MON	Achieving biochemical response in autoimmune hepatitis: A comparative study between Korean and American cohorts	Kwang Il Seo	Received

4501-MON	Hepatitis B-Derived P-I-R Classification Is Applicable to Antibody-Positive PBC: Evidence from Repeat Liver Biopsies	Hongli Liu	Received

4502-MON	A Novel BLyS/APRIL Dual Inhibitor in Treating refractory Autoimmune Hepatitis: a case series	Xiao Xiao	Received

4503-MON	Clinical epidemiology of autoimmune hepatitis in Latin America: data from the ALLATIN cohort	Guilherme Cancado	Received

4504-MON	BOLD and BOLD-EXT, the First Global Phase III Clinical Program to Evaluate the Long-Term Efficacy and Safety of Odevixibat in Infants with Biliary Atresia After Kasai Hepatoportoenterostomy - Study Design and Current Status	Ryan Fischer	Received

4506-MON	Characterization of a Cohort of Patients with Alagille Syndrome (ALGS) from two US Health Systems Identified Leveraging Natural Language Processing (NLP)	Seema Meloni	Received

4508-MON	Rate of liver events and related complications in a prevalent primary biliary cholangitis population: A US claims database analysis	Kaitlin Hagan	Received

4514-MON	Higher Cirrhosis Burden Among Minority Patients with Primary Biliary Cholangitis: A Health Disparities Study	Jade Pace	Received

4515-MON	Associations Between Patient-Reported Outcomes and Objective Disease Parameters in Primary Biliary Cholangitis: A United States Single-Center Study	Ana Marenco-Flores	Received

4516-MON	Autoimmune-related cirrhosis is associated with an initial lower risk of decompensation and healthcare utilization: A population-based analysis.	Raj Vuppalanchi	Received

4517-MON	Association Between Insomnia and Disease Severity in Primary Biliary Cholangitis: A Propensity-Matched Cohort Study	Sameer Rao	Received

4518-MON	Statins are safe and beneficial in patients with primary biliary cholangitis (PBC)	Mark Pedersen	Received

4519-MON	Fibrosis in Fast-Forward: MASLD Drives Fibrosis in PSC Without Affecting Mortality	Sushrut Ingawale	Received

4521-MON	Incidence, Causes and Patterns of Elevated Liver Enzymes after Heart or Lung Transplant for Sarcoidosis	Neil Garg	Received

4522-MON	The efficacy of elafibranor is not affected by body mass index in patients with primary biliary cholangitis	Andreas Kremer	Received

4523-MON	Symptom Profiles among Adults with Primary Sclerosing Cholangitis (PSC) Identifies Low, Moderate and High Burdened Groups	Donna Evon	Received

4525-MON	Assesing outcomes in Autoimmune Hepatitis presenting as Acute on Chronic Liver failure , with and without extrahepatic organ dsfunction.	Souveek Mitra	Received

4526-MON	Efficacy and Clinical Outcomes with Odevixibat in Patients with MDR3 Deficiency: Results from the PEDFIC 2 Phase III, Open-Label Extension Study	Tassos Grammatikopolous	Received

4527-MON	Longitudinal description of liver biochemistry among patients with primary biliary cholangitis in the United States	Kaitlin Hagan	Received

4528-MON	Estimating the Prevalence of Primary Biliary Cholangitis Among a National Cohort of Veterans in the United States	Robert Wong	Received

4529-MON	2nd line therapy for Primary biliary cholangitis (PBC) is underutilized in patients with suboptimal response to ursodeoxycholic acid (UDCA) and advanced fibrosis	Nancy Reau	Received

4530-MON	EPIDEMIOLOGY OF PRIMARY SCLEROSING CHOLANGITIS: INSIGHTS FROM ALLATIN COHORT	Guilherme Cancado	Received

4531-MON	Prevalence and Outcomes of Extrahepatic Autoimmune Diseases in U.S. Patients with Primary Biliary Cholangitis: A Real-World EHR Study	Romelia Barba	Received

4533-MON	Bile acid-mediated tissue factor activation in hepatocytes	Alex Nartey	Received

4536-MON	Creating Diagnostic Algorithms to Improve Identification of Primary Biliary Cholangitis	Alexander Zhao	Received

4537-MON	Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease on Hepatocellular Carcinoma Risk in Autoimmune Hepatitis	JIHYE LIM	Received

4538-MON	Altered three dimensional (3D) intrahepatic biliary structures visualized using tissue clearing methods in human hepatobiliary disease	Motoko Sasaki	Received

4539-MON	Antimicrobial Therapy in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Real-World Evidence Reveals Clinical Risks Despite Alkaline Phosphatase Improvement	Himaben Gohil	Received

4540-MON	´It´s more like a dull, achy pain that´s just constant´: Liver pain experiences in adults with primary sclerosing cholangitis (PSC) to inform measure development	Donna Evon	Received

4541-MON	Pathogenic molecules in Autoimmune Liver Disease (AILD) and its correlation with disease activity and severity	Sunil Taneja	Received

4542-MON	Assessing the Relationship Between Immunosuppressant Medications and COVID-19 Presence and Severity in an Autoimmune Hepatitis Cohort	Krish Rai	Received

4543-MON	Characterization of a Cohort of Patients with Later-Onset Progressive Familial Intrahepatic Cholestasis (PFIC) from two US Health Systems Identified Leveraging Natural Language Processing (NLP)	Seema Meloni	Received

4546-MON	T Cell Immune Dysregulation in Progressive Liver Disease: A Potential Contributor to Cirrhosis-Associated Immune Dysfunction	Aenne Harberts	Received

4549-MON	Anti-MRPS27 Antibodies as a Novel Biomarker for Autoimmune Hepatitis identified via Comprehensive Human Protein Microarray Profiling	JUN WADA	Received

4550-MON	IFRD1 orchestrates hepatocyte metabolism and macrophage interactions to facilitate liver regeneration	Taofei Zeng	Received

4552-MON	Epstein-Barr Virus Status as a Predictor of Primary Sclerosing Cholangitis in inflammatory bowel disease	Mohamed Nadeem	Received

4553-MON	Time-resolved hepatic single-cell sequencing during liver fibrosis regression identifies distinct ´regressive´ macrophage sub-populations	Katharina Bonitz	Received

4556-MON	Kv1.3 Regulates Macrophage Immune Function through the PI3K/AKT Pathway to Alleviate Metabolic Dysfunction-Associated Steatohepatitis	BAOMING WU	Received

4559-MON	Donor-derived extracellular vesicles have immunological properties dependent on liver age and donor type	Heather Jennings	Received

4560-MON	Hepatic infarction, an infrequently encountered complication of HELLP syndrome: a case report.	Jill Bhavsar	Received

4561-MON	Injured liver-released miR-122 leads to erythrocyte phagocytosis via the activation of TLR7	Yingyun Gong	Received

4563-MON	Pathogenic role of P2X7 on liver ischemic reperfusion injury	Osamu Yoshida	Received

4566-MON	Micronutrient changes in a murine model of CCl4-induced chronic liver disease	Jeffrey Singer	Received

4567-MON	Macro-aspartate Aminotransferase in a patient with Metabolic Dysfunction-Associated Steatohepatitis	Helena Steffens	Received

4568-MON	New SubmissionPeripheral Lymphocytes in human liver hepatocellularcarcinoma: a new druggable target as well as biomarker to help diagnosis and predict immunotherapy response	Andrea Dalbeni	Received

4569-MON	High Salt Diet Exacerbates Liver Fibrosis and Modulates Immune Responses in Mouse Models.	Amalia Tzoumpa	Received

4570-MON	Targeting Monocyte TLR8 as an Anti-Inflammatory Therapy in Decompensated Advanced Chronic Liver Disease	Malgorzata Grzelka	Received

4571-MON	Impact of Pediatric Age Cutoffs on US Liver Transplant Allocation: A Regression Discontinuity Design	Tomohiro Tanaka	Received

4572-MON	Large-scale Proteomic Study Reveals Total Serum IgG as a Candidate Novel Diagnostic Biomarker in Gestational Alloimmune Liver Disease	Katie Rose Conover	Received

4573-MON	Early changes in the fecal microbiota are associated with pediatric metabolic dysfunction-associated steatotic liver disease	Sarah Maxwell	Received

4574-MON	Intestinal Alistipes putredinis alleviates metabolic dysfunction-associated steatotic liver disease by regulating secondary bile acid homeostasis	Yan Ni	Received

4575-MON	Clinical Presentation, Outcomes, and Management of BSEP Deficiency with Truncated Mutations: A Cohort Study of PFIC2 Patients at a High-Volume Pediatric Liver Transplant Center	Mohammad Shagrani	Received

4576-MON	CHARACTERISTICS AND OUTCOMES OF FONTAN ASSOCIATED LIVER DISEASE IN CHILDREN FROM A MULTICENTER - INITIAL ANALYSIS OF 8 CENTERS IN USA	Chaowapong Jarasvaraparn	Received

4578-MON	Ethical Challenges in Pediatric Liver Transplant Selection related to Patient and Caregiver Social Determinants of Health: A National Survey of Clinician Perspectives	Danielle Rabinowitz	Received

4581-MON	Multicenter Report of Excellent Outcomes Following Liver Transplant in Sickle Cell Disease in Children and Young Adults	Pamela Valentino	Received

4582-MON	Molecular subtypes related to glucose metabolism and lactic acid metabolism and their prognostic characteristics in hepatocellular carcinoma	Fengsheng Dai	Received

4583-MON	Restoration of Portal Circulation in Children with Congenital Portosystemic Shunts Results in Spontaneous Involution of Hepatic Masses	Riccardo Superina	Received

4584-MON	Rectus Femoris Muscle Quantity and Quality is Associated with Pediatric Liver-related Outcomes, including Liver Transplantation (LT) and Mortality	Christopher Chu	Received

4585-MON	Significant increase in donor-derived cell-free DNA levels in pediatric liver transplant recipients with rejection compared to normal liver histology	Catherine Chapin	Received

4586-MON	The Context-Dependent Role of Cellular Senescence in Biliary Atresia	Katie Rose Conover	Received

4589-MON	Protective effects of butyrate along the gut liver axis in a murine model of parenteral nutrition	Colin Shearn	Received

4591-MON	Antisense Oligonucleotide-Mediated upregulation of Jagged-1 expression Ameliorates Disease Phenotypes in an ALGS Mouse Model	Lingdi Zhang	Received

4592-MON	Surgical Correction of Extrahepatic Portal Vein Obstruction and Congenital Portosystemic Shunts Improves Neurocognitive Outcomes in Children Using the NIH Toolbox Cognition Battery and a Scale of Adaptive Functioning	Riccardo Superina	Received

4594-MON	Beneficial Effects of Parabacteroides goldsteinii and Its Metabolites on the Therapeutic Potential for Cholestatic Liver Disease	Huey-Ling Chen	Received

4595-MON	Long-Term Safety of Children Following Maternal TAF or TDF Use During Pregnancy for the Prevention of Mother-to-Child Transmission of HBV	Kai-Chi Chang	Received

4597-MON	Influence of MASLD Subtypes During Pregnancy on Adverse Neonatal Outcomes: Results from a Prospective Cohort of Over 1000 Maternal-Infant Pairs	Cecilia Katzenstein	Received

4598-MON	Cyp2c70-deficient mice exhibit age-dependent liver injury and unfolded protein response (UPR) activation	Ryan Shaw	Received

4599-MON	Variants in MDR3 and KIF12 Genes: Natural History of Cholangiopathies and Liver Transplantation; A single center experience	Mohammad Shagrani	Received

4600-MON	Slow progression of liver stiffness in Fontan-associated liver disease in children	Anna Mania	Received

4602-MON	Prevalence of successful treatment withdrawal in children´s with Autoimmune Hepatitis	Saurabh Singh	Received

4603-MON	Predicting response to Odevixibat treatment and comparison between classical types and rarer forms of children with PFIC	Angelo Di Giorgio	Received

4604-MON	Distinct gut microbiota and metabolomic signatures associated with the absence of hepatic steatosis in obese and overweight children	Kai-Chi Chang	Received

4606-MON	ODEVIXIBAT RAPIDLY REDUCES PRURITUS AND SERUM BILE ACIDS IN CHILDREN WITH BILIARY ATRESIA AND CHRONIC CHOLESTASIS FOLLOWING KASAI PORTOENTEROSTOMY	Emanuele Nicastro	Received

4608-MON	Title: Epidemiological Characteristics of Children with Wilson Disease: A Single-Center Experience from Brazil	Rafaella Karen Sousa Monterlei	Received

4609-MON	Epidemiological and genetic characteristics of children with Alagille syndrome: a single-centre experience from Brazil	Rafaella Karen Sousa Monterlei	Received

4610-MON	Clinical Outcomes of Liver Transplantation in Pediatric Maple Syrup Urine Disease And Domino Liver Recipients at King Faisal Specialist Hospital and Research Center- Saudi Arabia	Mohammad Shagrani	Received

4611-MON	Cholangiocyte regulates macrophage activation through fibronectin-integrin interaction	Wenqi Li	Received

4613-MON	Liver cell-specific unfolded protein response gene expression is lower in neonatal compared to adult mice	Alyssa Kriegermeier	Received

4614-MON	Lauric Acid mitigates ductular reaction, oxidative stress and hepatocyte senescence in a mouse model of inflammatory cholangiopathy	Swati Ghosh	Received

4615-MON	Activation of regulatory macrophages by LRH1 agonist DLPC mediates reversal of cholestatic injury in the primary sclerosing cholangitis mouse model.	Swati Ghosh	Received

4617-MON	Evaluating the Impact of Genetic Diagnosis in Pediatric Liver Transplantation: A Retrospective Cohort Study of 179 Children at a Single Center	Erika Minonne	Received

4619-MON	Spermidine modulates immune networks and reduces severity of liver injury in the mouse model of biliary atresia	Sarah Taylor	Received

4620-MON	Characterizing cognitive deficits and neuroinflammation in a Novel Mouse Model of Pediatric Type C Hepatic Encephalopathy	Sharon DeMorrow	Received

4621-MON	Epidemiological Profile of Children with PFIC Undergoing Liver Transplantation at a Referral Center in Southeastern Brazil	Rafaella Karen Sousa Monterlei	Received

4623-MON	Role of Liver Transplantation in Managing Pediatric Organic Acidemias: A Single-Center Experience	Mohammad Shagrani	Received

4626-MON	Characterization of the Use of Anti-Thymocyte Globulin (Rabbit) for Allograft Rejection in Pediatric Liver Transplant Recipients: A Single Center Experience	Krupa Mysore	Received

4627-MON	The Farnesoid X receptor regulates circadian transcription factor expression along the gut-liver axis during Parenteral Nutrion	Colin Shearn	Received

4628-MON	Effect of General Anesthesia on Liver and Spleen Stiffness Measurements for Predicting High-Risk Varices in Children with Biliary Atresia	Shinya Yokoyama	Received

4629-MON	Elevated Bile Acids Decline After Surgical Ligation of Extrahepatic Congenital Portosystemic Shunt	Lisa Keys	Received

4630-MON	Hepatic Parenchymal Response to Interferon gamma in Mouse model of Familial Hemophagocytic Lymphohistiocytosis	Tamir Diamond	Received

4631-MON	Real-World Experience with pangenotypic Glecaprevir/Pibrentasvir Therapy for Chronic Hepatitis C in Children	Dorota Zarebska-Michaluk	Received

4633-MON	Efficacy of customized steroid based protocol in Post Kasai- Biliary Atresia	Anmol Anmol	Received

4634-MON	Impact of concurrent extrahepatic autoimmune disorders on outcome of pediatric autoimmune liver disease	Anmol Anmol	Received

4635-MON	Outcomes in children with Biliary Atresia post liver transplant at a High Volume paediatric liver transplant centre	Mohammad Shagrani	Received

4637-MON	Clinical phenotype and outcomes of ABCB4 (MDR3) variants in children: Results from a National Multicentre Registry	Bikrant Biharilal Raghuvanshi	Received

4639-MON	CardioMEMS pulmonary artery pressure measurements are associated with congestive hepatopathy imaging findings	Chelsea Pan	Received

4640-MON	Rates of Portal Venous Thrombosis in Cirrhotics With or Without Clotting Disorders: A 7-Year Nationwide Study	Ana Rivera	Received

4642-MON	Clinical Features and Risk Factors of Porto-Sinusoidal Vascular Disease with Chronic Gamma-Glutamyl Transferase Elevation	Weihua Cao	Received

4643-MON	Porto-sinusoidal vascular disorder: natural history and long-term outcome	Elisa Farina	Received

4644-MON	UDCA does not improve liver enzymes in patients with obliterative portal venopathy - an observational cohort comparison study	Ahmed Elhawary	Received

4646-MON	Body adiposity as a risk factor for portal vein thrombosis in patients with cirrhosis	Isabel Campos-Varela	Received

4647-MON	Investigating the Molecular Underpinnings and Pathobiology of Nodular Regenerative Hyperplasia of the Liver	Anne Mentzinger	Received

4648-MON	Dual cholate shunt test identifies patients at risk for portal hypertension and worsening hemodynamics in two cohorts with Fontan-associated liver disease	Maarouf Hoteit	Received

4650-MON	´Abernethy Syndrome: Case series of 8 patients´	Rafaella Karen Sousa Monterlei	Received

4652-MON	Thromboelastography-guided transfusions are safe and must be incorporated in clinical practice routinely for patients with cirrhosis undergoing neurosurgical interventions.	Rachana Domudala	Received

4653-MON	Flow Cytometry-Based Isolation of Platelet-Derived Microparticles from Plasma and Their Functional Interaction with Liver Endothelial and Stellate Cells	Nima Fattahi	Received

4654-MON	Utility of liver stiffness measurement as an early predictor of treatment response in Budd-Chiari Syndrome	Akash Shukla	Received

4655-MON	Elevated ALT is more predictive of adverse maternal outcomes than thrombocytopenia severity in HELLP syndrome: an analysis of over 40,000 patients	Kate Solpari	Received

4656-MON	ROTEM-defined Hypocoagulability Predicts Non-Portal Hypertensive Bleeding in Cirrhosis	Kymentie Ferdinande	Received

5021-SAT	SHORT-TERM HUMAN ALBUMIN THERAPY IMPROVES SERUM SODIUM CONCENTRATION AND REDUCES MORTALITY IN PATIENTS WITH CIRRHOSIS AND DILUTIONAL HYPONATREMIA	Adrià Juanola	Received

5029-SUN	Safety and HBsAg Reduction in Patients with Chronic Hepatitis B Treated by a Lentiviral Vector Therapeutic Vaccine (J-51): an Investigator-Initiated Pilot Trial	Jieyu Song	Received

5035-MON	HbA1c-independent benefits of semaglutide on liver histology and non-invasive tests in participants with biopsy-defined MASH: insights from post-hoc analysis of the ESSENCE trial part 1	Arun Sanyal	Received

5038-MON	A Real-World, Multicenter, Phase 4 Study to Evaluate the Safety and Efficacy of Saroglitazar 4 mg in Indian Patients with Non-Alcoholic Fatty Liver Disease and Associated Metabolic Comorbidities	Kevin Kansagra	Received

The Liver Meeting 2025

November 7-11, 2025

About us

Search and consult posters online
in an exclusive section
for each poster

ACTIVE FROM 15/11/2042 TO 15/11/2042

Poster
Gallery

Upload
Poster

Featured Poster

Vote poster

Poster Discussion
Forum



		Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.

About us

Terms and Conditions

Special Access

Commercial Web Access